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Abstract 
The technological advances in proteomics are allowing an increasingly detailed 
characterization of the complex panorama of post-translational modifications of proteins and 
are gradually developing towards an unbiased analysis of peptide modifications. The recently 
developed ultra-tolerant database search (open search, “OS”) uses precursor mass tolerances 
of hundreds of Daltons, allowing the identification of modified peptides never identified before 
by conventional (closed, “CS”) searches. Despite these improvements, OS algorithms still rely 
on the chance that the modification leaves enough unaffected fragment ions, thus identifies 
only half of the modified peptides and cannot pinpoint the modification site. Furthermore, there 
is a need of a generic quantification algorithm able to handle the huge variety of modified 
peptides resulting from an OS experiment.  
In this Thesis, I present a suit of developed algorithms and tools, designed to overcome the 
above-mentioned limitations. Comet-PTM is an improved search engine that applies the 
peptide modification mass to the fragmentation series upon score calculations for each peptide-
spectrum match (PSM). As a result, we emulate the scores produced by a CS for the same 
modification set as variable; double the yield attained by a regular OS and localize the modified 
residue with high accuracy. SHIFTS, controls the PSM false-discovery rate of the CometPTM 
results through a conservative three-layered approach taking into account the high mass 
accuracy of modern mass spectrometers.  
PtmSticker annotates the enormous wealth of modifications in a semi-supervised way, allowing 
for the first time the generation of a complete map of the modified peptidome as part of an 
automated pipeline. For the quantitative analysis of modified peptides, we developed and 
validated an algorithm based on a previously proposed WSPP workflow, for the simultaneous 
quantification of the modified peptidome, the whole proteome and systems biology. The model 
allows detection of PTMs changing independently of the protein abundance change.  
These developments were used to characterize the impact of mitochondrial heteroplasmy on 
the proteome and on the modified peptidome in mice, revealing that the heteroplasmy causes 
oxidative damage in heart OXPHOS proteins.  
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Resumen 
Los avances tecnológicos en proteómica permiten una caracterización cada vez más detallada 
del complejo panorama de las modificaciones postraduccionales de proteínas y están derivando 
hacia un análisis no sesgado de las mismas. Los recientes algoritmos de búsquedas ultra-
tolerantes en bases de datos, denominados búsquedas “abiertas, emplean tolerancias de cientos 
de Dalton alrededor del precursor y permiten la identificación de péptidos modificados que 
nunca antes se habían identificado en búsquedas convencionales. A pesar de estos indudables 
beneficios, para identificar un péptido modificado, las búsquedas abiertas siguen necesitando 
que la modificación deje suficientes fragmentos no-modificados. Por esta razón, sólo se 
identifica la mitad de los péptidos modificados en comparación con una búsqueda 
convencional, y no se llega a identificar el sitio de la modificación. Además, hasta la fecha no 
existe ningún modelo estadístico apropiado para la cuantificación de la enorme variedad de 
péptidos modificados que resulta de una búsqueda abierta. En esta tesis se presenta un conjunto 
de algoritmos y herramientas informáticas que resuelven todas estas limitaciones, llevando las 
búsquedas abiertas a un nivel superior de desarrollo. El Comet-PTM es un buscador en bases 
de datos capaz de tener en cuenta la masa de la modificación para aplicarla a los fragmentos a 
la hora de calcular la puntuación del par espectro-péptido (PSM). Como resultado, se logra 
emular la puntuación que se obtendría en una búsqueda convencional con esa misma 
modificación definida como variable. Además, se duplica rendimiento de PSMs de la búsqueda 
abierta y se localiza el sitio de la modificación. SHIFTS es una herramienta para controlar la 
Tasa de Falsos Descubrimientos, FDR (False Discovery Rate) de los resultados del Comet-
PTM, mediante una aproximación conservativa de 3 capas que tiene en cuenta la alta exactitud 
de masa que caracteriza a los equipos de espectrometría modernos. El PtmSticker anota las 
modificaciones de forma semi-supervisada, permitiendo por primera vez obtener un mapa 
completo del peptidoma modificado como parte de un flujo de trabajo automático. Sobre la 
base de un modelo estadístico existente en nuestro laboratorio, el WSPP, hemos desarrollado 
y validado un algoritmo para la cuantificación del “peptidoma modificado” de forma 
simultánea con el proteoma y el análisis de biología de sistemas. Finalmente, la plataforma 
Comet-PTM desarrollada en esta tesis ha sido aplicada al estudio del impacto de la 
heteroplasmia mitocondrial sobre el peptidoma modificado en diferentes tejidos de ratón. 
Nuestro estudio ha revelado que la heteroplasmia produce un daño oxidativo a las proteínas de 
la cadena de transporte mitocondrial fundamentalmente en el corazón.  
PhD Dissertation - Resumen Navratan Bagwan
xv 
 
Table of Content 
 
ACKNOWLEDGEMENT ............................................................................................... VII 
ABSTRACT ............................................................................................................................... XI 
RESUMEN ............................................................................................................................... XIII 
TABLE OF CONTENT .................................................................................................... XV 
ABBREVIATION ................................................................................................................ XIX 
INTRODUCTION ..................................................................................................................... 1 
1. WHAT ARE POST-TRANSLATIONAL MODIFICATION (PTMS) OF PROTEINS? ................................ 1 
2. IMPORTANCE OF PTMS IN BIOLOGICAL SYSTEMS ....................................................................... 2 
3. SECOND GENERATION (SHOTGUN) MS BASED PROTEOMICS ...................................................... 3 
3.1. CONVENTIONAL DATABASE SEARCH APPROACH FOR PEPTIDE IDENTIFICATION .................................. 4 
3.1.1. IDENTIFICATION QUALITY SCORES ............................................................................................ 6 
3.2. PTM IDENTIFICATION: LIMITATIONS OF CONVENTIONAL SEARCH ENGINES ....................................... 6 
3.3. UNWANTED SOURCES OF PEPTIDE MODIFICATION ........................................................................... 7 
3.4. HYPOTHESIS-FREE MODIFIED PEPTIDES IDENTIFICATION AND THE DARK MATTER .............................. 8 
4. IDENTIFICATION CONFIDENCE ..................................................................................................... 9 
4.1. TARGET/DECOY APPROACH ......................................................................................................... 9 
4.2. CONCERNS IN PTM FDR ........................................................................................................... 10 
5. QUANTIFICATION OF PEPTIDES AND PROTEINS ......................................................................... 11 
5.1. PTM QUANTIFICATION .............................................................................................................. 13 
OBJECTIVES ............................................................................................................................ 15 
MATERIAL AND METHODS ..................................................................................... 17 
PhD Dissertation - Table of contents Navratan Bagwan
xvi 
 
1. MOUSE MODEL OF HETEROPLASMY .......................................................................................... 17 
2. GENERATION OF HETEROPLASMY MICE .................................................................................... 17 
3. MICE BREEDING ........................................................................................................................ 17 
4. BENCHMARKING MASS SPECTROMETRY DATASET ................................................................... 18 
5. PREPARATION OF PROTEIN EXTRACTS ...................................................................................... 18 
6. PROTEIN DIGESTION, PEPTIDE LABELLING AND FRACTIONATION ............................................. 18 
7. LC-MS ANALYSIS ..................................................................................................................... 18 
8. DATABASE SEARCH ................................................................................................................... 19 
RESULTS ..................................................................................................................................... 21 
1. DEVELOPMENT OF NOVEL BIOINFORMATICS TOOLS ................................................................. 21 
1.1. COMET-PTM ........................................................................................................................... 21 
1.2. SYSTEMATIC HYPOTHESIS-FREE IDENTIFICATION OF MODIFICATIONS WITH CONTROLLED FDR BASED 
ON ULTRA-TOLERANT DATABASE SEARCH (SHIFTS) ............................................................................... 23 
1.2.1. MASS RECALIBRATION .......................................................................................................... 23 
1.2.2. PEAK IDENTIFICATION ........................................................................................................... 23 
1.2.3. PEAK ASSIGNATION .............................................................................................................. 23 
1.2.4. FDR CALCULATION .............................................................................................................. 25 
1.2.5. ISOTOPIC CORRECTION ...................................................................................................... 25 
1.3. PTMSTICKER: CONNECTING DOTS AND TRANSLATING NUMBERS TO MEANING ................................. 26 
1.4. PTM QUANTIFICATION AS COMPLEMENT TO WSPP MODEL ........................................................... 27 
2. BENCHMARKING OF ALGORITHMS AND TOOLS ......................................................................... 30 
2.1. COMET-PTM ENABLES COMPREHENSIVE IDENTIFICATION OF PEPTIDE MODIFICATION ...................... 30 
2.2. COMET-PTM DETECTS THE LOCATION OF MODIFICATIONS IN THE PEPTIDE SEQUENCE...................... 33 
2.3. A SINGLE INTEGRATED STATISTICAL FRAMEWORK ALLOWS QUANTIFICATION OF THE PROTEOME AND 
OF THE MODIFIED PEPTIDOME................................................................................................................. 36 
PhD Dissertation - Table of contents Navratan Bagwan
xvii 
 
3. APPLICATION OF DEVELOPED TOOLS ........................................................................................ 38 
3.1. HETEROPLASMY PRODUCES PROTEIN ALTERATIONS CONSISTENT WITH A MITOCHONDRIAL 
DYSFUNCTION IN THE HEART ................................................................................................................. 38 
3.2. HETEROPLASMY MAINLY PRODUCES OXIDATIVE MODIFICATIONS OF OXPHOS PROTEINS IN HEART ... 40 
DISCUSSION ............................................................................................................................ 49 
1. HYPOTHESIS- DRIVEN PROTEOMICS: IT’S ABOUT TIME WE MOVE FORWARD ............................ 49 
2. HYPOTHESIS-FREE PROTEOMICS: A POTENTIAL REPLACEMENT OF CONVENTIONAL DATABASE 
SEARCH APPROACHES ........................................................................................................................ 50 
3. HYPOTHESIS-FREE PTM ANALYSIS: FROM ALGORITHM DEVELOPMENT TO APPLICATION ....... 53 
4. FUTURE PERSPECTIVE ............................................................................................................... 55 
4.1. DECODING THE MASS COMBINATIONS AND AIM FOR A FASTER SEARCH TIME ................................. 55 
4.2. RE-RANKING OF PSMS: XCORR TO CORRECTED XCORR ................................................................ 56 
4.3. REDISCOVERING THE PLASMA PROTEOME: A SEARCH FOR BIOMARKER BEYOND PROTEINS ................ 56 
CONCLUSIONS ...................................................................................................................... 59 
REFERENCES .......................................................................................................................... 61 
APPENDICES ........................................................................................................................... 79 
1. APPENDIX 1: SUPPLEMENTARY TABLES .................................................................................... 79 
1.1. TABLE 1: BENCHMARKING OF COMET-PTM USING SYNTHETIC PHOSPHO-PEPTIDE .......................... 79 
1.2. TABLE 2: LIST OF FUNCTIONAL CATEGORIES SIGNIFICANTLY ALTERED BY HETEROPLASMY (FDR < 5%) 
AS A CONSEQUENCE OF A COORDINATED PROTEIN RESPONSE ..................................................................... 79 
1.3. TABLE 3: LIST OF MODIFIED PEPTIDES SIGNIFICANTLY ALTERED BY HETEROPLASMY (P < 0.05) ......... 79 
1.4. TABLE 4: CONSERVATION AND STRUCTURAL ANALYSIS OF HETEROPLASMY-MODIFIED PEPTIDES OF 
OXPHOS COMPLEXES I, III, IV, AND V .................................................................................................. 80 
2. APPENDIX 2: HELP FOR THE PROGRAMS DEVELOPED ............................................................... 80 
2.1. COMET-PTM ........................................................................................................................... 80 
PhD Dissertation - Table of contents Navratan Bagwan
xviii 
 
2.2. SHIFTS .................................................................................................................................. 82 
2.3. PTM-QUANT-STATS ................................................................................................................. 84 
2.3.1. TRILOGY ............................................................................................................................. 88 
2.4. PTMSTICKER ............................................................................................................................ 89 
3. PUBLICATION RELATED TO PHD WORK .................................................................................... 90 
3.1. COMPREHENSIVE QUANTIFICATION OF THE MODIFIED PROTEOME REVELS OXIDATIVE HEART 
DAMAGE IN MITOCHONDRIAL HETEROPLASMY ....................................................................................... 90 
3.2. PROTEOMIC FOOTPRINT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY: LONGITUDINAL STUDY OF 
THE AT-RISK AND REMOTE REGIONS IN THE PIG MODEL .............................................................................. 109 
4. OTHER PAPER PUBLISHED DURING PHD .................................................................................. 126 
4.2. SOFTWARE-AIDED QUALITY CONTROL OF PARALLEL REACTION MONITORING BASED QUANTITATION OF 
LIPID MEDIATORS ............................................................................................................................... 126 
 
 
 
 
 
 
 
 
 
 
 
PhD Dissertation - Table of contents Navratan Bagwan
xix 
 
Abbreviations 
 
term description 
AGE Advacance Glycation Products 
ANNOVA Analysis of Variances 
CS Close Search 
CVD Cardiovascular disease 
ESI Electrspray ionization 
FASP Filter Aided Sample Prepration 
FDR False Discovery Rate 
GIA Generic Integration Algorithm 
HILIC Hydrophilic Interaction Chromatography 
HPLC High Performance Liquid Chromatography  
IAM Iodoacetamide 
iTRAQ isobaric Tags for Relative and Absolute Quantitation 
m/z Mass-to-charge 
MAD Mean Absolute Deviation 
MS Mass Spectrometery 
MS/MS  tandem mass spectrometry 
MS1 survey scan (or full scan)  
MS2 fragmentation spectrum 
OS Open Search 
OXPHOS Oxidative Phosphorylation System 
PPM Parts Per Million 
PSM Peptide Spectrum Match 
PTM Post Translational Modfication 
SBT Systems Biology Triangle 
SIL Stable Isotop labelling 
TMT Tandem Mass Tags 
WSPP  Weighted Spectrum, Peptide, Protein [statistical model] 
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 Introduction 
1. What are post-translational modification (PTMs) of proteins? 
Proteins are fundamental biomolecules or macromolecules of the cell that carry out and 
regulate major biological functions. More importantly, they help to maintain the 
structure/shape of the cell and work as signal transmitters between inner and extra cellular 
environment. PTMs of proteins can be defined as in vivo biochemical mechanism in which the 
amino acid residues are covalently modified after protein translation (Prabakaran et al., 2012).  
PTMs can take place at different amino acids and the process is often driven by an enzymatic 
activity/reaction. In fact around 5% of the proteome is known to have enzymes that can result 
in hundreds of PTMs, and many of these PTMs are found to be linked with human disease-
associated mutations (Duan and Walther, 2015). Studies of PTMs ranging from yeast to human 
represents how important they are and known to control or modulate the functional activity of 
proteins (Mann and Jensen, 2003; Oliveira and Sauer, 2012). For instance, approx. half of the 
proteins in Saccharomyces cerevisiae are known to be affected by phosphorylation in a 
metabolic network (Chi et al., 2007). On the other hand, in humans, abnormal phosphorylation 
has been studied in many diseases, such as cancer and Alzheimer (Khadjavi et al., 2011).  
Unlike the changes in gene sequence which occurs on an evolutionary time scale and is not 
required for instant physiological change or development, PTMs permit amino acid properties 
to be changed “on the fly” if needed for specific response such as the continual battle against 
the disease (Prabakaran et al., 2012).  
PTMs on the different amino acid side chains or at protein C- or N- terminal can extend 
chemical arrangement up to 20 amino acids by modifying or adding different functional groups 
such as phosphate. The most studied functional groups added-on to amino acids are oxidation, 
acetylation, phosphorylation and ubiquitination. In many cases, multiple amino acids are 
modified by multiple PTMs, which leads to a combinatorial explosion of possible molecular 
and chemical states. Possible combinations of such PTMs are often the epicentre of 
sophisticated forms of cellular information processing that are essential for the emergence of 
organismal complexity. 
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 2. Importance of PTMs in biological systems 
The current advances in the field of systems biology and proteomics, has opened a new era of 
research where much of the focus has been on PTMs. In recent years the number of published 
papers has been increasing drastically (Figure 1).(Olsen and Mann, 2013).  
 
Figure 1: Bar plot, representing the number of papers published related to PTMs (PUBMED, keyword; “Post 
Translational Modification”) in the last three decades. 
The growing need to understand and predict the molecular cause of disease remain as a major 
bottleneck of current medicinal biology. However, taking into account the importance of 
PTMs, a continuous interest is developing towards computational analysis of disease associated 
amino acids modification. To this end, various studies have successfully demonstrated the role 
of PTMs in different diseases such as cardiovascular disease (CVD), aging, mitochondrial 
dysfunction and Alzheimer. 
CVD is one of the leading causes of mortality and morbidity all around the world (Roth et al., 
2015). There has been a great emphasis on PTM (Carbamylation, Glycation and Oxidation, 
phosphorylation) research as they are involved in pathogenesis of CVD (Santos and Lindner, 
2017) and eventually lead to progression of other forms of chronic disease such kidney disease 
(Sadayappan et al., 2009; Gupta and Robbins, 2014; Gajjala et al., 2015). 
In other studies,  acetylation has been linked to number of diseases, for example, in cancer 
where N-acetyl provides a unusual subcellular distribution of the tumour antigen (Chammas et 
al., 1999). In dementia, acetylation impairs synaptic plasticity (Mattson, 2010; Pirooznia and 
Elefant, 2013). Glycosylation is another well-studied PTM, which results from the addition of 
sugar to a protein. A class of glycosylation, O-linked glycosylation has been proven to have a 
positive effect on Alzheimer’s disease, as it reduces the neurofibrillary tangles in neurons 
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 (Broncel et al., 2010). Advanced Glycation End products (AGEs) are also targets in 
cardiovascular pathologies, and are commonly used a biomarkers, since AGEs have a key role 
in the progression of cardiovascular diseases in patients with diabetes (Hegab et al., 2012).  
Moreover, novel medical technologies aiming to prevent mitochondrial genetic diseases, to 
improve fertility, or to deliver foreign mitochondria with therapeutic goals, can produce 
mitochondrial heteroplasmy. Mitochondrial heteroplasmy is the presence of more than one 
variant of mtDNA in the same cytoplasm. In collaboration with the lab of José Antonio 
Enríquez Domínguez, efforts are made to facilitate a mechanistic model (mouse model), 
explaining the role of PTMs and understand why the heteroplasmy is harmful in tissues that do 
not resolve it. 
Without any doubt, enormous efforts are made to get a complete glimpse of PTMs in biological 
systems, but we are still far away from understanding and unravelling the combinatorial 
complexity of PTMs. Technologies such as mass spectrometry (MS) -based proteomics, are 
definitely increasing the quality of PTM identification and also allowing us to identify new 
modifications of proteins. With the constant increasing list of new modifications, the dynamics 
of protein function needs to be re-evaluated, as most studies concerning PTMs start with a prior 
knowledge or hypothesis, focusing only on a limited number of PTMs, hence neglecting the 
completeness of proteome. If the personalized medicine or protein-based biomarkers are the 
next big platform, it is important to develop tools and methods, which can identify all PTMs in 
a given biological system, thereby facilitating the complete study of the nexus between the 
proteome and PTMs. 
3. Second generation (Shotgun) MS based proteomics 
The term shotgun proteomics refers to the bottom-up proteomics approach where peptides from 
digested protein are identified using a combination of a high performance liquid 
chromatography (HPLC) and mass spectrometry. In a typical workflow (Figure 2), proteins are 
extracted and denatured either in urea or by high temperature incubation with sodium dodecyl 
sulphate (SDS). Disulfide bonds are reduced, for example with dithiothreitol (DTT), and 
alkylated, usually with iodoacetamide (IAM), to prevent protein renaturation. Afterwards, 
proteins are digested, typically with trypsin (Lina P. Aristoteli, Mark P. Molloy, † and Mark S. 
Baker*, †, 2006), and the resulting peptide mixtures are fractionated by different means, such 
as high pH reversed-phase or strong cation exchange chromatography (Junmin Peng et al., 
2002).  
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 Peptides are further separated by reversed-phase high-performance liquid chromatography 
(HPLC) on-line with MS. As peptides elute from the chromatographic column, they are ionized 
by electrospray ionization (ESI) and injected into the MS instrument. The mass-to-charge (m/z) 
ratios of the peptide ions are measured to determine the molecular mass of each peptide, 
producing the MS spectrum. Then, from the top ten most abundant ions, each peptide ion is 
isolated in the first mass analyzer (MS 1) and directed into a collision cell, where it collides 
with neutral gas molecules (for example, helium) and becomes fragmented. The mass-to-
charge ratios of the resulting fragments are measured in the second mass analyzer (MS 2), 
producing a tandem mass spectrum (MS/MS spectrum). Fragmentation of ions is mostly 
performed by collision induced dissociation (CID) (Mitchell Wells and McLuckey, 2005) or 
higher energy dissociation (HCD) (Ferries et al., 2017). In these fragmentation techniques, 
peptide precursor ions are broken into pieces at their peptide bonds, and the resulting fragment 
ions have mass differences corresponding to the residue masses of the respective amino acids. 
To identify the resulting fragments, the Roepstorff-Fohlman annotation is generally used, 
where, ions from the N-terminus of the peptide are known as b ions, while fragments from the 
C-terminus are called y ions (Roepstorff and Fohlman, 1984). This cycle of alternating MS and 
MS/MS spectra is repeated throughout the chromatographic run, for what is known as the data-
dependent acquisition (DDA).  
Following the data collection, the MS/MS spectra are further used for high throughput 
identification of peptide and proteins in a database using different computational algorithm 
such as Sequest (Eng, McCormack and Yates, 1994), comet (direct descended of academic 
version of Sequest) (Eng, Jahan and Hoopmann, 2013a), Mascot (Perkins et al., 1999) and 
X!!Tandem (Bjornson et al., 2008). In the database search engines, each experimental spectrum 
is matched and scored against the most plausible theoretical peptide in the database (Figure 2). 
3.1. Conventional database search approach for peptide identification 
A crucial component of the analysis of shotgun proteomics datasets is the search engine, 
an algorithm that attempts to identify the peptide sequence from the parent molecular ion 
that produced a certain fragment ion spectrum in the dataset. For simpler understanding of 
this process, database search can be categorized in three basic steps: 1) collection of all 
MS/MS spectra and querying a sequence database for peptides (theoretical peptide) of 
specific mass; 2) scoring the theoretical peptide against experimental peptide; 3) providing 
validation for the putative peptide identification.  Briefly, for every MS/MS spectra, 
experimental peptide mass is calculated using its m/z and charge. The database search 
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 algorithm then collects the set of theoretical peptides having similar or approximate masses 
to the experimental peptide. For every candidate peptide, fragment ion masses are 
calculated, matched with the ones of the experimental spectrum, and the peptide candidates 
are ranked according to their peptide spectrum match (PSM) score.  
 
Figure 2: schematic representation of a typical shotgun proteomics experiment. Left side showing the process 
where tryptic peptides are generated from a biological protein sample. The obtained peptide mixture is usually 
fractionated/or not and sent to mass spectrometer usually through a coupled RP-HPLC. The resulting data mainly 
provides MS1 and MS2 spectra, where MS1 represents intensity versus the m/z of the ionized components at a 
given retention time, and MS2 contains the intensity versus the m/z of the fragmented products of a component 
from MS1 at given retention time. The produced data is then searched against theoretical mass spectra of peptides 
generated from in-silico digested proteins from a database of choice. Upon matching the theoretical and 
experimental spectra, every match is scored and results in a candidate peptide. Then, using the target/decoy 
approach, candidate peptides are filtered out by false discovery rate.   
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 3.1.1. Identification quality scores 
For ensuring the quality of identification from MS based experiments, it is necessary 
that the search engine has a scoring function that consistently ranks correct PSMs better 
than the poor matches. In the past, there have been multiple publications and tools 
suggesting different strategies. One of the most widely used approaches is from Sequest 
(Eng, McCormack and Yates, 1994), where scores are determined on how well the 
experimental and theoretical spectra are matched/overlapped using cross correlation, 
which is a sum of all intensities between theoretical and experimental peptide. Being 
robust and fast, Xcorr function form Sequest is being widely used and studied in 
proteomics. The first version of Sequest Xcorr was calculated in a two-step process, 
where, initially a preliminary score was calculated and followed by a cross correlation 
for the matches which passed a preliminary score.  
Sequest Xcorr has experienced significant improvements over the years (Eng et al., 
2008; Klammer, Park and Noble, 2009; Diament and Noble, 2011). Particularly, a new 
search engine, Comet (Eng, Jahan and Hoopmann, 2013b), has implemented the 
Sequest algorithm with an improved cross correlation (Eng et al., 2008). Comet avoids 
using Fast Fourier Transformation (FFT) to calculate the full cross correlation, which 
is computationally expensive. Instead, a pre filter of a preliminary score is used. In 
addition, the Xcorr calculation is simplified and is calculated for every candidate 
peptide, associating an E-value for the significant match.  E-value increases the 
sensitivity and allows a simple comparison among scores of spectra, where E-value 
represents the number of peptides that are expected to match and score well above the 
best match just by chance.  
On the other hand, some approaches use statistical probability methods to compute 
quality of match, such as MASCOT (Perkins et al., 1999). In MASCOT, the score is 
the probability that the observed match between the experimental and theoretical 
peptide is just by chance. The open source search engine Andromeda (Cox et al., 2011) 
follows an approach similar to MASCOT. 
3.2. PTM identification: limitations of conventional search engines 
More than 500 PTMs have been described on UniProt database (April 2018). Hundreds of 
them have been described in Homo sapiens. Over the years, PTM identification study was 
mainly limited to a protein or a specific pathway since most of those studies started with a 
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 specific question and a hypothesis. Technological advancements in MS has encouraged 
scientist to perform database searches with increasingly narrower precursor and fragment 
mass tolerance, which is usually set in the parts-per-million (PPM) range (Bonzon-
Kulichenko et al., 2015). The need to discard incorrect matches and faster database search 
are one of the few reasons behind the use of narrow tolerance (Hsieh et al., 2010; Bonzon-
Kulichenko et al., 2015). However, considering the fact that the number of possible peptide 
modifications is overwhelming and impossible to anticipate, the database searches aiming 
to identify modified peptides possesses a greater challenge if narrow tolerances on 
precursor and fragments are used. In most cases, common chemical modifications, such as 
methionine oxidation or cysteine alkylation, are added to the search, together with some 
known biological PTMs. However, the mass shifts produced by unknown modifications 
are not considered during the search, resulting in lower PSM scores and/or miss-
assignments. 
3.3. Unwanted sources of peptide modification 
For a number of reasons, MS spectra generated from peptides with modifications outside 
of the user-specified rules may be present in tandem MS datasets. Non-protease-specific 
peptides could arise from in-source fragmentation (Kim et al., 2013); chemical artifacts 
introduced during sample preparation (Savitski, Nielsen and Zubarev, 2006), for instance, 
over-alkylation (and and Fales*, 2001). Studies have shown that tryptophan oxidation may 
occur following protein purification and isolation, particularly with the use of gel 
electrophoresis. Moreover, electrospray ionization has also been reported to induce 
oxidation of methionine, tryptophan or tyrosine residues (Potgieter et al., 1997). In 
addition, the labile nature of some modifications also makes them difficult to identify by 
MS. For instance, oxidative modifications, glycosylation and phosphorylation (on serine 
and threonine residues) are labile modifications and modified peptides can undergo loss of 
the substituent under conditions used in electrospray ionization (Carapito et al., 2009; 
Chick et al., 2015).   
In addition, peptides having more than one residue capable of bearing a modification, for 
instance, peptide with phosphorylation with multiple serine and threonine residues. In such 
cases, during the spectrum match, the confidence of localizing a modification to a particular 
residue is dependent on the presence of fragment ions in the MS/MS spectrum derived from 
the fragmentation between the possible sites of modification. Conventional search engines 
currently pay little or no attention to representing the certainty or ambiguity of modification 
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 localization in their top scoring result. Considering all the limitations in the existing 
algorithms mentioned above, only a small fraction of modified peptides is identified and 
only in a targeted way. Thus, there is a need of an algorithm that would anticipate the mass 
shift present in the precursor and fragments. 
3.4. Hypothesis-free modified peptides identification and the dark matter 
In the age of MS-based high-throughput proteomics (Link et al., 1999), despite having 
access to millions of spectra, most experiments start with a hypothesis driven approach, 
especially considering analysis of PTMs. In such cases, the studies tend to consider a subset 
of modification and the unmodified form of the peptide to draw a conclusion and leaves 
out the possibilities of having a complete picture of a biological system. Hence, despite the 
advances in speed and sensitivity which allow the generation of millions of spectra per 
experiment, only a minority of these spectra could be mapped to proteins (Skinner and 
Kelleher, 2015; Griss et al., 2016). A large proportion of unassigned spectra are thought to 
arise from peptides containing sequence variants or unknown chemical and 
posttranslational modifications (PTM) (Griss et al., 2016), and their characterization is one 
of the most interesting and challenging goals in proteomics. A number of computational 
methods have been proposed for the detection of these unmatched peptides (Marshall Bern, 
Yuhan Cai and Goldberg, 2007; Chen et al., 2009; Kim and Pevzner, 2014; Ma and Lam, 
2014; Shortreed et al., 2015; Griss et al., 2016).  
Recently, an “open search” (OS) strategy, where precursor mass tolerances of hundreds of 
Da were used with a conventional search engine, was reported to identify modified peptides 
at an unprecedented scale (Skinner and Kelleher, 2015). OS established that many of the 
unexplained/unidentified spectra could be explained: by unexpected PTMs or rarely but 
possibly, from amino acid substitutions not present the search database. They used an ultra-
wide tolerant of <1000 Da in Sequest search that identifies hundreds of different type of 
chemical and biological PTMs.  
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Figure 3: : Conventional OS methods can identify modified peptides from MS/MS spectra, but only the fragments 
unaffected by the modification (Orange Square) are matched; this effect diminishes the score assigned to modified 
peptides, decreasing identification performance 
 
Another report demonstrated that OS could be performed at orders-of-magnitude faster 
speeds using a novel fragmentation-ion indexing algorithm (MSFragger) (Kong et al., 
2017). MSFragger uses the indexing of nonredundant set of peptide and then with mass 
binning and mass ordering in fragment index to facilitate the faster retrieval of candidate 
peptides. MSFragger demonstrated it use for OS even with variable modification.These 
two methods may have a considerable impact on the field, opening the way to true 
hypothesis-free analysis of PTMs by MS; however, OS algorithms still rely on the chance 
that the modification leaves enough unaffected fragment ions for matching by the search 
engine (Figure 3). OS strategies can therefore identify only approximately half the modified 
peptides detectable by conventional “closed” searches (CS) (Chick et al., 2015). Moreover, 
existing OS approaches cannot directly identify the modification site. 
4. Identification confidence 
Conventional search engines in the era of high throughout proteomics enabled the identification 
of hundreds of thousands of peptides in MS/MS data on a routine bases, but at the same time 
made validation of identifications a tedious process. Thus, the false discovery rate (FDR) is 
generally used to control the percentage of the possible wrong identifications. FDR estimates 
the number of false positives in a given dataset, which is the ratio of the number of incorrect 
PSMs and in the total number of PSMs at a chosen identification score threshold (Choi and 
Nesvizhskii, 2008; Nesvizhskii, 2010). 
4.1. Target/Decoy approach 
Most accepted and widely used strategy to evaluate the FDR is based on the target/decoy 
approach (Elias and Gygi, 2007; Bonzon-Kulichenko et al., 2015), where spectra a 
searched nor only against the target data base, but also against a “decoy” or false database 
XCorr
Theoretical
Experimental+
PhD Dissertation - Introduction 9 Navratan Bagwan
 of the same size as the target data base. The decoy database is made in silico from the target 
database model organism by either reversing or by shuffling the tryptic peptides. The idea 
behind this approach is that the PSMs that hit the decoy database are false, and the number 
of these false PSMs is equal to the number of false PSMs from the target database at a 
certain score threshold. Creating a decoy is one of the most important factors, which can 
directly create a bias in identification sensitivity. Moreover, creating a perfect decoy 
database is almost impossible without losing the composition of target sequence. For these 
reasons, decoy database made by shuffling or reversing the target sequence, should 
maintain a target sequence composition, for instance, decoy database should have a similar 
amino acid distribution and length distribution as target protein database. Moreover, there 
should only be one decoy sequence for every target counterpart, as this helps to reduce the 
chances of randomisation and will help to get reproducible results (Elias and Gygi, 2007; 
Jeong, Kim and Bandeira, 2012).  
These target/decoy databases can be used in a concatenated or separated form. In the 
separated search, both target and decoy databases will be searched separately, so that the 
score distribution form both searches can be assessed and used for FDR calculation. In the 
same stream, a concatenated search is conducted by combining the decoy and target 
databases together. This search reportedly has many benefits, starting with a reduced search 
space around 20% and an increased sensitivity, since it gives a fair chance of competition 
between target and decoy match, and only the best match will be chosen for each scan from 
either target or decoy database(Elias and Gygi, 2007). 
4.2. Concerns in PTM FDR 
One of the major concerns regarding PTM identification and FDR control is that the FDR 
for modifications can drastically vary from the unmodified form of peptides. Some recent 
studies (Fu, 2012; Fu and Qian, 2014; Kong et al., 2017; Li et al., 2017) suggested solutions 
and the discussed possible reasons for such cases. In most proteomics studies only a subset 
of PTMs are defined as variable modification and a global FDR is calculated and raises the 
risk of under or over estimating FDR. The reasons of happening are that: 1) spectra of 
modified peptides can have their own features (e.g. insufficient fragmentation or neutral 
losses), thus, can have different score distributions from those of unmodified peptides, 2) 
the proportions of modified and unmodified peptide are different in a sample, so the 
chances of obtaining a correct peptide sequence are different. In a similar way, as the 
proportions are different for candidate peptides in the search space, the prior chances of 
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 having an incorrect identification are also different. Therefore, a separate FDR also known 
as “local FDR” has been suggested and used in recent studies.  
Alongside the “local” FDR issue, using multiple variable modifications in the search can 
also increase the search space drastically, which results in two main problems. On one hand, 
in a huge time complexity. For example, searching for phosphorylation on serine and 
threonine and oxidation on methionine in peptide “YFDSTDYNMAK” would generate 
25=32 possibilities. Considering this same scenario for thousands of peptides would lead to 
search space orders of magnitude bigger than a search without PTM. On the other hand, 
because of an increased search space, the FDR increases as the probability of matching a 
false identification just by chance increases. Another parameter in the search engine that 
can drastically influence the quality of identification is the precursor mass tolerance; for 
instance, in ultra-tolerant database search, specifying it to a higher error rate will allow a 
bigger search space, which will result in reduced sensitivity as chances of random matching 
increases. 
5. Quantification of peptides and proteins 
The simplest definition of quantitative proteomics can be defined as the “study of overall or 
global changes in protein expression”. However, the nature of MS based proteomics is not 
inherently quantitative; a large number of variables contribute to the peak intensity in a mass 
spectrum such as: absolute amount of protein, relative amount of protein among samples. In 
addition, proteins with similar concentration may generate completely different spectra and 
signal intensities. For instance, peptides generated from a protein digestion may produce 
different signals or some peptides might not be identified. One of the most tedious bottlenecks 
of current high throughput proteomics, where a large number of differential expression data is 
collected, is to determine and discriminate whether the observed change in protein is 
statistically significant or it has been stacked up from PSM or peptide level outliers. 
Despite all the hurdles, MS can be used for generating quantitative data. In brief, quantification 
can be classified in two major categories: stable isotope labelling (SIL) and label free (LF). In 
the most general way, in the LF technique, for each sample a separate analysis is performed 
comparing peptide peak intensities. Wherein each protein is then quantified by, taking the most 
intense peptides averaged from three different technical replicates, or by using spectral or 
peptide counting, by taking the number of spectra or peptides for each protein.  
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 Most importantly, in any of the label free techniques the reproducibility of the reverse-phase 
HPLC-MS instrument is critical. There are several statistical models previously published 
taking into account all the limitations of such a technique, some of the most prominent models 
uses an analysis of variance (ANOVA) (Daly et al., 2008; Clough et al., 2009; Karpievitch et 
al., 2009). In brief, label-free quantitation involves analyzing several technical replicates of the 
same sample or biological replicates belonging to more than one different conditions. The need 
of having several replicates helps to overcome the difference in ionization efficiency that arises 
from the same peptide from the different samples analyzed separately in the MS. Because of 
label free data’s multiplicative nature, different factors such as fixed and random error source 
come into play, thus the quantitative data is usually subjected to logarithmic transformation. 
Such transformation allows treating the error source as additive, which makes it easier to model 
the replicate structure within the analysis of ANOVA. 
On the other hand, stable isotope labelling (SIL) includes three major categories: metabolic 
labelling such as SILAC which refers to isotope labelling of amino acids in cell culture (Ong 
and Mann, 2007). Enzymatic labelling such as 18O (Xudong Yao et al., 2001) and compares 
only two samples per experiment. Chemical labelling such as iTRAQ (Ross et al., 2004) or 
TMT (Thompson et al., 2003) are one of the most widely used techniques for large comparative 
experiments. In SIL, since the same peptide from the different samples ionizes at the same 
time, it has the same ionization efficiency. In comparison to label free, SIL provides improved 
quantitative precision, accuracy. 
In general there are many statistical models to study and to deal with the variation and outliers 
in SIL approaches (Chee Sian Gan et al., 2007; Hultin-Rosenberg et al., 2013). Most of these 
studies use a simplistic way of calculating the protein values as an average (mean or median) 
of peptide ratios and comparing them among different experiments or replicates using a 
student’s t-test or advancing slightly by ANOVA. Moreover, most models and statistical 
significance tests are based on normality assumptions that have not been tested despite the fact 
that heterogeneity of variance has been documented in all SIL methods. These techniques are 
based on peptide-centric measurements, and the lack of general models leads to the subjective 
choice of a method for combining multiple peptide readings to estimate protein ratios. For 
example, ANOVA, which considers the same number of scans per peptide and the same 
number of peptides per protein. This is far from true in a data-dependent experiment, 
characterized by under-sampling. 
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 However, many of these limitation were dealt with in a single statistical framework previously 
developed in out laboratory called weighted spectrum, peptide, and protein model (WSPP) 
(Navarro et al., 2014a). WSPP model allows a systematic comparison and establishes a validity 
of null hypothesis at each one of the levels (spectrum, peptide and protein). WSPP model 
provides a detailed description of the behavior of the technical variance, and by analyzing it 
independently at the spectrum, peptide, and protein levels, the model is able to capture 
separately the specific error sources of each SIL and MS method, demonstrating that error 
distributions are accurately modeled in all cases at the three levels. Last, but not least, it is 
applicable to any kind of quantitative proteomics experiment and instrument. 
5.1. PTM quantification 
The quantification of PTMs, although very important to understand the biological 
processes, is technically challenging. On one hand, PTM-containing peptides are often low 
abundant. As stated before, the very high dynamic range of protein concentrations in a cell 
poses serious difficulties for the quantification of PTMs. In addition, it is difficult or 
impossible to devise a strategy allowing the separation and analysis of all the structurally 
diverse protein isoforms, because of the number of possible combinations of PTM locations 
within a protein with several PTMs. Importantly, PTM quantification not only has to cover 
the proteins change in abundance but also the determination of the modification site. 
In general, these enrichment steps enrich a specific type of PTM and/or deplete the big 
portion of non-modified peptides that impede the PTM analysis. Therefore, this approach 
creates a need for two separate experiments one for PTM and the other one for unmodified 
peptides. Different strategies are used to enrich PTMs, for instance, strong cation exchange 
chromatography is used for phospho or glycopeptides (Lohrig, Sickmann and 
Lewandrowski, 2011). Some technique also target the physiochemical characteristics of 
modified peptides, which results in specific retention times in reversed phase (Batth, 
Francavilla and Olsen, 2014) or Zwitterionic hydrophilic interaction chromatography (Zic-
HILIC) (Parker et al., 2013). In some cases, to fractionate the sample more, a combination 
of affinity chromatography and HILIC is used. On other hand, immobilized metal affinity 
chromatography (IMAC) (Thingholm and Larsen, 2016a) or Titanium dioxide (TiO2) 
(Thingholm and Larsen, 2016b) is mainly used for selective enrichment of phosphopeptides 
(Engholm-Keller et al., 2012). For most PTMs, however, no strategy or protocol for 
enrichment exists at the moment, and are often either left out of the study, or have to be 
analysed one by one on protein-by-protein bases (Olsen and Mann, 2013).  
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 Considering the growing interest in the cross talk between different PTMs, there is an 
urgent need for new methods and tools, which would enable identification and 
quantification of multiple PTMs simultaneously. Many algorithms (Lu et al., 2007; Cox 
and Mann, 2008) have provided a promising way for quantification of proteins and can be 
directly extrapolated to PTMs. For Instance, MaxLFQ a part of MaxQunat However, there 
is still a need of a generic quantification model for PTMs, which can detect changes in PTM 
independent of the protein change. A further important consideration is that OS methods 
have not been previously used to quantify PTM alterations, and a general statistical model 
for the analysis of data of this kind is currently lacking. 
The WSPP model (see also section 5) considers three different variance sources (at the 
scan, peptide and protein levels), which allows a more accurate modelling of the 
heterogeneous variance at all levels. This variance heterogeneity at all levels is taken into 
account by applying weighted averages to quantify scans, peptides and proteins and 
resolves the under-sampling problem of DDA MS experiments. Along with WSPP model, 
another model called systems biology triangle (SBT) was developed in our lab, that allows 
the study of protein coordination by pairwise quantitative proteomics (García-Marqués et 
al., 2016).  
In the past the WSPP model has been applied to modified peptides to analyse the change 
in the redox state of the cysteine containing peptides (Martínez-Acedo et al., 2012). 
Analysis was performed in two steps; first, proteins were quantified and peptide variance 
was estimated with non-cysteine-containing peptides. Furthermore, in a second step, 
cysteine-peptides were introduced and their deviation was calculated from the 
corresponding protein. This allows in a single analysis, a reliable detection of quantitative 
alteration in the peptides independent of the protein change in abundance. However, in 
second step, when cysteine-peptides are introduced, protein means are recalculated, 
introducing a bias in protein quantification and reducing the sensitivity to detect modified 
peptides changes in abundance. Modified peptides derived from proteins detected with less 
than one non-modified peptide (orphan modified peptides) were excluded from the 
analysis. 
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 Objectives 
Post-translational modifications hugely increase the functional diversity of proteomes. Recent 
algorithms based on ultra-tolerant database searching (Open search, OS) have opened the way 
towards unbiased analysis of peptide modifications by shotgun mass spectrometry. However, 
OS approaches identify only one-half of the modified forms detectable by conventional 
“closed” searches and do not map the modified residue. Moreover, OS has not been used for 
the quantification of modified peptides and reliable statistical models for these kinds of 
experiments are currently lacking.  
Mitochondrial heteroplasmy (a condition produced by mitochondrial replacement therapies 
used in the treatment of infertility and other mitochondrial-linked diseases in humans) has been 
demonstrated to produce adverse physiological effects. However, the underlying mechanisms 
are unknown and the biomedical importance of this situation makes it urgent to understand 
better how these undesired effects are produced. 
 
For these reasons, my PhD thesis is centered on the following general objectives:  
1. To develop new algorithms for the comprehensive hypothesis-free identification of all 
MS-detectable peptide modifications, allowing accurate location of the modified 
residue. 
 
2. To take further the statistical model for quantitative proteomics previously developed 
in our laboratory, adapting it for simultaneous quantification of the modified peptidome 
and the proteome and for systems biology interpretation. 
 
3. To illustrate the performance of the newly developed tools by uncovering the changes 
in the modified peptidome brought about by mitochondrial heteroplasmy in different 
mouse tissues. 
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 Material and methods 
All the heteroplasmic mice generation and animal handling was performed in the lab José 
Antonio Enríquez Domínguez. (Functional Genetics of the Oxidative Phosphorilation System 
(GENOPHOS)) 
1. Mouse model of heteroplasmy 
All animal procedures conformed to EU Directive 86/609/EEC and Recommendation 
2007/526/EC regarding the protection of animals used for experimental and other scientific 
purposes, enforced in Spanish law under Real Decreto 1201/2005. The mice were fed a 
standard chow diet (5K67 LabDiet). 
2. Generation of heteroplasmy mice 
Heteroplasmic mice were generated by electro-fusing cytoplasts from conplastic 
BL/6NZB zygotes to recipient C57BL/6JOlaHsd (BL/6C57) one cell embryos, cultured overnight 
and transplanted as two-cell embryos into pseudo pregnant Hsd:ICR (CD-1®) females to 
complete development to term as previously described (Jenuth et al., 1996). To the best of our 
knowledge, no consensus rule to name heteroplasmic mouse strains exists. Here, we propose 
the following designation to name heteroplasmic mouse strains: NUCLEAR GENOME-
mtCYTOPLASMIC GENOME #1 + CYTOPLASMIC GENOME #2 [i.e., C57BL/6J-
mtC57BL/6+NZB, a strain with the nuclear genome of C57BL/6J and the cytoplasmic 
(mitochondrial) genome of C57BL/6J and NZB]. To simplify we are calling it BL/6C57-
NZB along this report. The female heteroplasmic offspring (named BL/6C57-NZB) were mated 
with C57BL/6JOlaHsd males to prevent nuclear genetic drift in our particular mice lines. Only 
offspring of the established heteroplasmic mice were used. 
3. Mice breeding 
Heteroplasmic females (BL/6C57-NZB) were outcrossed with males BL/6C57. Only females with 
an initial level of NZB heteroplasmy above 20% were used for colony maintenance. 
The mice used in this work were 12-week-old control (C57BL/6JOlaHsd strain) and 
heteroplasmic males (containing more than one mtDNA in the same cytoplasm, C57BL/6 
background). The effect of heteroplasmy on the PTMs of the proteome of different tissues was 
studied on liver, heart, and skeletal muscle (gastrocnemius) samples. In the last two tissues, the 
heteroplasmy was stable, while the liver was selected as a control tissue since it spontaneously 
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 selected one of the alternative variants of mtDNA (manuscript in submission For each tissue, 
biological replicates from different control (N = 3) and heteroplasmic mice (N = 4) were 
analysed. 
4. Benchmarking mass spectrometry dataset 
To test the performance of the developed algorithms, we used the publicly available HEK293 
dataset (Chick et al., 2015), containing 1.121.149 MS/MS spectra in 24 raw files acquired on 
a Q-Exactive Orbitrap mass spectrometer. For the bench-marking of site localization through 
CometPTM we used a synthetic phosphopeptide data set from the Pride database (dataset 
identifier PXD007058) (Ferries et al., 2017). 
5. Preparation of protein extracts 
Mice were sacrificed by cervical dislocation. After that liver, heart and skeletal muscle tissues 
were extracted. 20 mg of each tissue were homogenized in lysis buffer (10mM Tris-HCL 
pH7.4, 1 mM EDTA, 0.32 M sucrose, 2% SDS) freshly supplemented with protease and 
phosphatase inhibitors (Roche) and 50 mM DTT, using a MagNA Lyser instrument (Roche). 
The lysate was boiled for 5 min and cell debris were removed by centrifugation. 
6. Protein digestion, peptide labelling and fractionation 
Proteins were treated with 50 mM iodoacetamide (IAM) and digested with trypsin using the 
Filter Aided Sample Preparation (FASP) digestion kit (Expedeon) (Wiśniewski, Zielinska and 
Mann, 2011) according to manufacturer’s instructions. Dried peptides were labeled using 10 
plex-TMT reagents according to manufacturer’s instructions (Thermo Fisher Scientific), 
desalted on OASIS HLB extraction cartidges (Waters Corp.) (Leyfer and Weng, 2005), 
separated into 7 fractions using the high pH reversed-phase peptide fractionation kit (Thermo 
Fisher Scientific) and dried-down before MS analysis. 
7. LC-MS analysis 
Each fraction of the labelled peptide samples were analysed using an Easy Nano-flow HPLC 
system (Thermo Fisher Scientific) coupled via a Nano-electrospray ion source (Thermo Fisher 
Scientific, Bremen, Germany) to a Q Exactive HF mass spectrometer (Thermo Fisher 
Scientific, Bremen, Germany). C18-based reverse phase separation was used with a 2-cm trap 
column and a 50-cm analytical column (EASY column, Thermo). Peptides were loaded in 
buffer A (0.1% formic acid (v/v)) and eluted with a 240 min linear gradient of buffer B (80% 
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 acetonitrile, 0.1% formic acid (v/v)) at 200 nL/min. Mass spectra were acquired in a data-
dependent manner, with an automatic switch between MS and MS/MS using a top 15 method. 
MS spectra were acquired in the Orbitrap analyser with a mass range of 400–1500 m/z and 
60,000 resolutions. HCD fragmentation was performed at 27 of normalized collision energy 
and MS/MS spectra were analysed at 60,000 resolutions in the Orbitrap. 
8. Database search 
Unless indicated otherwise, all searches were performed using Comet release 2016 (Eng, Jahan 
and Hoopmann, 2013b; Eng et al., 2015). Using trypsin digestion with 1 missed cleavages 
(unless otherwise specified) and fixed Cys carbamidomethylation (57.021464 Da). For 
heteroplasmic mice data, TMT labelling at N-terminal end and Lys was also considered as a 
fixed modification (229.162932 Da). Fragment ion tolerance was 0.02 Da, 0 mass offset. 
Precursor tolerance type and isotope error were set to 1. Precursor charge range was 2-4, 
maximum precursor charge 5 and maximum fragment charge 3. Only y- and b-ions were used 
for scoring. 
Closed searches (CS) were performed at 5-ppm precursor ion tolerance, using three dynamic 
modifications: Met oxidation (15.994915), Asn and Gln deamidation (0.984016) and Ser and 
Thr phosphorylation (79.966331). Peptide identification from MS/MS data was performed 
using the probability ratio method (Martínez-Bartolomé et al., 2008). False discovery rates 
(FDR) of peptide identifications were calculated using the refined method (Navarro and 
Vázquez, 2009; Bonzon-Kulichenko et al., 2015); 1% FDR was used as the default criterion 
for peptide identification. Open searches (OS) with Comet and Comet-PTM were performed 
in the same conditions as CS, except that precursor ion tolerance was set to 500 Da. 
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 Results 
In the theme of this thesis, to overcome and to highlight the issues regarding PTM identification 
and studies build around PTMs, the results are divided into three sections: development, 
benchmarking and application. In development section, a detailed explanation of novel 
algorithms and tools developed is provided.  In benchmarking, the performances of developed 
tool is analysed and discussed thoroughly. To show the impact of these newly developed 
algorithms, the suit of these bioinformatics tool was applied on a biological model of 
mitochondrial heteroplasmy and biological conclusions are discussed concerning PTMs. 
1. Development of novel bioinformatics tools 
1.1. Comet-PTM 
CometPTM was developed (in collaboration with Spiros Michalakopoulos and Marco 
Trevisan-Herraz) by modifying the open-source database search engine (Eng et al., 2015). 
For every sequence candidate Comet-PTM calculates the difference between theoretical 
and experimental precursor mass (Mass), and adds up this mass iteratively to each one of 
the amino acid masses in the peptide sequence, calculating a Xcorr score in each one of the 
possible modified forms of the peptide (Figure 4). The selected candidate is the modified 
peptide form that produces the highest Xcorr. This design allows Comet-PTM to reach the 
score that would have been obtained by performing a targeted CS with the same 
modification in the same position (Also with OS). Note that the scores are not exactly 
identical, since CS uses the theoretical mass of the modification and Comet-PTM estimates 
it from the difference between the precursor mass and the theoretical mass of the non-
modified peptide, and experimental errors on this estimate may affect fragment matching. 
This effect is, however, small when low ppm precursor mass accuracies are used (Figure 5 
A and B). Comet-PTM has a user-selectable option of scoring also the non-modified 
peptide sequence (even when ΔMass is different from zero), to take into account labile 
modifications (Kong et al., 2017). 
Comet-PTM was developed to take full advantage of the multi-thread design of Comet. 
Comet-PTM used less than 4 hours to perform a 500 Da-wide open search of 16 LC-MS 
runs, containing an average of 44,390 MS/MS spectra each, using a computer cluster with 
16 nodes, where each node is built of 2 x Intel Xeon E5-2695v2 at 2.40 GHz and contained 
46 threads/124 gigabyte. 
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Figure 4: Schematic representation of comet-PTM algorithm. Comet-PTM firstly calculates the difference 
between the mass of the candidate and the mass of the precursor ion detected by the mass spectrometer (ΔMass). 
ΔMass is then iteratively added to each amino acid in the peptide sequence and the position that yields the best 
score is selected as the correct match. 
 
 
Figure 5: Peptide identification performance of Comet-PTM (A-B). Comparison of scores obtained from Comet-
PTM and CS in the population of PSM that produced the same match with the two engines. A match was 
considered identical when the peptide sequence was the same and the difference between ΔMass obtained by 
Comet-PTM and the theoretical mass of the modification selected in CS was within 5 ppm (A) or 0.5 ppm (B). 
Note that the scores were practically identical, and the dispersion around the identity line was diminished when 
the tolerance decreased; this demonstrates that the small differences in the score are a consequence of the error in 
the estimation of ΔMass and not in the design of the score in Comet-PTM. 
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 1.2. Systematic Hypothesis-free Identification of modifications with 
controlled FDR based on ultra-Tolerant database Search (SHIFTS) 
SHIFTS is a program that was develop to identify peaks in frequency distribution of 
modified peptides on the basis of the mass change/shift of their modification (ΔMass 
distribution), to assigns PSM to peaks and to calculate FDR for peptide identification 
(Figure 6). SHIFTS uses as input the files obtained from Comet-PTM search. 
1.2.1. Mass recalibration 
SHIFTS firstly recalibrate precursor peptide masses independently in each raw file. 
Recalibration was performed on a population of non-modified peptides with a very high 
score (user selectable; recommended values are those yielding 0.1% global FDR or 
lower). The selected population were assumed to be true identifications and are used to 
calculate the systematic mass error (median deviation in m/z scale), which is assumed 
to be constant in each raw file. From these data, SHIFTS also calculates the standard 
deviation of the mass error (ߪெ) using the median absolute deviation (MAD) method 
(Figure 6).  
1.2.2. Peak identification 
Recalibrated ΔMass values were binned using 0.001 Da bins to construct the Mass 
distribution. The distribution was smoothed using the median of a 7-point sliding 
window and then peak apexes were detected as downward zero-crossings in the first 
derivative of the smoothed curve. Peak widths were similarly calculated as the zero-
crossing points of the second derivative; in the current version of SHIFTS they are 
computed only for informative purposes. 
1.2.3. Peak assignation 
By default SHIFTS assigns a PSM to the closest Mass peak if the mass deviation of 
the PSM from the peak falls within3ߪெ, so that approximately 99% of PSM in each 
peak are assigned. This value can be user adjusted. PSM not assigned to peaks were 
considered as orphan PSM. The use of MAD to assign a PSM to peak was driven by 
simple hypothesis; that the distribution of Mass at any charge or any range of Mass 
follows the same distribution of “True” non-modified peptide distribution. Hence, the 
deviation of very high scoring non-modified PSM was measured as a MAD (Figure 7). 
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Figure 6: Schematic representation of SHIFTS. The workflow depicts how the output from Comet-PTM is 
processed, including mass recalibration, peak detection and FDR calculation 
 
 
Figure 7: distribution of Oxidation in different charge state. Plots represents distribution of “True” non-modified 
peptides, which was used as MAD to assign PSMs to peak apex. 
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 1.2.4. FDR calculation 
SHIFTS calculates the FDR of identification using a conventional target/decoy strategy 
using the corrected Xcorr score (cXcorr) (Keller et al., 2002; Choi, Fermin and 
Nesvizhskii, 2008). A global FDR was calculated for each PSM as the ratio of the 
number of decoy PSMs to the number of target PSMs having a cXcorr equal or higher. 
Decoy peptides matched by Comet-PTM were observed to be almost as abundant as 
target peptides in the negative Mass region below the peak corresponding to neutral 
loss of Gly (Figure 8A), where Mass peaks were mostly produced by neutral loss of 
amino acids. For this reason, the global FDR was only calculated in the Mass region 
above -56 Da (Figure 8A). All the PSM are required to have FDR lower than the global 
FDR, without exception. 
In addition, local FDR filters are also applied. Some Mass peaks were observed to 
contain an unusually high number of decoy PSMs. To avoid matching false positive 
target PSM in these peaks, SHIFTS also calculates a peak FDR counting up the number 
of decoys and target PSM assigned to each peak and these PSM are required to pass the 
peak FDR filter in addition to the global FDR filter (Figure 8C). Note that peak FDRs 
are often very low suggesting that the majority of PSM in these peaks are true, even 
when they have a low cXcorr. This happens because the probability of finding a decoy 
PSM in a peak by chance alone is extremely low. SHIFTS avoids matching these low 
scoring target PSMs by applying the global FDR filter. 
To apply a local filter to PSM which are not assigned to ΔMass peaks, e.g. to orphan 
PSM, SHIFTS models the periodic mass distribution of decoy PSM into ~1 Da-bins 
centered at the regions where ΔMass values concentrate, and calculates a local FDR by 
counting up decoy and target PSM in each one of these regions (Figure 8B). The local 
FDR filter is applied 0to orphan PSM in addition to the global FDR filter. Default 
values for peptide identification were 1% for peak and local FDR; 5% for global FDR. 
1.2.5. Isotopic correction 
SHIFTS also perform a simple isotopic correction to minimize miss assignations of the 
correct monoisotopic peak of the precursor. When two PSM having the same sequence 
are encountered having a ΔMass difference within 1 ppm of the mass difference 
expected for either one or two 13C or one 34S, that of the lightest one substitutes the 
ΔMass of the heaviest precursor.  
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Figure 8: Distribution of target/decoy PSMs and FDR calculations. (A) ΔMass distribution of target and decoy 
PSMs and range of application of the global score threshold. The vertical scale is enlarged to show the distribution 
of decoy PSMs. (B) Local score thresholds applied in each ~1 Da bin in the ΔMass distribution(C) Peak score 
thresholds applied to the peaks detected by SHIFTS in the ΔMass distribution. 
1.3. PtmSticker: connecting dots and translating numbers to meaning 
PtmSticker is an algorithm that enables semi-supervised annotation of peptide 
modifications. In the Comet-PTM output, PtmSticker searches the ΔMass values against 
the Unimod database with a user-defined tolerance (in PPM range), taking into account the 
modified amino acid. In addition, the algorithm also takes into account the preceding and 
the consecutive residues of the initially modified residue and compares them with the list 
of amino acids that could be subjected to the modification according to Unimod. Upon 
failing to match the Δmass and the residue in UniMod, it checks the residues, containing 
modifications that were fixed in the database search. Residues with fixed modifications 
were considered with and without the fixed modification; when not indicated, the amino 
acid contains the fixed modification (e.g., C_oxidation means oxidation of 
carbamidomethylated Cys and K_oxidation, oxidation of TMT-labelled Lys). ΔMass 
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 values that could not be matched were tentatively tested assuming one 13C miss assignment 
of the monoisotopic mass of the precursor and as combinations of two modifications from 
a list of the most abundant modifications found in the corresponding proteome (Figure 9). 
Unexplained ΔMass values were termed as unknown.  
 
Figure 9: a workflow showing the steps in PtmSticker. PtmSticker, firstly assigns and labels the ΔMass of non-
modified, c13, ammonium, sodium adduct and isotopic label (for instance, TMT10Plex) respectively. Further, it 
checks if the difference is smaller than user input, if so, it takes in account modified residue and check for it in 
UniMod database. Upon not finding it in UniMod at 0th position, it considers preceding and consecutive amino 
acids. PtmSticker takes in account the static modification and labelling mass if specified. As a last resort in cases 
where it fails to find in UniMod, PtmSticker creates a set of combination (from user provided list), check them in 
UniMod, and labels them accordingly. 
1.4. PTM quantification as complement to WSPP model 
The quantitative information from TMT reporter intensities was integrated from the 
spectrum level to the peptide level and then to the protein level on the basis of the WSPP 
model (Martínez-Acedo et al., 2012; Navarro et al., 2014b) using the Generic Integration 
Algorithm (GIA) (García-Marqués et al., 2016).  
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 The new algorithm “SanXotGhost” was developed and later also was include into GIA 
workflow for the statistical model the quantitative values of modified peptides as part of 
the automated workflow (Figure 10A). Before PTMs can be quantified, another tool was 
developed called “Trilogy”. Trilogy generates peptide-to-protein relations tables in which 
peptides are tagged as non-modified, modified or orphans (e.g., when the protein is detected 
only with modified peptides). This allows user-selectable calculation of protein averages 
and peptide variances using only the unmodified peptide forms. Hence, it is possible to 
detect modified peptides that significantly deviate from the weighted average of the 
unmodified peptides from the same protein  
 
Figure 10: Quantification workflow (A, B). (A)Scheme of the integrative workflow used to quantify modified 
peptides, proteins or categories. Each arrow represents a step performed with the generic integration algorithm. 
Standardized log2-ratio values at the peptide level (Zpq) are obtained from the peptide-to-protein integration. The 
algorithm provides corrected peptide values by taking account of the corresponding protein changes. The same 
workflow is used for protein quantification and systems biology analysis of coordinated protein responses with 
the SBT model. (B) Scheme of the generic integration algorithm (GIA) adapted for the analysis of modified 
peptides in the peptide-to-protein integration step. The relations table include tags that can be used to indicate that 
modified peptides are excluded from the computation of protein averages. 
Briefly, for each sample ݅ the values ݔ௤௣௦ ൌ 	logଶ ௜ܵ/ܥ were calculated, where ௜ܵ is the 
intensity of the TMT reporter corresponding to sample ݅ in the MS/MS spectrum ݏ coming 
from peptide ݌ and protein ݍ, and ܥ is the average intensity of all the TMT reporters from 
the control samples, which is used as a common reference. The log2-ratio of each peptide 
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 (ݔ௤௣) was calculated as the weighted average of its spectra, the protein values (ݔ௤) were the 
weighted average of its peptides, and the grand mean (̅ݔ) was calculated as the weighted 
average of all the protein values (Navarro et al., 2014b). The statistical weights of spectra, 
peptides and proteins (ݓ௤௣௦, ݓ௤௣ and ݓ௤, respectively) and the variances at each one of the 
three levels (ߪ܁ଶ, ߪ۾ଶ, and ߪۿଶ, respectively), were calculated as described(Navarro et al., 
2014b). For each modified peptide, the standardized variable (ݖ௣௤) was calculated as 
ࢠ࢖ࢗ ൌ ൫࢞ࢗ࢖ െ ࢞ࢗ൯	ඥ࢝࢖ࢗ	ට ࢔࢖࢔࢖ି૚	,							࢔࢖>1 
Where ݊௣ is the number of non-modified peptides with which the corresponding protein 
was quantified. ݖ௣௤ Expresses the deviation between the peptide log2-ratio and the 
corresponding protein value in units of standard deviation. Similarly, orphan peptides can 
be quantified using grand mean of proteins. 
ࢠ࢖ࢗ ൌ ൫࢞ࢗ࢖ െ ࢞൯	ඥ࢝࢖ࢗ	ට ࢔࢔ െ ૚						 
Where n denotes the number of proteins identified in experiment, and x is protein grand 
mean. 
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 2.  Benchmarking of algorithms and tools 
2.1. Comet-PTM enables comprehensive identification of peptide 
modification 
To test the performance of Comet-PTM, the results were compared with those obtained 
with OS and with CS using 3 common variable modifications. As expected, OS assigned 
higher scores to a large population of peptide-spectrum matches (PSM) containing 
modifications not included in the CS list of variable modifications (Figure 11A, left). 
However, CS assigned a higher score than OS to a large population of PSMs with 
modifications included in the CS list, because the modifications affected the matching of 
fragment ions, decreasing the OS-assigned score (Figure 11A left). This effect reduced the 
identification performance of OS to around 50% of the PTMs identified by CS (Figure 
11B), confirming previous results(Chick et al., 2015). In contrast, scores obtained with 
Comet-PTM matched or exceeded OS (Figure 11A, centre).  
In addition, Comet-PTM identified the same ΔMass peaks as OS (Figure 11C); however, 
most of these peaks contained about 2-fold more PSMs (Figure 11C-H), reflecting the 
superior performance. As expected, this effect was not observed when the modification did 
not affect the fragmentation series. Thus, the 13C peak, produced by errors in assignment 
of the monoisotopic precursor mass, was observed with exactly the same number of PSMs 
(Figure 11I). The number of PSMs was also similar for modifications in N-terminal 
position of the peptide, which only affect b-series and has a negligible effect on 
identification by HCD fragmentation (Figure 11J, K).  
Comet-PTM produced scores similar to or higher than those obtained with CS (Figure 11A, 
right), except for a small population of peptides for which CS found 2 or more 
modifications (Figure 11A, orange dots). This effect was not due to differences between 
CS and Comet-PTM scores (Figure 5A and B). Therefore, and unlike OS, Comet-PTM had 
a similar identification performance to that of CS for the preselected modifications (Figure 
11B). In several instances, Comet-PTM correctly located an oxidation on Trp, Pro or Tyr 
that CS wrongly assigned to oxidation on Met, the predefined variable modification residue 
in CS (Figure 12 A, B, C).  
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Figure 11: overview of peptide identification and CometPTM performance. (A)The HeLa dataset from the 
original OS article was searched using Comet in closed search (CS) mode with 3 variable modifications (Met 
oxidation, Asn and Gln deamidation and Ser and Thr phosphorylation), with Comet in OS mode, or with Comet-
PTM (500 Da tolerance in the later 2 cases). The scores obtained for the same spectra in the different searching 
conditions are compared. Yellow points in the rightmost graph are PSMs that match peptides with more than one 
modification in CS mode. (B)Identification performance of OS and Comet-PTM relative to CS in the populations 
of peptides modified by oxidation, deamidation or phosphorylation. The number of PSMs was obtained after 
filtering by the score threshold corresponding to 1% FDR in the CS. PSMs matching peptides with more than one 
modification in CS are indicated by orange bars. (C) Frequency distribution of PSMs obtained by OS and Comet-
PTM as a function of ΔMass. (D-K) Details of the frequency distribution around the indicated modifications. The 
charts to the right of (J) and (K) show the distribution of PSMs as a function of the quantile position of the 
modification in the peptide sequence assigned by Comet-PTM 
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Figure 12: Vseq analyses of 3 peptides containing oxidations incorrectly assigned to Met by CS. Comet-PTM 
correctly assigns the oxidation to Trp (A) Pro (B) or Tyr (C). 
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 2.2. Comet-PTM detects the location of modifications in the peptide 
sequence 
Peptides were identified after Comet-PTM searches with SHIFTS, an algorithm that detects 
the peaks in the ΔMass distribution and controls the peptide false discovery rate (FDR) 
through a conservative, 3-layered approach (Figure 8A-C; see also result section 1.2). From 
the output of a search against a concatenated target-decoy database, SHIFTS calculates a 
global score threshold to control FDR in the population of PSMs with ΔMass > -56 Da 
(Figure 8A). A local score threshold is also defined to control FDR separately within each 
of the ~1 Da-bins in the ΔMass distribution (Figure 8B). Finally, a peak score threshold is 
calculated to control FDR separately within each peak detected in the ΔMass distribution 
(Figure 8C). A PSM is considered to be correctly identified when its score is above the 
global and peak thresholds; when a PSM does not form part of a peak, instead of the peak 
threshold the local threshold is used. This conservative approach allows full control of 
FDR, avoiding any bias due to the specific behaviour of certain kinds of peptide 
modifications that may be more prone to match decoy sequences. 
An advantage of Comet-PTM over existing OS approaches is that it automatically assigns 
the modification to the residue in the peptide sequence that produces the best score and 
therefore is the modified position that best explains the fragmentation data. Assigning 
modifications to specific residues is considered a much less reliable process than 
identifying peptides, partly because there is frequently insufficient information to 
determine the exact modified residue (Chalkley et al., 2008). To estimate the accuracy of 
Comet-PTM assignation of a modification to the correct site, we filtered correct 
identifications using the conservative method described above with a 1% FDR threshold 
and then calculated the fraction of PSMs in which the mass shift was located in amino acids 
predicted to harbour well-known modifications. Oxidation was located to Met, Trp or Pro 
in 82% of cases, and deamidation to Asn, Gln or carbamidomethylated Cys in 86% of cases 
(Figure 13A). Considering 6 well-known modifications, the overall accuracy of Comet-
PTM was estimated at ~85%. To test more specifically the performance of Comet-PTM for 
the correct assignation of phosphorylation sites, we analysed a dataset obtained from 
synthetic phosphorylated peptides (Ferries et al., 2017). Comet-PTM assigned the correct 
position with 81% accuracy, and in 94% of the cases, the modification was in the correct 
or in an adjacent position (Appendix Table 1). 
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Figure 13: Identification of modified peptides and location of the modified site. (A) Percentage of successful 
assignment of the indicated modification to the indicated residues.  (B) Inset horizontal bar graphs plot the 
frequency distributions of PSMs assigned by Comet-PTM to the indicated amino acids and modifications. Vertical 
bar graphs: frequency of PSMs assigned to the indicated amino acids after substracting the average frequency of 
the 3 previous and the 3 subsequent positions. Residues that accumulate counts in the histogram at position 0 are 
labelled in red. (C) Vseq results for 2 representative peptides containing iodinated Trp. Both the MS2 spectra (left 
panels) and the V-shaped heatmap distributions for the main fragmentation series (right panels), demonstrate the 
location of the modification in Trp. 
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 We then analyzed which amino acids were assigned to known modifications with a higher 
frequency than expected by chance. Among the most frequent, we only found well-known 
modifications like oxidized Met and Trp, deamidated Asn, Gln and carbamidomethylated 
Cys, phosphorylated Ser, trioxidized Cys and Trp and kynurenine-modified Trp (Figure 
13B). Some Pro modifications were also found with the ΔMass of kynurenine-modified 
Trp (Figure 13B), but all of them corresponded to homologous peptides that contained the 
Pro > Thr substitution, which has the same ΔMass (Figure 14), and that were assigned the 
same score. 
 
Figure 14: peptides containing a Pro > Thr substitution assigned as a kynurenin modification in Pro. Peptide 
sequences together with their corresponding proteins are listed, highlighting (in red) the position of Pro and Thr 
residues. 
Finally, Trp iodination was also clearly detected above background (Figure 13 B). This 
modification was unexpected because although Trp halogenases have been described in 
bacteria (van Pée and Patallo, 2006) they are not present in mammals, and Trp iodination 
has not been described before as a chemical artifact. The majority of peptides containing 
iodinated Trp contained neither Tyr nor His, the 2 amino acids known to react with iodine. 
A careful inspection of their fragment spectra confirmed the presence of y-fragments that 
could only be explained by Trp being the modified residue (Figure 13 C). In addition, the 
only modification described in Unimod that matched the observed mass shift corresponded 
to iodination. From all these data, we concluded that Trp was iodinated in these peptides, 
most probably as a side-chain reaction of the iodine produced from the Cys-alkylating 
reagent iodoacetamide. This finding further highlights the accuracy with which CometPTM 
locates the site of modification and suggests that this OS engine may be useful for detecting 
novel peptide modifications in specific amino acids. 
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Pituitary homeobox 3 isoform X1 Pituitary homeobox 2 isoform c
Casein kinase II subunit alpha Casein kinase II subunit alpha isoform X1
Glucose 1,6-bisphosphate synthase Phosphoglucomutase-1 isoform X1
Disks large homolog 2 isoform X1 Disks large homolog 2 isoform X1
ATPase, H+/K+ transporting alpha polypeptide Na+/K+ transporting ATPase subunit alpha 3
Carbonic anhydrase 3 isoform CRA-b Carbonic anhydrase 2 isoform X1
DTCNSSIASIR
EAMEHTYFYPVVK
EGFHFEETITGFK
IITGGAAAEDGR
VDNSSITGESEPQ TR
YAAEIHIVHWNTK
Mass(Kynurenin):  3.994915 Da
Mass(Pro > Thr):   3.994915 Da
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 2.3. A single integrated statistical framework allows quantification of the 
proteome and of the modified peptidome 
Quantification algorithm includes a peptide-to-protein integration step that quantifies 
protein values from the unmodified peptide forms and then computes the standardized log2-
ratio of the modified peptides with respect to these protein values (ܼ௣௤) (Figure 10B). This 
makes it possible to detect modified peptides whose behaviours deviate significantly from 
those of the unmodified peptides from the same protein. When applied to a biological 
model, the ܼ௣௤ distributions of the unmodified and modified peptide forms precisely 
followed the expected null hypothesis distribution in different tissues from two mouse 
strains (Figure 15).  
In absence of changes, the distributions of ݖ௣௤ followed very closely the normal distribution 
ܰሺ0,1ሻ (Figure 10C), validating the accuracy of the model. These results convincingly 
demonstrate that the quantitative behaviour of the entire population of modified peptides 
can be modelled accurately, providing a robust statistical framework within which to 
analyse abundance changes in high-throughput experiments. This allowed detection of 
significant changes in certain modified peptides against the null hypothesis in specific 
situations (Figure 15, lower left).  
 
Figure 15: Distributions of Zpq values for nonmodified (Non-Mod) and modified peptides (Mod). These data 
come from the analysis of mouse tissues in a model of mitochondrial heteroplasmy; each graph correspond to a 
tissue from an individual animal. The inset plots show the Zpq distributions for peptides containing the kynurenine 
Trp modification. Note that the distribution is displaced to the right in the hearts of heteroplasmic mice, indicating 
increased abundance. 
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 The same workflow used for peptide quantitation allowed the analysis of protein abundance 
changes and the characterization of functional categories that were affected by the 
coordinated action of proteins, using the Systems Biology Triangle (SBT) model (García-
Marqués et al., 2016) (Figure 10A). This statistical design thus allowed a full description 
of the alterations in the modified peptidome in the global context of changes in the 
proteome. Significant abundance changes of modified peptides were detected by Student’s 
t-test comparing the ݖ௣௤ values of samples from heteroplasmic mice (N=4) with those of 
control mice (N=3) (Appendix Table 2) 
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 3. Application of developed tools 
3.1. Heteroplasmy produces protein alterations consistent with a 
mitochondrial dysfunction in the heart 
We used Comet-PTM and associated tools to study the molecular impact of mitochondrial 
heteroplasmy on the proteome and the modified peptidome in heart, liver and skeletal 
muscle from 12 week-old mice. This age was considered the most appropriate to study 
molecular alterations before more extensive damage was produced as a consequence of 
heteroplasmy. SBT model analysis of the quantitative protein data from the heart revealed 
a coordinated decrease of proteins related to muscle function and the oxidative 
phosphorylation system (OXPHOS) and a coordinated increase of tubulins, myosins and 
proteins involved in vesicle trafficking. The muscle-function proteins included KCRS 
(mitochondrial creatine kinase) and VDAC3, which are key suppliers of phosphocreatine 
to the sarcomere, and SGCG and KGP1, which are essential for sarcomere contraction 
(Appendix Table 2). These alterations in heteroplasmic mice are highly consistent with the 
decreased ATP synthesis and the abnormal increase in phosphocreatine/ATP ratio in the 
heart and with the increase in plasma creatine kinase we have reported in this animal model 
(unpublished data), and provide evidence that heteroplasmic cardiac mitochondria have a 
compromised ability to supply energy to the sarcomere. Among the increased vesicle 
trafficking proteins, STXB3 and VAMP2 are implicated in the insulin-dependent 
movement of GLUT4 from inner vesicles to the plasma membrane. This finding also agrees 
with the higher glucose uptake we detected in heteroplasmic hearts, pointing to a shift 
toward glycolytic metabolism in order to compensate the reduced phosphocreatine supply 
from the OXPHOS. The coordinated decrease in blood proteins and the increase in heart 
cytoskeletal proteins in heteroplasmic animals suggest a homeostatic effort to maintain 
cardiac cell structure. 
 Heteroplasmy did not affect OXPHOS protein levels in liver, but did produce a coordinated 
increase of DHA signaling pathway proteins (Figure 16), including AKT2, BID and B2CL1 
(Appendix Table 2). AKT2 plays an essential role in the progression of the inflammatory 
response and apoptosis (López-Carballo et al., 2002); consistent with this finding, we 
detected signs of inflammation in the liver of heteroplasmic mice with aging (unpublished 
data). Heteroplasmic liver also showed coordinated increases in a group of myosins and 
phosphatidylinositol pathway proteins, probably reflecting a homeostatic response. These 
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 data thus indicate that at 12 weeks of age, heteroplasmy produces a decrease in OXPHOS 
proteins in the heart, probably reflecting mitochondrial dysfunction, but the same effect is 
not seen in liver. In heteroplasmic muscle, we detected a coordinated decrease of proteins 
regulating cell shape, such as tubulins and microtubule proteins (Figure 16). On the other 
hand, the thick-filament myosins, as well as calcium transporting proteins, were increased, 
suggesting the induction of compensatory mechanisms. However, we found no evidence of 
altered mitochondrial protein levels in muscle at this age. 
 
 
Figure 16: Characterization of coordinated protein alterations produced by heteroplasmy in heart, liver and muscle 
using the SBT model. Zqa values are standardized log2-ratio averages of proteins from heteroplasmic mice 
relative to controls. Proteins are grouped into representative functional categories with a statistically significant 
change. The upper panel presents proteins in the OXPHOS category that are decreased in the heteroplasmic heart 
and that contain heteroplasmy-induced oxidative modifications. 
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 3.2. Heteroplasmy mainly produces oxidative modifications of OXPHOS 
proteins in heart 
To study the impact of heteroplasmy on the modified peptidome, we first compared the 
ΔMass distribution of peptides searched with CometPTM and identified with SHIFTS in 
the three tissues. The distribution of the most abundant peaks was very similar in liver, 
heart and muscle (Figure 17). In addition to the most intense peak corresponding to 
unmodified peptides, we found peaks corresponding to oxidized and deamidated peptides, 
and dioxidized peptides were also frequent. Other frequent modifications were artifacts 
produced by TMT reagents and iodoacetamide treatments, sodium adducts and missed 
cleavages. Some tissue-specific modifications were also detected, mostly in the region from 
50 to 100 Da. Among these, phosphorylated peptides were more abundant in muscle and 
90% of these peptides belonged to proteins implicated in muscle contractility, consistent 
with the regulatory role of phosphorylation in the sarcomere. Within each Δmass peak, we 
analyzed the distribution of the modified amino acid residues, which were assigned to 
frequent modifications using the unbiased approach followed in Figure 14B. Confirming 
the results described above, amino acids known to harbour specific modifications were 
mostly located correctly (Figure 18). Interestingly, the relative proportion of modified sites 
was remarkably preserved across the three tissues, with the exception of tyrosine 
iodination, which was prominent in heart but less frequent in liver and skeletal muscle 
(Figure 18). This analysis also detected the increased frequency of phosphorylation in 
muscle (Figure 18). We estimated that about one quarter of the total peptidome in the 3 
tissues had known posttranslational modifications, mostly oxidation and deamidation; less 
than 10% of modifications were chemical artifacts (Figure 19A).  
Second, we analysed the quantitative data with the integrative statistical algorithm (Figure 
10A), to determine the pattern of modifications that are specifically affected by 
heteroplasmy in each tissue. Heteroplasmy induced marked tissue-specific modifications, 
most of them concentrated in heart and barely detectable in skeletal muscle (Figure 19B 
and Appendix Table 3). The vast majority of increased modifications in heart were 
oxidative, affecting mostly Tyr, Trp, Pro and Phe and to a lesser extent Asn, Cys and Asp 
(Figure 19C). Heteroplasmy also induced phosphorylation and methylation in the heart. 
The modification pattern was similar in liver, but the effect of heteroplasmy in this tissue 
was significantly less pronounced. 
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Figure 17: ΔMass distribution of modified peptides identified in the 3 mouse tissues. Assignations of the most 
frequent ΔMass peaks are indicated. 
 
 
Figure 18: Distribution of amino acids containing the most frequent modifications. The horizontal and vertical bar 
graphs have the same meaning as in Figure 13B 
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 Functional enrichment analysis revealed that heteroplasmy-induced modifications in mice 
heart were mostly located in mitochondrial proteins, particularly those located in the inner 
mitochondrial membrane; moreover, most of the modified proteins were OXPHOS 
proteins, which were enriched with multiple oxidative modifications (Figure 20A). TCA 
cycle proteins and those related to the oxidoreductase complex were enriched in several 
modifications. Deamidation affected several mitochondria-related categories, and 
phosphorylation affected proteins related to contractility. Heteroplasmy-induced 
modifications affected considerably fewer categories in liver (Figure 20B) and were not 
significantly enriched in muscle (Figure 20C), where only a few categories were decreased, 
containing low numbers of proteins. Deamidated peptides were found in proteins related to 
mitochondria, NAD binding and extracellular exosomes in both heart and liver, suggesting 
that these modifications do not contribute to the tissue-specific phenotypic differences 
between heteroplasmic and control mice. 
Interestingly, heteroplasmy decreased phosphorylations in proteins related to chaperone 
activity in the heart but had the opposite effect in liver (Figure 20A and B). This category 
contains the 2 HSP90 isoforms (HSP90AA1 and HSP90AB1), which harbour PTM sites 
involved in the regulation of the chaperone activity (Mollapour and Neckers, 2012). These 
isoforms are known to be phosphorylated at Ser263 and Ser255, respectively (Wang et al., 
2010; Hu et al., 2015), within the CK2 phosphorylation motif (S-X-X-E), which is crucial 
for protein activity. In particular, phosphorylation at Ser255 is required for the activation 
of MAPK/ERK pathway. Comet-PTM and SHIFTS identified these 2 phosphorylated sites, 
and heteroplasmy decreased their levels in heart while increasing them in liver (Figure 
20D).  
These findings suggest that heteroplasmy differentially affects chaperone activity and 
support the roles in cardiac heteroplasmy we have proposed for the endoplasmatic 
reticulum and the mitochondrial unfolded stress response (unpublished data). 
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Figure 19: (A) Complete map of the basal peptidome, expressed as a percentage of the total number of peptides 
identified in each tissue (circular bar graphs: h, heart; l, liver; m, muscle). For simplicity, peptides oxidized on 
Met (light blue) are included in the group of nonmodified peptides. The plot to the right shows proportions of 
artifacts produced by sample manipulation. (B) Number of PTM-containing peptides significantly increased (+) 
or decreased (-) in heteroplasmic mouse tissues (n = 4) relative to controls (n = 3). (C) Statistically significant 
PTM increases in heteroplasmic mouse tissues according to the type of modification and the modified residue. 
The circular inner bars show the peptide proportion for each modification in the basal state, and the radial red bars 
represent the proportion of peptides of each kind (in parts per 10,000) that are increased in heteroplasmic tissues. 
For the sake of clarity, three different scales are used depending on the type of modification. DeA, deamidation; 
meth, methylation; phos, phosphorylation; MC, missed cleavages; Chem, chemical derivatives produced by 
sample preparation; TMT, extra addition of the isobaric labelling reagent; Adducts, Na, K, and ammonia adducts. 
Uppercase letters indicate the single-letter amino acid code. ox, oxidation; 2ox, dioxidation; 3ox, trioxidation; 
Kyn, Trp to kynurenine; OH, Trp to hydroxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-
hydroxy formyl kynurenine; red triangle, Trp to oxolactone; red square, Trp to quinone; q, quinone, Tyr to 
quinone; Iodo, iodination; asterisk, Met to homocysteic acid; hashtag, Met to homoserine. 
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Figure 20: Functional distribution of proteins posttranslationally modified by heteroplasmy. (A-C) Functional 
enrichment analysis of the proteins containing PTMs that are significantly increased (brown scale) or decreased 
(blue scale) in different tissues of heteroplasmic mice in relation to control mice. The analysis was performed 
separately per different kinds of modification (slices). Color intensity represents the number of proteins in each 
category. Asterisks indicate statistical significance of category enrichment relative to the list of proteins identified 
in each tissue. Inner circular rings are used for categories at the cellular component level, whereas outer rings 
correspond to biological processes. (D) Heat map of the Zpq values for 2 modified proteotypic peptides from the 
2 HSP90 isoforms (HSP90AB1 and HSP90AA1) for all control and heteroplasmic replicates in the heart and in 
liver. These 2 isoforms are included in the “chaperone protein assembly” functional category displayed in A and 
B. 
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 Heteroplasmy also altered phosphorylation levels at sites known to regulate protein activity 
in a tissue-specific manner. Phosphorylation at Ser42 from PTRF, which regulated 
transcriptional activity in response to metabolic challenges (Huttlin et al., 2010; Liu and 
Pilch, 2016), was decreased in heart but was increased in muscle, in agreement with the 
different metabolic status of these tissues (Appendix Table 3). Similarly Ser133 from MYG, 
which regulates contractility (Lundby et al., 2013), was more phosphorylated in heart, in 
line with the coordinated decrease of proteins related to muscle function (Figure 16), 
suggesting alterations in the contractile function of the heart in heteroplasmic animals. In 
the liver, the active site Ser117 from PGM1, which regulates glycogen biosynthesis (Huttlin 
et al., 2010; Lee et al., 2014), was less phosphorylated, suggesting a lower fuel storage in 
this tissue (Appendix Table 3). These results reinforce the notion that the impact of 
heteroplasmy is tissue-specific.  
The rest of phosphorylated sites affected by heteroplasmy had unknown regulatory roles, 
but it should be noted that all of them have been described previously, supporting the 
accuracy of the algorithms used to detect them. They include Ser181 in PGRMC1(Jin et 
al., 2004), Ser442 in SRCA (Dai et al., 2007), Ser475 in JPH1(Rigbolt et al., 2011), and 
Ser298 and Ser304 in BIN1 (Ballif et al., 2004; Huttlin et al., 2010). 
To compare the alterations in the modified peptidome with the changes observed at the 
protein level, we mapped the proteins harbouring post-translational modifications affected 
by heteroplasmy onto the protein distribution plots depicting coordinated protein responses 
(red and blue dots in Figure 16). Most increased modifications mapped onto the OXPHOS 
protein category in heart, which was decreased, whereas proteins belonging to other 
categories were mostly unaffected. This finding suggests that the oxidative damage 
produced by heteroplasmy in heart OXPHOS proteins induced their degradation, and is 
consistent with the increase in oxidative stress we have observed in heart slices, embryonic 
fibroblasts and adult fibroblasts of heteroplasmic mice (Unpublished data).  
Most heteroplasmy-induced oxidative modifications in OXPHOS proteins occurred in the 
four respiratory protein complexes, except for Trp oxidations, which were mostly 
concentrated in C-IV (Figure 21,22). The modifications were clustered in groups of proteins 
located together in the structure of the complexes, and predominantly affected proteins 
orientated toward the mitochondrial matrix, where proteins are more exposed to 
mitochondrial ROS. In further analysis, we used Consurf to calculate evolutionary 
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 conservation profiles for the affected residues (Ashkenazy et al., 2016) and mapped the 
modifications onto the known 3D structures of the complexes, when available, or onto their 
predicted models (Meier and Söding, 2015). We found that 70% of the modified residues 
were conserved or interacted with conserved regions (Appendix Table 4). Moreover, most 
of the modifications were located on the protein surface, and those that were buried tended 
to have high conservation scores, suggesting they are important for structural stability or 
folding (Appendix Table 4). These findings suggest that these oxidative modifications 
compromise OXPHOS protein function. This view is supported by the decreased ATP 
synthesis capacity we have detected in heteroplasmic heart. 
 
 
Figure 21: PTMs Induced by Heteroplasmy in OXPHOS Proteins. Scheme of heteroplasmy-induced PTMs in 
proteins of complex I (upper), and complex III (lower) from the OXPHOS system.  
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Figure 22: PTMs Induced by Heteroplasmy in OXPHOS Proteins. Scheme of heteroplasmy-induced PTMs in 
proteins of complex IV (upper) and complex V (lower) from the OXPHOS system. PTMcontaining proteins are 
highlighted in red, with the spatial position of the modified residue indicated. The heat maps show statistically 
significant changes in abundance (Zpq) of the indicated peptides in heart and liver from control mice (Ctrl) and 
heteroplastic mice (Htpl). Grey squares indicate that the modified peptide was not detected in the tissue sample. 
Modified residues that are unambiguously assigned are underlined bold red letters; tentatively assigned sites are 
in bold blue letters. Asterisks mark statistically significant changes between control and heteroplasmic samples 
according to Student’s t test (p < 0.05). The modification type is indicated in the column to the right of the peptide 
sequences: ox, oxidation; 2ox, dioxidation; 3ox, trioxidation; Kyn, Trp to kynurenine; OH, Trp to 
hydroxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-hydroxy formyl kynurenine; OL, Trp to 
oxolactone; Q, Trp to quinone; I, iodination. 
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 Discussion 
1. Hypothesis- driven proteomics: it’s about time we move forward 
MS has traditionally been used to identify and map modifications on proteins. Historically, 
PTM identification was one of the first applications of MS in protein research (Stenflo et al., 
1974). Even though PTM identification had a promising start in early MS development, the 
deeper investigation of PTMs and the high-throughput PTM analysis of have started only in 
the last decade. Although with the current state-of-art MS equipment near complete proteome 
analysis is within grasp, this is not the case with PTMs. The identification of PTMs in a 
comprehensive way is more challenging from both technological and conceptual points of 
view. There are several principal differences between proteome and PTM analysis. For 
instance, in a typical proteome measurement, a protein is characterized by several peptides, 
making identification and quantification of the proteome more robust, whereas in an 
experiment focusing on PTM measurements, each peptide representing a modification site of 
interest needs to stand on its own. Beside, modified peptides can be in lower abundance than 
their non-modified counterpart, creating a necessity for PTM enrichment that are often limited 
to just some kinds of PTMs. 
Comprehensive analysis of PTMs in mass-spectrometry data obtained through shotgun 
approaches has historically presented a bioinformatics challenge because conventional (or 
closed) database searches can only identify predefined subsets of modifications. For instance, 
most efforts are dedicated to the most prominent and known modifications, such as 
phosphorylation, ubiquitination, glycosylation, and acetylation. However, several hundreds of 
modifications are known, and considering chemically induced modifications, the list grows 
drastically. Conventional PTM identification requires prior assumption of the kind of PTMs 
present in a given sample. Possible modifications and modified amino acids must be specified 
in the search engines (usually a maximum of 6 to 8 modifications). However, due to the 
continuous improvement in MS accuracy, improved search algorithms and PTM 
knowledgebase, tens of modifications are studied and used in the search engines in a single 
experiment, making the analysis very challenging and resource demanding, in some cases 
resulting in months of search time. Despite the much-debated cons of this kind of targeted 
analysis, it is conceptually straightforward and has therefore become an important part in the 
routine proteomic experiments.  
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 Moreover, in experiments aiming at PTM analysis, it is very important that there is sufficient 
information in the tandem MS spectra, which can result in confident peptide identification and 
modified site localization. These limitations hinder truly hypothesis-free analysis of 
modifications, to the point that the proportion of chemical and post-translational protein 
modifications in biological systems has remained unknown.  
To overcome above-mentioned issues, the proteomics community needs to develop novel 
algorithms and tools to make PTM analysis faster in similar ways as the genomics community 
has done with next-generation sequencing. Fortunately, in recent days new trends and 
developments are very encouraging, as is the deep phospho analysis performed in a single day 
measurement time (Bai et al., 2017; Hogrebe et al., 2018).  
2. Hypothesis-free proteomics: a potential replacement of conventional 
database search approaches 
The recently published open database search strategy (Chick et al., 2015) provided a starting 
point for resolving this problem, allowing a truly unbiased high-throughput identification of 
modified peptides without previous knowledge on the nature of these modifications. Later, an 
improved fragment-ion indexing method (MSFragger) demonstrated that open searches can be 
performed on a timescale similar to or shorter than that required for closed searches (Kong et 
al., 2017). The open search strategy has the additional advantage that modified and 
nonmodified peptide forms are identified simultaneously (Kong et al., 2017). These strategies, 
however, has a major drawback as they rely on the chance that the modification leaves enough 
unaffected fragment ion to be matched by search engine, or in other terms; these algorithm 
identifies modified peptides from MS/MS spectra, but only with the non-modified fragments. 
These OS strategies therefore diminishes the score assigned to a modified peptide and only half 
of the modified peptides detectable by conventional searches (CS) are identified. In addition, 
OS methods also fails to pinpoint or locate the modified amino acid in a peptide. Considering 
all current limitations in the current state, OS approaches are not comprehensive and provide 
limited information on the nature of modified residues.  
The novel computational approach presented in this thesis enables the open search strategy to 
match the performance of closed searches, identifying the vast majority of the MS-detectable 
peptide modifications. Although Comet-PTM is built on the framework of a well-known 
database-search engine, it is important to note that the underlying concept in it can be 
PhD Dissertation -Discussion 50 Navratan Bagwan
 extrapolated to any other searching engine, opening the way to near-complete analysis of the 
protein-modification landscape in biological systems using tools already used by the 
proteomics. The fact that Comet-PTM takes into account the mass shift in fragments, the 
identification scores are improved and as result, Comet-PTM not only outperforms the classical 
OS approaches but also produces a performance equal to targeted ssearch (CS). In several 
instances, Comet-PTM also corrects PTMs wrongly assigned by CS. For instance, oxidation 
was assigned to different amino acids such as Trp, Pro and Tyr that were forcibly assigned to 
Met in CS. This finding shows that conventional PTM searches using a variable modification 
on selected amino acids can force false assignation of the modified residue. Taken together, 
these data show that the CometPTM OS engine efficiently resolves the modification mass-shift 
in the fragmentation series, doubling the number of modified peptides identified by 
conventional OS and matching the identification performance of targeted CS. 
Localizing the modifications to specific residues is often considered a less reliable process than 
identifying peptides, partly because there is frequently insufficient information to determine 
the exact modified residue.  For this reason, there is a clear lack of algorithms, which not only 
identify all possible PTMs, but also localize the modified amino acid in single-pass searches. 
Usually, site localization algorithms are used post identification and the majority of these 
algorithms are optimized for specific modifications; such is the case of PhosphoRS (Taus et 
al., 2011) or Ascore (Taus et al., 2011). Comet-PTM resolves these issues and provides 
information on the most probable site containing the modification with an estimated accuracy 
of ~85%. It should be noted that, in its current state of development, the method might fail if 
the peptide contains more than one modification. However, the impact of this limitation on the 
general performance of the algorithm seems small, since, according to our data the fraction of 
multiply modified peptides that were not identified was almost negligible.  
In current researches of shotgun proteomics experiment the use of separate FDR for PTMs has 
been suggested and discussed thoroughly. The idea of a separate FDR or Local FDR comes in 
paly due to the basic difference in nature of spectra of modified and non-modified; that is the 
modified spectra can have a neutral loss or insufficient fragmentation. Due to their own specific 
features in spectra, modified peptides can have different score distribution compared to non-
modified peptide. In addition, abundance difference in modified and non-modified peptide in 
a given sample adds another challenge in FDR estimation, as chances of matching to a correct 
and incorrect peptide sequence are different. In order to overcome the problem in PTM FDR, 
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 we developed and introduced a conservative, three-layered approach to control the FDR of 
peptide identification. Our local FDR calculation is similar to that used by MSFragger (Kong 
et al., 2017), with the only difference that we used the decoy/target competition strategy to 
estimate FDR. However, Kong et al. modelled local score distributions, in the same 1-Da bins 
as a mixture of correct and incorrect identifications and calculated the probability of correct 
identification by the Bayes rule. As recognized by these authors, their approach did not take 
into account the p.p.m. levels of accuracy produced by high-resolution instruments (Kong et 
al., 2017), which we have considered in our model by applying an additional peak FDR 
estimation. In addition, we found it necessary to introduce a third global FDR filter to avoid 
identification of low-scoring peptides in local bins or in peaks that, as in the case of oxidation, 
concentrate high numbers of target PSMs. 
The new algorithm allowed us to produce peptide maps containing realistic proportions of 
unmodified peptides, posttranslational modifications, and chemical artifacts in mouse tissues 
and of amino acid residues subjected to each type of modification. Many of the modifications 
are introduced during sample preparation, including those induced by exposure to Cys-
alkylating and amine-directed isobaric labelling reagents; while these agents are thought to be 
highly specific, in practice they produce secondary reactions with other nucleophiles. 
We show that the basal distribution of modifications and modified amino acids is remarkably 
similar across the 3 mouse tissues studied, indicating that the algorithm generates reproducible 
results and that most peptide modifications are of an oxidative nature.  
In the direction of revelling the importance of PTMs, the statistical approach presented here 
enables quantitative analysis of the modified peptidome within the same framework used to 
analyse the unmodified proteome; this approach thus allows coherent interpretation of all the 
results and opens the way to integrated systems-biology analysis. We demonstrate the 
performance of the new algorithm by simultaneously characterizing, in three tissues of a mouse 
model, the quantitative impact of heteroplasmy on the proteome and on the modified 
peptidome. To our knowledge, this is the first study to apply open-search-based approaches 
together with quantitative mass spectrometry, allowing comprehensive and unbiased 
characterization of alterations in the protein modification landscape produced in a biological 
system.  
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 3. Hypothesis-free PTM analysis: from algorithm development to 
application 
The ability to perform a truly hypothesis-free high-throughput analysis of modifications can 
contribute to a deeper understanding of the relation between protein chemistry and function. 
However, the most important biological insight obtainable with shotgun proteomics is how 
these modifications are altered during normal physiological processes or because of disease. 
Detecting these specific alterations allows concentrating the study on biologically meaningful 
modifications, obviating the analysis of the abundant artifacts produced by sample preparation. 
Understating disease mechanisms has been mainly done with the help of either animal models 
or cell culture. However, more and more different omics analysis including proteomics are 
contributing towards clinical sample analysis. If the precision and personalized medicine is the 
future of medical science, PTMs might open a completely new path towards biomarker 
identification. Although, multiple PTMs are reported as potential biomarker of disease, only a 
few are routinely used for diagnostic purpose (Silva, 2015). Considering the complexity of a 
disease, in many cases a single molecule or a single PTMs or modification site may be 
insufficient as specific biomarker for diagnosis. Recent studies suggests, that combining 
different omics (genomics, lipidomics, metabolomics) with an extensive PTM map and 
identification would be to our advantage for identifying specific disease patterns and signatures 
(Huang et al., 2017). 
Nowadays an increasing amount of diseases is being linked to mitochondrial DNA (Ferries et 
al., 2017). Several medical technologies, mainly in the infertility treatments, have emerged 
aiming to prevent the transmission of these mtDNA-linked diseases (Tachibana et al., 2009; 
Craven et al., 2010; Woods and Tilly, 2015). However, the main “side effect” of these 
techniques is the generation of heteroplasmy, which is the presence of more than one variant 
of mtDNA co-existing in the same cytoplasm. Interestingly, some tissues (liver, blood cells) 
are able to slowly resolve the heteroplasmy, while others (heart, skeletal muscle, brain) cannot 
(Sharpley et al., 2012; Burgstaller et al., 2014). Some authors have raised concerns about the 
phenotypic impact on the offspring of some kinds of heteroplasmy (Battersby, Redpath and 
Shoubridge, 2005; Sharpley et al., 2012). In addition, recent results from the Functional 
Genetics of the Oxidative Phosphorylation System laboratory (CNIC) led by Juan Antonio 
Enriquez have evidenced that some kinds of wild type heteroplasmy can cause severe 
pathology upon aging, consisting in heart, lung and skeletal muscle wasting. Consequently, 
heteroplasmic mice present premature ageing-like symptoms and a higher frequency of early 
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 death (manuscript in preparation). The molecular cause of these negative effects of 
heteroplasmy in the different tissues of the offspring remains unknown. Thus, we selected this 
biological model to test the performance of our newly developed tools and the same time, to 
shed some light on the possible molecular mechanisms underlying the pathological effects of 
heteroplasmy, when they are being set up at an early age (12-week-old animals). Thus, we 
studied the protein levels and performed a systems biology analysis in a tissue able to resolve 
heteroplasmy during aging like the liver, and in two tissues where heteroplasmy remains stable 
with age, like the heart and skeletal muscle.  
First, we observed a generalized decrease in OXPHOS proteins in heteroplasmic hearts, but 
not in liver or skeletal muscle. Consistently, our collaborators we have reported a decreased 
ATP synthesis and an abnormal increase in phosphocreatine/ATP ratio in the heart and an 
increase in plasma creatine kinase in this animal model (manuscript in preparation). Thus, we 
provide further molecular evidence that heteroplasmic cardiac mitochondria have a 
compromised ability to supply energy to the sarcomere. In addition, the increased levels of 
vesicle trafficking proteins involved in the insulin-stimulated glucose uptake, agree with the 
higher glucose uptake our collaborators detected in heteroplasmic hearts, and point to a shift 
toward glycolytic metabolism in order to compensate the reduced phosphocreatine supply from 
the OXPHOS.  
Next, we hypothesized that tissue-specific PTMs could be a possible explanation for the 
reduction in the levels of OXPHOS proteins in heteroplasmic hearts. To answer this question, 
we first took advantage of the ability given by our newly developed tools to estimate for the 
first time the real proportions of the non-modified and modified peptide forms in a proteome, 
and studied the basal “modificome” maps of the three tissues. As expected, the relative 
proportions of artefactual modifications was the same among the three tissues, but to our 
surprize, the physiological PTMs were quite similar too.  
However, the changing PTMs brought about by heteroplasmy were quite different in the three 
tissues not only in its nature, but also in its extent. The heart was the most “modified” tissue in 
heteroplasmic animals, being most changing PTMs of oxidative nature, mainly on Tyr, Trp and 
Pro, and affecting mostly OXPHOS proteins. Although most changing modifications in liver 
were also oxidative, they were much fewer compared to the heart and were not concentrated 
on specific categories. The skeletal muscle was the least affected tissue, containing mainly 
increased deamidations, scattered on just a few proteins.   
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 Thus, the application of our tools reveals that the major hallmark of mitochondrial 
heteroplasmy in 12-week-old animals is oxidative damage to OXPHOS proteins in the heart. 
This is mainly reflected in the increased levels of oxidative modifications and in the decreased 
levels of OXPHOS proteins. Our data support the notion that heteroplasmy involving different 
nonpathological mtDNA variants affects the performance of the OXPHOS system in the heart; 
resulting in compromised mitochondrial ROS handling that triggers an oxidative stress 
response and impairs the ability to supply energy to the sarcomere. Heteroplasmy is known to 
be related to ROS production (Hamalainen et al., 2013; Hämäläinen et al., 2015) and also 
affects the levels of contractile proteins in muscle. These alterations do not occur in liver, which 
we have shown to be able to resolve heteroplasmy (unpublished data). Our data thus provide a 
molecular mechanism that explains the functional findings we have observed in the 
heteroplasmic heart, which include a diminished ability of mitochondria to produce ATP, 
increased glucose uptake, an exacerbated phosphocreatine/ATP ratio, and mitochondrial 
disruption and structural alterations. 
4. Future perspective 
Taking into account, the algorithms and tools developed for PTMs identification and 
quantification, to best of our knowledge, for the first time, we have formalized a way to 
automate the whole process to analyse the modified peptidome in a true hypothesis-free 
manner. Further, applying these developments to a biological model has greatly improved our 
understanding of PTMs in the context of not only technical but also chemical level. At the same 
times, we have also realized the potential challenges and problem, which we will have to deal 
within the near future. 
4.1. Decoding the mass combinations and aim for a faster search time 
With Comet-PTM, we have been able to localize the modification on their site with a very 
high accuracy, as Comet-PTM uses mass on fragments and then calculates the Xcorr for 
retrieving the modified peptide. However, Comet-PTM fails in very limited number of 
cases where mass is a combination of two different modification, resulting in either wrong 
identification or lower Xcorr. To a certain extent, this problem is taken care of post 
identification using PtmSticker: in which mass combination is broken into known 
modification masses, still leaving out the possibility of assigning the modification to it’s 
corresponding site. In present, we are working on an integration of an algorithm to Comet-
PTM, which can decipher the mass pre handed and then locate the modification site. 
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 On the other hand, due to considering the mass on fragments and Xcorr calculation on 
every amino acid makes Comet-PTM very computationally expensive. As a result, a high 
performance computer cluster is needed. To resolve the issue, we are working on a 
database-indexing algorithm, which will facilitate a faster candidate peptide retrieval. 
4.2. Re-ranking of PSMs: Xcorr to corrected Xcorr 
Like any other search engine, Comet-PTM provides multiple candidates for a scan, which 
are sorted based on their score (Xcorr in Comet-PTM). In brief, Xcorr is calculated based 
on the number of fragments matched between theoretical and experimental spectra. As a 
result, longer peptide scores better than shorter peptides, increasing the probability of a 
false identification just by chance. We are currently working on an idea where corrected 
Xcorr (Keller et al., 2002) will be calculated within Comet-PTM and PSMs would be 
ranked accordingly. This improvement will help us to retrieve PSMs from far negative side 
to FDR controlled region (FDR control in SHIFTS).  
Similarly, we are working on a potential idea where; instead of the mass (obtained from 
the difference between experimental and theoretical mass), the theoretical mass of the 
modification can be used in the fragments to calculate the identification scores. The reason 
behind the idea is that in some cases, either due to the instrument error, or to the low 
abundance of the modified precursor, the mass is introduced in the fragments with a slight 
deviation (has a slight error in mass), mismatching some of the fragments. Providing a 
curated list of theoretical Unimod delta masses would result in slightly better scores 
compared to the experimental mass and would recover some identifications, which are 
likely to be left out in FDR due to low score. 
In the same direction, I am working on PtmSticker to include an error model, which will 
take into account the peak abundance to annotate the mass distribution automatically 
(using Monte Carlo simulation). In this way, we will avoid using a fixed error to assign the 
peaks to PTMs and achieve a reliable annotation. 
4.3. Rediscovering the plasma proteome: a search for biomarker beyond 
proteins 
Currently the suit of developed algorithms and tools is being applied on a plasma proteome 
in a follow-up study to find biomarkers for subclinical atherosclerosis. Although many 
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 efforts have been made to find systemic biomarkers, none of the candidates has provided 
clinical diagnostic relevance yet. On the other hand, evidences are accumulating that the 
modified lipoproteins could be involved in the progression of the disease (Nicholls and 
Hazen, 2009; Delporte et al., 2013). Such evidences suggest that post-translational (PTMs) 
and structural modifications could potentially be used as biomarkers. Using these new 
developments for first time a quantitative map of human plasma PTMs is being created 
which will open a window to the pathogenic mechanisms underlying atherosclerosis (PhD 
thesis, Ileana Beatriz González Valdés). 
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 Conclusions 
 
1. The CometPTM pipeline enables a true hypothesis-free and unbiased identification of 
PTMs. 
 
2. Comet-PTM opens a way to near complete identification of all peptide modifications 
detectable by MS. 
 
3. Comet-PTM provides information on the amino acid affected by the PTM with an accuracy 
compatible with its use in high-throughput proteomics experiments. 
 
4. The new statistical method allows automated quantification of modified peptides, 
independent of protein change in abundance, and simultaneous analysis of the proteome 
and of the modified peptidome.  
 
5. The new bioinformatics tools generate for the first time the complete landscape of post-
translational modifications containing realistic proportions of unmodified and modified 
peptides and of chemical artifacts. 
 
6. Mitochondrial heteroplasmy in mice affects mainly the heart, inducing oxidative damage 
to proteins of the oxidative phosphorylation system.  
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 Appendices 
1. Appendix 1: Supplementary tables 
Due to the multiple big files, the links are provided. In addition, a copy of Tables in excel sheet 
forms, has been provided in CD 
1.1. Table 1: Benchmarking of Comet-PTM using synthetic Phospho-
peptide 
Comet-PTM correctly localized the position of the modified residue in 81% (122 out of 
151) of the cases. In 94% of the cases (144 out of 151), the site was localized in the correct 
or in an adjacent position. 
Link to download file: 
https://www.cell.com/cms/attachment/2119363229/2092777175/mmc2.xlsx 
1.2. Table 2: List of functional categories significantly altered by 
heteroplasmy (FDR < 5%) as a consequence of a coordinated protein 
response 
Increases in the heteroplasmic tissues, in relation to the average protein abundance of all 
samples are coloured in red, whereas decreases are in blue, according to the graded scale. 
Link to download file:  
https://www.cell.com/cms/attachment/2119363229/2092777176/mmc3.xlsx 
1.3. Table 3: List of modified peptides significantly altered by 
heteroplasmy (p < 0.05) 
Increases in peptide abundance in the heteroplasmic tissue compared to the average of 
peptide abundance of all samples are coloured in red, whereas decreases are in blue, 
according to the graded scale. P values are calculated using Student’s t test. 
Link to download file:  
https://www.cell.com/cms/attachment/2119363229/2092777177/mmc4.xlsx 
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 1.4. Table 4: Conservation and structural analysis of heteroplasmy-
modified peptides of OXPHOS complexes I, III, IV, and V 
The residues harbouring the modification are underlined. Residues predicted to be 
functional (conservation score 8-9 and exposed) are highlighted in red; residues predicted 
to have structural implications (conservation score 9 and buried), in blue; highly conserved 
residues (conservation score > 5), in green. Most PTMs are on highly conserved residues 
or next to highly conserved residues. Conservation scores were rated from 9 (highest 
conservation) to 1 (highest variability) by the ConSurf server 
Link to download file: 
https://www.cell.com/cms/attachment/2119363229/2092777178/mmc5.xlsx 
 
2. Appendix 2: Help for the programs developed 
2.1. Comet-PTM 
Comet-PTM is a modified version of the Comet project for the thorough analysis of post-
translational modifications, developed at the Cardiovascular Proteomics laboratory at 
CNIC (Spain). Link to download: https://github.com/CNIC-Proteomics/Comet-PTM 
Here i will describe the details that are different in Comet-PTM, especially the Comet-PTM 
specific parameters and its output. For the remaining parameters and output common with 
the original version of Comet, you have complete documentation at http://comet-
ms.sourceforge.net/ 
Input information: 
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 use_delta_xcorr,  checks  whether  the  DeltaXCorr  (the  mass  difference  between  the 
theoretical mass of the peptide identified and the experimental mass of potentially 
modified peptides) will be used or not (this is needed to use Comet‐PTM). 
 delta_outer_tolerance, the tolerance in Da for the maximum Delta XCorr that should 
be considered to calculate the mass of the modified peptide. 
 delta_inner_tolerance,  the  minimum  value  of  the  Delta  Xcorr,  under  which  a  mass 
difference  is  not  taken  into  consideration  (for  being  considered  a  non‐modified 
peptide). 
 use_delta_back_jumps, to consider isotopologues after the peak analysed. 
 use_delta_forward_jumps, to consider isotopologues before the peak analysed. 
 dont_calc_pseudo_non_mod, by default the nonmodified peptide is included among search 
results; by activating this parameter, those peptides will not be presented. 
 
Output information: 
Depending on the options in the params file, the output information can be in a number 
of formats. For handling information we recommend using the tab‐separated tables generated 
by setting output_txtfile = 1 
The generated file contains a number of columns. The following columns are the same as 
the  columns  used  in  regular  comet: scan,  num,  charge,  exp_neutral_mass, 
calc_neutral_mass,  e‐value,  xcorr,  delta_cn,  sp_score,  ions_matched,  ions_total, 
plain_peptide, retention_time, modifications (in regular comet this column appears at the 
end),  prev_aa,  next_aa,  protein,  protein_count.  The  column modified_peptide does  not 
appear as such in Comet‐PTM. 
The columns described below are Comet‐PTM specific: 
 exp_mz, the experimental m/z calculated as exp_neutral_mass ‐ proton_mass * z. 
 q_score, dot product of intensities of matched ions. 
 peptide, same as plain_peptide, but including previous and posterior amino acids. 
 delta_mods, the mass difference between the theoretical (non‐modified) peptide and 
the  modified  peptide  calculated  and  assigned  to  the  residue,  calculated 
as exp_neutral_mass ‐ calc_neutral_mass. 
 b_series_delta_mods, the fragments of the b‐series that have been observed to have a 
displacement of mass delta_mods. Every fragment that has been observed with such mass 
shift is followed by the "<" character. 
 y_series_delta_mods, sama as previous, but for the y‐series fragments. Every fragment 
that has been observed with such mass shift is preceded by the ">" character. 
 delta_jumps,  can  be  '‐2',  '‐1',  '0',  '+1',  '+2',  and  shows  the  backward/forward 
correction to select the monoisotopic peak from the isotopic envelope (deprecated, 
for regular options it always shows '0'). 
 delta_peptide, shows the sequence presented in plain_peptide, but including the mass 
shift observed in delta_mods in brackets. 
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 2.2. SHIFTS 
SHIFTS is a program made in the Jesus Vazquez Cardiovascular Proteomics Lab at Centro 
Nacional de Investigaciones Cardiovasculares (CNIC), for high throughput PTM (Post 
translation modifications) processing SHIFTS identifies peaks in the Delta Mass 
distribution, assigns PSM to peaks and calculates FDR for peptide identification. SHIFTS 
is developed in python programming language as command line tool and its works with 
cometPTM produced “.txt” files. Link to download: https://github.com/CNIC-
Proteomics/SHIFTS 
 
Input information: 
There are eight input parameters for SHIFTS. 
‐P,   ‐‐Path2master 
‐‐Input will be a text file, containing two columns: first, would be 
master path and second as sub path. This parameter will help to analyse 
multiple experiment of a project together, i.e. Project name = PTM, 
experiments in project PTM: heart, liver. Therefore, path/PTM will be 
master Path and heart and liver will be sub path. 
‐B,   ‐‐BinSize 
‐‐Bin size for slope modelling, the most standard bin to use is 0.001 
which has been tested for several experiments, however you are free to 
choose  depending  on  your  machine  resolution.  Lower  the  resolution 
bigger the bin. 
‐X,   ‐‐Xcor 
‐‐Corrected  Xcorr  threshold  for  choosing  the  best  non‐modified 
peptides, based on provided Xcorr, mass calibration will be performed. 
In most cases, 0.20 or 0.25 would be good enough. 
‐F,   ‐‐Fastafile 
‐‐path to Protein database which was used for searches (Concatenated). 
‐A,   ‐‐ApexFilter 
‐‐Apex threshold, a simple integer input (example 10 0r 15 0r 8) for 
ignoring the PTM peaks which have less PSMs than specified number. It 
will help  to  avoid  the background noise.  However in  cases of  small 
experiments using 0 would be useful, as some good PTMs will be very 
low frequent. 
‐f,   ‐‐FDRthreshold 
‐‐Global FDR filtration threshold. Example: 0.01 0r 0.05. 
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 ‐O,   ‐‐OutPutname 
‐‐output  folder  name,  specified  name  will  be  created  in  every 
experiment folder with all the results file. 
 
‐i,   ‐‐isotopeCorrection 
‐‐it´s True/false condition for isotopic correction. 0 for false and 1 
for true. A simple isotopic correction to minimize miss assignations 
of the correct monoisotopic peak of the precursor. When two PSM having 
the same sequence are encountered having a Mass difference within 1 
ppm of the mass difference expected for either one or two 13C or one 
34S, the ?Mass of the heaviest precursor is substituted by that of the 
lightest one. 
‐l,   ‐‐localFDR 
‐‐Local FDR filtration threshold. Example: 0.01 0r 0.05. 
 
‐p,   ‐‐localFDR 
‐‐Peak FDR filtration threshold. Example: 0.01 0r 0.05. 
Output information: 
1)"experimentName_TargetData_Calibration.txt"   
‐‐This  is  the  first  file  to  be  created  by  SHIFTS,  and  will 
contain  all  the  fractions  from  an  experiment  with  the 
calibration error per fraction with recalibrated masses. From 
here  to  the  results,  this  file  will  be  used  by  SHIFTS 
internally. 
2)"GlobalFDR.txt" 
‐‐This  file  will  contain  the  global  FDR  Xcorr  threshold  for 
specified FDR in input parameter "‐f". 
3)"sigmaCalculations.txt" 
‐‐This file will contain the fitting value for sigma. 
4)"heart_Median_log.txt" 
‐‐This file contain all the calibration error value, and number 
of PSM/Fraction from which error has been calculated. 
5)"target_Peak_identification_histogram.txt" 
‐‐This file contains a histogram and Gaussian derivatives for 
all the delta masses, which are used for peak apex picking. 
6)"Decoy_Peak_identification_histogram.txt" 
‐‐This file contains a histogram from decoys. 
7)"SlopeFDRfile.txt" 
‐‐This file contains all the data, like the calibration file, 
but with Local FDR calculated with every 1 Da. 
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 8)"Peak_and_Slope_FDRfile.txt" 
‐‐This file contains all the data, like the SlopeFDR file, but 
with Peak FDR, calculated with every peak apex. 
9)"NotassignedSequences.txt" 
‐‐This  file  contains  some  duplicated  (for  computing 
convenience) information, which will be found in final file. 
10)"AllWithSequence‐massTag.txt" 
‐‐This file contains all the data with FDR filtration and PSM 
to peak apex tagging. (PSM to Peak assignment). This will be a 
final File in case of where ‐i from parameter defined as 0. 
11)"IsotopCorrection_TargetData_withSequence‐massTag.txt" 
‐‐Will be the final file in case of where ‐i is defined as 1. 
Contains  all  the  PSMs  after  FDR  filter  and  with  isotopic 
corrections. 
 
2.3. PTM-Quant-Stats 
The GIA workflows are constructed using three executables: klibrate.exe, sanxot.exe and 
sanxotsieve.exe. Workflows are assembled in .bat files that are executed automatically 
under Windows command prompt (the same .bat file was used to perform the results 
provided in this thesis). All the executables and detailed help is provided online with 
example dataset. Link to download the pipeline and data: https://github.com/CNIC-
Proteomics/PTM-Quant-Stats 
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Supplementary Figure 1: representation quantification workflow, in which the automated pipeline had been 
executed 
 
 
Detail explanation of .Bat file, used in this work. 
REMImportant: before performing the integration, change "full path" by the path containing 
data and relation tables 
 
 
REM********************************************* 
REM*********** PART 1: integrations ************ 
REM******** scan > peptide > protein *********** 
REM********************************************* 
REM********** CALIBRATION OF WEIGHTS (as in the WSPP model) 
 
REMCalculation of calibration constant k of the set of scans belonging to the NM‐peptides 
REMk transforms un‐calibrated weights into true weights (inverses of variances) 
REM‐a sets the indicated prefix into the output file 
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 REM‐o names the output file as "NM_scan_Calibrated.txt" 
klibrate.exe ‐d"full_path/scan_XsVs_NM.txt" ‐r"full_path/s2pNM_Rels.txt" ‐k1 ‐v0 ‐aNM_scan 
‐o"full_path/NM_scan_Calibrated.txt" 
 
REMCalibration of weights of the set of scans belonging to the PTM‐peptides 
REM‐f avoids k and variance recalculation (uses variance seed as final variance) 
REMthe variance and calibration constant k from the set of scans corresponding to the non‐
modified (NM) peptides are used to calibrate the scans from the PTM‐containing peptides 
(PTM) 
klibrate.exe ‐d"full_path/scan_XsVs_PTM.txt" ‐full_path/s2pPTM_Rels.txt" –f ‐
K"full_path/NM_scan_infoFile.txt" ‐V"full_path/NM_scan_infoFile.txt" ‐aPTM_scan ‐
o"full_path/PTM_scan_Calibrated.txt" 
 
REMprepares a joined scan data file from NM and PTM peptides 
Copy "full_path/NM_scan_Calibrated.txt"+"full_path/PTM_scan_Calibrated.txt" 
"full_path/ALL_scan.txt" 
 
REMprepares a joined scan to peptide relations file from NM and PTM peptides 
copy "full_path/s2pNM_Rels.txt"+"full_path/s2pPTM_Rels.txt" "full_path/s2pALL_Rels.txt" 
 
REM********** SCAN TO PEPTIDE INTEGRATION 
REM‐‐tags"NonMod" selects the group of scans from the NM peptides as the null‐hypothesis to 
calculate the scan variance. 
REMThe tag is included in the third column of the scan‐to‐peptide relations file. 
REMA file named "s2pNM_OutStats.xls" is created. It contains Zsp for scans from NM and PTM‐
peptides, and FDRsp for scans only from NM peptides. 
REMAlso a file named "NM_peptide.xls" is created. It contains Xp and Vp values from NM‐
peptides to perform the following peptide‐to‐protein integration. 
sanxot.exe ‐d"full_path/ALL_scan.txt" ‐r"full_path/s2pALL_Rels.txt" ‐a"s2pNM" ‐
o"NM_peptide.xls" ‐‐tags"NonMod" 
 
REM‐f avoids variance recalculation (uses variance seed as final variance) 
REM‐V"s2pNM_infoFile.txt" forces the previously obtained null‐hypothesis scan variance as 
seed to integrate the scans from the PTM‐peptides. 
REM‐‐tags"PTM" selects the group of scans from the PTM‐peptides to perform the integration. 
REMA file named "s2pPTM_OutStats.xls" is created. It contains Zsp for scans from NM and 
PTM‐peptides, and FDRsp for scans only from PTM peptides. 
REMAlso a file named "PTM_peptide.xls" is created. It contains Xp and Vp values from PTM‐
peptides to perform the following peptide‐to‐protein integration. 
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 sanxot.exe ‐d"full_path/ALL_scan.txt" ‐r"full_path/s2pALL_Rels.txt" ‐f ‐
V"full_path/s2pNM_infoFile.txt" ‐a"s2pPTM" ‐o"PTM_peptide.xls" ‐‐tags"PTM" 
 
REM********** PEPTIDE TO PROTEIN INTEGRATION 
REMprepares a joined NM‐ and PTM‐peptide data file 
copy "full_path/NM_peptide.xls"+"full_path/PTM_peptide.xls" "full_path/peptide_ALL.xls" 
 
REM‐‐tags"NonMod" selects the NM peptides as the null‐hypothesis to calculate the peptide 
variance and the protein mean. 
REMThe tag is included in the third column of the peptide‐to‐protein relations file. 
REMA file named "protein.xls" is created. It contains protein Xq and Vq values to perform 
the following protein‐to‐category integration. 
REMAn additional file is created "p2q_OutStats.xls" containing the Zpq for NM and PTM‐
peptides, and the FDRpq for NM peptides only. 
 
sanxot.exe ‐d"full_path/peptide_ALL.xls" ‐r"full_path/p2qRels_ALL.xls" ‐a"p2q" ‐‐
tags="NonMod" ‐o"protein.xls" 
 
REM********************************************* 
REM****** PART 2: SYSTEMS BIOLOGY TRIANGLE ***** 
REM********************************************* 
REM********* PROTEIN TO CATEGORY INTEGRATION**** 
 
 
REMinitial protein>category integration 
REMThe output file "q2c_OutStats.xls" contains Zqc and FDRqc. 
sanxot.exe ‐d"full_path/protein.xls" ‐r"full_path/q2cRels.txt" ‐a"q2c_inouts" 
 
REMThe output file "removingOutliers_q2c_tagged.xls" file is created by tagging as "out" 
the protein outliers withinh each category at 1% FDRqc in the q2cRels.txt file. 
sanxotsieve.exe ‐d"full_path/protein.xls" ‐r"full_path/q2cRels.txt" ‐f0.01 ‐
V"full_path/q2c_inouts_infoFile.txt" ‐a"removingOutliers_q2c" ‐‐tags="!out" 
 
REMreintegrate protein>category without outliers 
sanxot.exe ‐d"full_path/protein.xls" ‐r"full_path/removingOutliers_q2c_tagged.xls" ‐
a"q2c_NoOuts" ‐o"category.xls" ‐‐tags="!out" ‐f ‐V"full_path/q2c_inOuts_infoFile.txt" 
 
REM********* CATEGORY TO ALL INTEGRATION 
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 REM‐C forces integration to all, obviating the use of a (category‐to‐all) relations table. 
REMThe output file "c2A_OutStats.xls" contains Zca and FDRca. 
sanxot.exe ‐d"full_path/category.xls" ‐C ‐v0 ‐f ‐a"c2A" 
 
REM********* PROTEIN TO ALL INTEGRATION 
 
REMThe output file "q2A_OutStats.xls" contains Zqa and FDRqa 
sanxot.exe ‐d"full_path/protein.xls" ‐C ‐V"full_path/q2c_inouts_infoFile.txt" ‐f ‐a"q2A" 
 
echo on 
 
2.3.1. Trilogy 
Trilogy V0.03 is a program made in the Jesus Vazquez Cardiovascular Proteomics Lab 
at Centro Nacional de Investigaciones Cardiovasculares, used to tag peptides in 
relations files where non-modified peptides are used as reference in PTM analysis. 
Trilogy can be downloaded from the link; the program is also supported with the 
example dataset:  https://www.cnic.es/wiki/proteomica/index.php/Trilogy 
Input information 
‐‐version               show program's version number and exit 
 ‐h,    ‐‐help             
Show this help message and exit 
 ‐a,    ‐‐analysis=ANALYSIS 
Use  a  prefix  for  the  output  files.  If  this  is  not 
provided, then no prefix will be garnered. 
 ‐p,    ‐‐place=OUTPUTFOLDER 
Provide the output folder location, If this not provided 
then output files will be created in the same location 
as input file. 
 ‐i,    ‐‐inputFile=INPUTFILE 
Enter the path for inputFile, any tab‐separated file can 
be used as an input. Example: SHIFTS output or Aljamia 
output 
 ‐c,    ‐‐peptideHeader=PEPTIDECOLUMN 
                         Identifier for the peptide coloumn 
 ‐C,    ‐‐proteinHeader=PROTEINCOLUMN 
                         Identifier for the protein/Fasta Description column 
 ‐s,    ‐‐ScanHeader=SCANCOLUMN 
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                          Identifier for the scan column 
 ‐f,    ‐‐RawfileHeader=RAWCOLUMN 
                        Identifier for the raw filename coloumn 
 ‐n,    ‐‐NonmodMass=NMAPEXMASS 
               This  parameter  allows  to  TAG  non‐modified  peptides. 
Tagging can be done in a very flexible manner by using different Tagging 
options in combination. Some default tagging options are also included 
Check  for  example  option  below  1)  [‐0.000232]|[1.001701]&!D=NonMod. 
Multiple  things  can  be  considered  to  a  Null‐hypothesis  in  eg.1,  [‐
0.000232] and [1.001701] both areconsideredas NH, seprated by a |. In 
addition,  additional  conditionscan  be  used  as  [1.001701]&!D, 
means,[1.001701]  shouldbe  in  peptide  but  D  should  notbe.  anythying 
after = will used as tag for NH 
 ‐t,    ‐‐PTMtags=PTMTAGS 
                This parameter allows to TAG modified peptides. Tagging 
be done in a very flexible manner by using different Tagging options 
in combination. Some default tagging options are also included example 
1) [15.994862] =Oxidation, [0.010924] =c13|PTMs, in this eg. Multiple 
things are considered as modification and all of them have different 
label, however for the things, which are not in input, can also be 
tagged as modification by using 
 
2.4. PtmSticker 
PtmSticker is a program made in the Jesus Vazquez Cardiovascular Proteomics Lab at 
Centro Nacional de Investigaciones Cardiovasculares, used to facilitate the semi-
supervised annotation of PTMs. 
Input information 
‐h,  ‐‐help   show this help message and exit 
    ‐i,  ‐‐pathforInputfile = INPUTF 
                         Enter the path to input file 
   ‐d,  ‐‐UniModDatabaseFile = DATABASE 
                          Enter the path for unimod file 
    ‐a,  ‐‐Artefectfile = ARTEFACT 
                          Enter the path for artefact file 
    ‐p,  ‐‐peptideColumn = PEPCOL 
                          Enter integet coloumn mnumber 
    ‐E,  ‐‐ErrorExp = EXPERIMENTALERROR 
                          Enter the Error value you expect 
    ‐e,  ‐‐ErrorCombi = COMBINATIONERROR 
                          Enter the Error value for mass combination 
    ‐O,  ‐‐OutPutname=OUTNAME 
                          Enter the output file name 
PhD Dissertation - Appendices 89 Navratan Bagwan
 3. Publication related to PhD work 
3.1. Comprehensive Quantification of the Modified Proteome Revels 
Oxidative Heart Damage in Mitochondrial Heteroplasmy 
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SUMMARY
Post-translational modiﬁcations hugely increase the
functional diversity of proteomes. Recent algorithms
based on ultratolerant database searching are forg-
ing a path to unbiased analysis of peptide modiﬁca-
tions by shotgun mass spectrometry. However,
these approaches identify only one-half of the modi-
ﬁed forms potentially detectable and do not map the
modiﬁed residue.Moreover, tools for the quantitative
analysis of peptide modiﬁcations are currently lack-
ing. Here, we present a suite of algorithms that allows
comprehensive identiﬁcation of detectablemodiﬁca-
tions, pinpoints the modiﬁed residues, and enables
their quantitative analysis through an integrated
statistical model. These developments were used
to characterize the impact of mitochondrial hetero-
plasmy on the proteome and on the modiﬁed pepti-
dome in several tissues from 12-week-old mice.
Our results reveal that heteroplasmy mainly affects
cardiac tissue, inducing oxidative damage to pro-
teins of the oxidative phosphorylation system, and
provide amolecular mechanism explaining the struc-
tural and functional alterations produced in heart
mitochondria.
INTRODUCTION
Shotgun mass spectrometry (MS)-based proteomics (Link et al.,
1999) has become a powerful tool for biotechnological and
biomedical research. Advances in speed and sensitivity allow
the generation of millions of spectra per experiment, but only a
minority of these spectra can be mapped to proteins (Griss
et al., 2016; Skinner and Kelleher, 2015). A large proportion of
unassigned spectra are thought to arise from peptides contain-
ing sequence variants or unknown chemical and post-transla-
tional modiﬁcations (PTMs) (Griss et al., 2016), and their charac-
terization is one of the most interesting and challenging goals in
proteomics. A number of computational methods have been
proposed for the detection of these unmatched peptides (Bern
et al., 2007; Chen et al., 2009; Griss et al., 2016; Kim and Pevz-
ner, 2014; Ma and Lam, 2014; Shortreed et al., 2015). Recently,
an ‘‘open search’’ (OS) strategy, where precursor mass toler-
ances of hundreds of daltons were used with a conventional
search engine, was reported to identify modiﬁed peptides at
an unprecedented scale (Skinner and Kelleher, 2015). Another
report demonstrated that OS can be performed at orders-of-
magnitude faster speeds using a fragmentation-ion indexing al-
gorithm (MSFragger) (Kong et al., 2017). These two methods
may have a considerable impact on the ﬁeld, opening the way
to true hypothesis-free analysis of PTMs by MS; however, OS
algorithms still rely on the chance that the modiﬁcation leaves
enough unaffected fragment ions for matching by the search en-
gine (Figure 1A). OS strategies can therefore identify only
approximately one-half of the modiﬁed peptides detectable by
conventional ‘‘closed’’ searches (CS) (Chick et al., 2015). More-
over, existing OS approaches cannot directly identify the
modiﬁcation site. A further important consideration is that OS
methods have not previously been used to quantify PTM alter-
ations, and a general statistical model for the analysis of data
of this kind is currently lacking.
Here, we present a suite of bioinformatics tools designed to
overcome these limitations. Our tools double the coverage
attained by existing algorithms, enabling the generation of
comprehensive peptide maps that include practically all of the
modiﬁcations potentially detectable by MS and CS of the data-
base. Our approach also allows accurate location of the modi-
ﬁed residues and quantitative analysis of PTMs in the context
of proteome-wide studies. We demonstrate the performance
of our tools by performing a comprehensive, tissue-speciﬁc
characterization of PTMs induced by mitochondrial hetero-
plasmy in a mouse model. Heteroplasmy has recently attracted
the attention of the biomedical community because it can be
produced during mitochondrial replacement therapies aimed at
preventing transmission of pathogenic mutations in mitochon-
drial DNA (Craven et al., 2010) or at treating infertility (Wolf
Cell Reports 23, 3685–3697, June 19, 2018 ª 2018 The Author(s). 3685
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Overview and Peptide Identiﬁcation Performance of Comet-PTM
(A) Conventional OS methods can identify modiﬁed peptides from MS/MS spectra, but only the fragments unaffected by the modiﬁcation (orange square) are
matched; this effect diminishes the score assigned to modiﬁed peptides, decreasing identiﬁcation performance.
(B) Comet-PTM ﬁrst calculates the difference between the mass of the candidate and the mass of the precursor ion detected by the MS (Dmass). DMass is then
iteratively added to each amino acid in the peptide sequence, and the position that yields the best score is selected as the correct match.
(C) The HeLa dataset from the original OS article (Chick et al., 2015) was searched using Comet in closed search (CS) mode with three variable modiﬁcations (Met
oxidation, Asn and Gln deamidation, and Ser and Thr phosphorylation), with Comet in OS mode, or with Comet-PTM (500-Da tolerance in the latter two cases).
The scores obtained for the same spectra in the different searching conditions are compared. Yellow points in the rightmost graph are PSMs that match peptides
with more than one modiﬁcation in CS mode.
(D) Identiﬁcation performance of OS and Comet-PTM relative to CS in the populations of peptides modiﬁed by oxidation, deamidation, or phosphorylation. The
number of PSMs was obtained after ﬁltering by the score threshold corresponding to 1% FDR in the CS. PSMs matching peptides with more than one modi-
ﬁcation in CS are indicated by orange bars.
(E) Frequency distribution of PSMs obtained by OS and Comet-PTM as a function of Dmass.
(F–M) Details of the frequency distribution around oxidation (F), formylation (G), aminoethylbenzenesulfonylation (H), iron (I), iodination (J), 13C (K), carbamylation
(L), and pyroglutamylation (M). The charts to the right of (L) and (M) show the distribution of PSMs as a function of the quantile position of the modiﬁcation in the
peptide sequence assigned by Comet-PTM.
See also Figure S1.
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et al., 2015). Mitochondrial heteroplasmy in mice can be genet-
ically unstable and produce adverse physiological effects
(Sharpley et al., 2012). The exact molecular mechanisms that
produce the pathological effects are unclear and the potential
health risk produced by heteroplasmy in the offspring is debated.
Our results show that heteroplasmy between nonpathological
mitochondrial DNA variants induces an array of oxidative modi-
ﬁcations in the heart that predominantly affect proteins of the
oxidative phosphorylation system. The tools presented here
thus improve our ability to interpret the totality of information
present in MS/MS datasets and provide proteome-wide per-
spectives for systems biology analysis in high-throughput
proteomics.
RESULTS
Comet-PTM Enables Comprehensive Identiﬁcation of
Peptide Modiﬁcations
We developed Comet-PTM, an improved OS engine that takes
into account the mass shift produced by the modiﬁcation in
the fragmentation series, producing the same score as a CS
search using the same mass increment as a variable modiﬁca-
tion (Figure 1B). To test the performance of Comet-PTM, the
results were compared with those obtained with OS and with
CS using three common variable modiﬁcations. As expected,
OS assigned higher scores to a large population of peptide-
spectrummatches (PSMs) containingmodiﬁcations not included
in the CS list of variable modiﬁcations (Figure 1C, left). However,
CS assigned a higher score than OS to a large population
of PSMs with modiﬁcations included in the CS list, because
the modiﬁcations affected the matching of fragment ions,
decreasing the OS-assigned score (Figure 1C, left). This effect
reduced the identiﬁcation performance of OS to around 50%
of the PTMs identiﬁed by CS (Figure 1D), conﬁrming previous re-
sults (Chick et al., 2015). In contrast, scores obtained with
Comet-PTM matched or exceeded OS (Figure 1C, center). In
addition, Comet-PTM identiﬁed the same Dmass peaks as OS
(Figure 1E); however, most of these peaks contained about
2-fold more PSMs (Figures 1E–1J), reﬂecting the superior perfor-
mance. As expected, this effect was not observed when the
modiﬁcation did not affect the fragmentation series. Thus, the
13C peak, produced by errors in assignment of the monoisotopic
precursor mass, was observed with exactly the same number of
PSMs (Figure 1K). The number of PSMswas also similar formod-
iﬁcations in N-terminal position of the peptide, which only affect
b-series and have a negligible effect on identiﬁcation by higher-
energy collisional dissociation (HCD) fragmentation (Figures 1L
and 1M).
Comet-PTM produced scores similar to or higher than those
obtained with CS (Figure 1C, right), except for a small population
of peptides for which CS found two or more modiﬁcations (Fig-
ure 1C, orange dots). This effect was not due to differences be-
tween CS and Comet-PTM scores (Figures S1A and S1B).
Therefore, and unlike OS, Comet-PTM had a similar identiﬁca-
tion performance to that of CS for the preselected modiﬁcations
(Figure 1D). In several instances, Comet-PTM correctly located
an oxidation on Trp, Pro, or Tyr that CS wrongly assigned to
oxidation on Met, the predeﬁned variable modiﬁcation residue
in CS (Figures S1C–S1E). This ﬁnding shows that conventional
PTM searches using a variable modiﬁcation on selected amino
acids can force false assignation of the modiﬁed residue. Taken
together, these data show that the Comet-PTM OS engine efﬁ-
ciently resolves the modiﬁcation mass shift in the fragmentation
series, doubling the number of modiﬁed peptides identiﬁed by
conventional OS and matching the identiﬁcation performance
of targeted CS.
Comet-PTMDetects the Location ofModiﬁcations in the
Peptide Sequence
Peptides were identiﬁed after Comet-PTM searches with
SHIFTS, an algorithm that detects the peaks in the Dmass distri-
bution and controls the peptide false-discovery rate (FDR)
through a conservative, three-layered approach (Figures 2A–
2C; see also STAR Methods). From the output of a search
against a concatenated target-decoy database, SHIFTS calcu-
lates a global score threshold to control FDR in the population
of PSMs with Dmass greater than 56 Da (Figure 2A). A local
score threshold is also deﬁned to control FDR separately within
each of the 1-Da bins in the Dmass distribution (Figure 2B).
Finally, a peak score threshold is calculated to control FDR sepa-
rately within each peak detected in the Dmass distribution (Fig-
ure 2C). A PSM is considered to be correctly identiﬁed when
its score is above the global and peak thresholds; when a PSM
does not form part of a peak, instead of the peak threshold the
local threshold is used. This conservative approach allows full
control of FDR, avoiding any bias due to the speciﬁc behavior
of certain kinds of peptide modiﬁcations that may bemore prone
to match decoy sequences.
An advantage of Comet-PTM over existing OS approaches is
that it automatically assigns themodiﬁcation to the residue in the
peptide sequence that produces the best score and therefore is
the modiﬁed position that best explains the fragmentation data.
Assigning modiﬁcations to speciﬁc residues is considered a
much less reliable process than identifying peptides, partly
because there is frequently insufﬁcient information to determine
the exactmodiﬁed residue (Chalkley et al., 2008). To estimate the
accuracy of Comet-PTM assignation of amodiﬁcation to the cor-
rect site, we ﬁltered correct identiﬁcations using the conservative
method described above with a 1% FDR threshold and then
calculated the fraction of PSMs in which the mass shift was
located in amino acids predicted to harbor well-knownmodiﬁca-
tions. Oxidation was located to Met, Trp, or Pro in 82% of cases,
and deamidation to Asn, Gln, or carbamidomethylated Cys in
86% of cases (Figure 2D). Considering six well-known modiﬁca-
tions, the overall accuracy of Comet-PTM was estimated at
85%. To test more speciﬁcally the performance of Comet-
PTM for the correct assignation of phosphorylation sites, we
analyzed a dataset obtained from synthetic phosphorylated
peptides (Ferries et al., 2017). Comet-PTM assigned the correct
position with 81% accuracy, and in 94% of the cases the modi-
ﬁcation was in the correct or in an adjacent position (Table S1).
We then analyzed which amino acids were assigned to known
modiﬁcations with a higher frequency than expected by chance.
Among the most frequent, we only found well-known modiﬁca-
tions like oxidized Met and Trp, deamidated Asn, Gln and carba-
midomethylated Cys, phosphorylated Ser, trioxidized Cys and
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Trp, and kynurenine-modiﬁed Trp (Figure 2E). Some Pro modiﬁ-
cations were also found with the Dmass of kynurenine-modiﬁed
Trp (Figure 2E), but all of them corresponded to homologous
peptides that contained the Pro>Thr substitution, which has
the same Dmass (Figure S2), and that were assigned the same
score. Finally, Trp iodination was also clearly detected above
background (Figure 2E). This modiﬁcation was unexpected
because, although Trp halogenases have been described in bac-
teria (van Pe´e and Patallo, 2006), they are not present in mam-
mals, and Trp iodination has not been described before as a
chemical artifact. The majority of peptides containing iodinated
Trp contained neither Tyr nor His, the two amino acids known
to react with iodine. A careful inspection of their fragment
spectra conﬁrmed the presence of y-fragments that could only
be explained by Trp being the modiﬁed residue (Figure S3). In
addition, the only modiﬁcation described in Unimod that
matched the observed mass shift corresponded to iodination.
From all of these data, we concluded that Trp was iodinated in
these peptides, most probably as a side-chain reaction of the
iodine produced from the Cys-alkylating reagent iodoacetamide.
This ﬁnding further highlights the accuracy with which Comet-
PTM locates the site of modiﬁcation and suggests that this OS
engine may be useful for detecting novel peptide modiﬁcations
in speciﬁc amino acids.
A Single Integrated Statistical Framework Allows
Quantiﬁcation of the Proteome and of the Modiﬁed
Peptidome
For the quantitative analysis of modiﬁed peptides, we developed
an algorithm based on a previously proposed systematic work-
ﬂow (Garcı´a-Marque´s et al., 2016; Navarro et al., 2014) (Fig-
ure 3A). The algorithm includes a peptide-to-protein integration
step that quantiﬁes protein values from the unmodiﬁed peptide
forms and then computes the standardized log2-ratio of the
modiﬁed peptides with respect to these protein values ðZpqÞ(Fig-
ure 3B). This makes it possible to detect modiﬁed peptides
whose behaviors deviate signiﬁcantly from those of the unmod-
iﬁed peptides from the same protein. Note that the algorithm cal-
culates peptide abundances relative to the parent protein, not to
themean of all the peptides in the sample, so that changes at the
peptide level are unaffected by changes in protein abundance.
When applied to a biological model, the Zpq distributions of the
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Figure 2. Identiﬁcation of Modiﬁed Peptides and Location of the Modiﬁed Site
(A) DMass distribution of target and decoy PSMs and range of application of the global score threshold. The vertical scale is enlarged to show the distribution of
decoy PSMs.
(B) Local score thresholds applied in each 1-Da bin in the Dmass distribution.
(C) Peak score thresholds applied to the peaks detected by SHIFTS in the Dmass distribution.
(D) Percentage of successful assignment of the indicated modiﬁcation to the indicated residues.
(E) Inset horizontal bar graphs plot the frequency distributions of PSMs assigned by Comet-PTM to the indicated amino acids and modiﬁcations. Vertical bar
graphs: frequency of PSMs assigned to the indicated amino acids after subtracting the average frequency of the three previous and the three subsequent
positions. Residues that accumulate counts in the histogram at position 0 are labeled in red.
See also Figures S2 and S3.
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unmodiﬁed and modiﬁed peptide forms precisely followed the
expected null hypothesis distribution in different tissues from
two mouse strains (Figure 3C). These results convincingly
demonstrate that the quantitative behavior of the entire popula-
tion ofmodiﬁed peptides can bemodeled accurately, providing a
robust statistical framework within which to analyze abundance
changes in high-throughput experiments. This allowed detection
of signiﬁcant changes in certain modiﬁed peptides against the
null hypothesis in speciﬁc situations (Figure 3C, lower left).
The same workﬂow used for peptide quantitation allowed the
analysis of protein abundance changes and the characterization
of functional categories that were affected by the coordinated
action of proteins, using the systems biology triangle (SBT)
model (Garcı´a-Marque´s et al., 2016) (Figure 3A). This statistical
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Figure 3. Quantitative Analysis of Alterations Produced by Heteroplasmy in the Modiﬁed Peptidome and in the Proteome
(A) Scheme of the integrative workﬂow used to quantify modiﬁed peptides, proteins or categories. Each arrow represents a step performed with the generic
integration algorithm (Garcı´a-Marque´s et al., 2016). Standardized log2-ratio values at the peptide level ðZpqÞ are obtained from the peptide-to-protein integration.
The algorithm provides corrected peptide values by taking account of the corresponding protein changes. The same workﬂow is used for protein quantiﬁcation
and systems biology analysis of coordinated protein responses with the SBT model (Garcı´a-Marque´s et al., 2016).
(B) Scheme of the generic integration algorithm (GIA) (Garcı´a-Marque´s et al., 2016) adapted for the analysis of modiﬁed peptides in the peptide-to-protein
integration step. The relations table include tags that can be used to indicate that modiﬁed peptides are excluded from the computation of protein averages.
(C) Distributions of Zpq values for nonmodiﬁed (Non-Mod) and modiﬁed peptides (Mod). These data come from the analysis of mouse tissues in a model of
mitochondrial heteroplasmy; each graph corresponds to a tissue from an individual animal. The inset plots show the Zpq distributions for peptides containing the
kynurenin Trp modiﬁcation. Note that the distribution is displaced to the right in the hearts of heteroplasmic mice, indicating increased abundance. For further
details, see STAR Methods.
(D) Characterization of coordinated protein alterations produced by heteroplasmy in heart, liver, and muscle using the SBT model. Zqa values are standardized
log2-ratio averages of proteins from heteroplasmic mice relative to controls. Proteins are grouped into representative functional categories with a statistically
signiﬁcant change. The upper panel presents proteins in the OXPHOS category that are decreased in the heteroplasmic heart and that contain heteroplasmy-
induced oxidative modiﬁcations (Figure 6).
See also Table S2.
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design thus allowed a full description of the alterations in the
modiﬁed peptidome in the global context of changes in the
proteome.
Heteroplasmy Produces Protein Alterations Consistent
with a Mitochondrial Dysfunction in the Heart
We used Comet-PTM and associated tools to study the molec-
ular impact of mitochondrial heteroplasmy on the proteome
and the modiﬁed peptidome in heart, liver, and skeletal muscle
from 12-week-old mice. This age was considered the most
appropriate to study molecular alterations before more exten-
sive damage was produced as a consequence of hetero-
plasmy. SBT model analysis of the quantitative protein data
from the heart revealed a coordinated decrease of proteins
related to muscle function and the oxidative phosphorylation
system (OXPHOS) and a coordinated increase of tubulins,
myosins, and proteins involved in vesicle trafﬁcking. The mus-
cle-function proteins included KCRS (mitochondrial creatine ki-
nase) and VDAC3, which are key suppliers of phosphocreatine
to the sarcomere, and SGCG and KGP1, which are essential for
sarcomere contraction (Table S2). These alterations in hetero-
plasmicmice are highly consistent with the decreased ATP syn-
thesis and the abnormal increase in phosphocreatine/ATP ratio
in the heart and with the increase in plasma creatine kinase we
have observed in this animal model (unpublished data), and
provide evidence that heteroplasmic cardiac mitochondria
have a compromised ability to supply energy to the sarcomere.
Among the increased vesicle trafﬁcking proteins, STXB3 and
VAMP2 are implicated in the insulin-dependent movement of
GLUT4 from inner vesicles to the plasma membrane. This
ﬁnding also agrees with a higher glucose uptake we detected
in heteroplasmic hearts, pointing to a shift toward glycolytic
metabolism in order to compensate the reduced phosphocrea-
tine supply from the OXPHOS. The coordinated decrease in
blood proteins and the increase in heart cytoskeletal proteins
in heteroplasmic animals suggest a homeostatic effort to main-
tain cardiac cell structure.
Heteroplasmy did not affect OXPHOS protein levels in liver but
did produce a coordinated increase of docosahexaenoic acid
(DHA) signaling pathway proteins (Figure 3D), including AKT2,
BID, and B2CL1 (Table S2). AKT2 plays an essential role in the
progression of the inﬂammatory response and apoptosis (Lo´-
pez-Carballo et al., 2002); consistent with this ﬁnding, we de-
tected signs of inﬂammation in the liver of heteroplasmic mice
with aging (unpublished data). Heteroplasmic liver also showed
coordinated increases in a group of myosins and phosphatidyli-
nositol pathway proteins, probably reﬂecting a homeostatic
response. These data thus indicate that, at 12 weeks of age, het-
eroplasmy produces a decrease in OXPHOS proteins in the
heart, probably reﬂecting mitochondrial dysfunction, but the
same effect is not seen in liver.
In heteroplasmicmuscle, we detected a coordinated decrease
of proteins regulating cell shape, such as tubulins and microtu-
bule proteins (Figure 3D). On the other hand, the thick-ﬁlament
myosins, as well as calcium transporting proteins, were
increased, suggesting the induction of compensatory mecha-
nisms. However, we found no evidence of altered mitochondrial
protein levels in muscle at this age.
Heteroplasmy Mainly Produces Oxidative Modiﬁcations
of OXPHOS Proteins in Heart
To study the impact of heteroplasmy on themodiﬁed peptidome,
we ﬁrst compared the Dmass distribution of peptides searched
with Comet-PTM and identiﬁed with SHIFTS in the three tissues.
The distribution of the most abundant peaks was very similar in
liver, heart, and muscle (Figure S4). In addition to the most
intense peak corresponding to unmodiﬁed peptides, we found
peaks corresponding to oxidized and deamidated peptides,
and dioxidized peptides were also frequent. Other frequentmod-
iﬁcations were artifacts produced by TMT reagents and iodoace-
tamide treatments, sodium adducts, and missed cleavages.
Some tissue-speciﬁc modiﬁcations were also detected, mostly
in the region from 50 to 100 Da. Among these, phosphorylated
peptides were more abundant in muscle and 90% of these pep-
tides belonged to proteins implicated in muscle contractility,
consistent with the regulatory role of phosphorylation in the
sarcomere. Within each Dmass peak, we analyzed the distribu-
tion of the modiﬁed amino acid residues, which were assigned
to frequent modiﬁcations using the unbiased approach followed
in Figure 2E. Conﬁrming the results described above, amino
acids known to harbor speciﬁc modiﬁcations were mostly
located correctly (Figure S5). Interestingly, the relative propor-
tion of modiﬁed sites was remarkably preserved across the three
tissues, with the exception of tyrosine iodination, which was
prominent in heart but less frequent in liver and skeletal muscle
(Figure S5). This analysis also detected the increased frequency
of phosphorylation in muscle (Figure S5). We estimated that
about one-quarter of the total peptidome in the three tissues
had known PTMs, mostly oxidation and deamidation; less than
10% of modiﬁcations were chemical artifacts (Figure 4A).
Second, we analyzed the quantitative data with the integrative
statistical algorithm (Figure 3A) to determine the pattern of mod-
iﬁcations that are speciﬁcally affected by heteroplasmy in each
tissue. Heteroplasmy induced marked tissue-speciﬁc modiﬁca-
tions, most of them concentrated in heart and barely detectable
in skeletal muscle (Figure 4B; Table S3). The vast majority of
increased modiﬁcations in heart were oxidative, affecting mostly
Tyr, Trp, Pro, and Phe and to a lesser extent Asn, Cys, and Asp
(Figure 4C). Heteroplasmy also induced phosphorylation and
methylation in the heart. The modiﬁcation pattern was similar
in liver, but the effect of heteroplasmy in this tissue was signiﬁ-
cantly less pronounced.
Functional enrichment analysis revealed that heteroplasmy-
induced modiﬁcations in mouse heart were mostly located in
mitochondrial proteins, particularly those located in the inner
mitochondrial membrane; moreover, most of the modiﬁed pro-
teins were OXPHOS proteins, which were enriched with multiple
oxidative modiﬁcations (Figure 5A). Tricarboxylic acid (TCA) cy-
cle proteins and those related to the oxidoreductase complex
were enriched in several modiﬁcations. Deamidation affected
several mitochondria-related categories, and phosphorylation
affected proteins related to contractility. Heteroplasmy-induced
modiﬁcations affected considerably fewer categories in liver
(Figure 5B) and were not signiﬁcantly enriched in muscle (Fig-
ure 5C), where only a few categories were decreased, containing
low numbers of proteins. Deamidated peptides were found in
proteins related to mitochondria, NAD binding, and extracellular
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exosomes in both heart and liver, suggesting that these modiﬁ-
cations do not contribute to tissue-speciﬁc phenotypic differ-
ences between heteroplasmic and control mice.
Interestingly, heteroplasmy decreased phosphorylations in
proteins related to chaperone activity in the heart but had the
opposite effect in liver (Figures 5A and 5B). This category con-
tains the two HSP90 isoforms (HSP90AA1 and HSP90AB1),
which harbor PTM sites involved in the regulation of the chap-
erone activity (Mollapour and Neckers, 2012). These isoforms
are known to be phosphorylated at Ser263 and Ser255, respec-
tively (Hu et al., 2015; Wang et al., 2017), within the CK2 phos-
phorylation motif (S-X-X-E), which is crucial for protein activity.
In particular, phosphorylation at Ser255 is required for the activa-
tion of mitogen-activated protein kinase (MAPK)/extracellular
signal-regulated kinase (ERK) pathway. Comet-PTM and
SHIFTS identiﬁed these two phosphorylated sites, and hetero-
plasmy decreased their levels in heart while increasing them in
liver (Figure 5D). These ﬁndings suggest that heteroplasmy
differentially affects chaperone activity and support the roles in
cardiac heteroplasmywe have proposed for the endoplasmic re-
ticulum and the mitochondrial unfolded stress response (unpub-
lished data).
Heteroplasmy also altered phosphorylation levels at sites
known to regulate protein activity in a tissue-speciﬁc manner.
Phosphorylation at Ser42 from PTRF, which regulated transcrip-
tional activity in response to metabolic challenges (Huttlin et al.,
Figure 4. Alterations Produced by Heteroplasmy in the Modiﬁed Peptidome in Different Mouse Tissues
(A) Complete map of the basal peptidome, expressed as a percentage of the total number of peptides identiﬁed in each tissue (circular bar graphs: h, heart; l,
liver; m, muscle). For simplicity, peptides oxidized onMet (light blue) are included in the group of nonmodiﬁed peptides. The plot to the right shows proportions of
artifacts produced by sample manipulation.
(B) Number of PTM-containing peptides signiﬁcantly increased (+) or decreased () in heteroplasmic mouse tissues (n = 4) relative to controls (n = 3).
(C) Statistically signiﬁcant PTM increases in heteroplasmic mouse tissues according to the type of modiﬁcation and the modiﬁed residue. The circular inner bars
show the peptide proportion for eachmodiﬁcation in the basal state, and the radial red bars represent the proportion of peptides of each kind (in parts per 10,000)
that are increased in heteroplasmic tissues. For the sake of clarity, three different scales are used depending on the type of modiﬁcation. DeA, deamidation; meth,
methylation; phos, phosphorylation; MC, missed cleavages; Chem, chemical derivatives produced by sample preparation; TMT, extra addition of the isobaric
labeling reagent; Adducts, Na, K, and ammonia adducts. Uppercase letters indicate the single-letter amino acid code. ox, oxidation; 2ox, dioxidation; 3ox,
trioxidation; Kyn, Trp to kynurenine; OH, Trp to hydroxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-hydroxy formyl kynurenine; red triangle, Trp
to oxolactone; red square, Trp to quinone; q, quinone, Tyr to quinone; Iodo, iodination; asterisk, Met to homocysteic acid; hashtag, Met to homoserine.
See also Figures S4 and S5 and Table S3.
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2010; Liu and Pilch, 2016), was decreased in heart but was
increased in muscle, in agreement with the different metabolic
status of these tissues (Table S3). Similarly Ser133 from MYG,
which regulates contractility (Lundby et al., 2013), was more
phosphorylated in heart, in line with the coordinated decrease
of proteins related to muscle function (Figure 3D), suggesting al-
terations in the contractile function of the heart in heteroplasmic
animals. In the liver, the active site Ser117 from PGM1, which
regulates glycogen biosynthesis (Huttlin et al., 2010; Lee et al.,
2014), was less phosphorylated, suggesting lower fuel storage
in this tissue (Table S3). These results reinforce the notion that
the impact of heteroplasmy is tissue speciﬁc. The rest of phos-
phorylated sites affected by heteroplasmy had unknown regula-
tory roles, but it should be noted that all of them have been
described previously, supporting the accuracy of the algorithms
used to detect them. They include Ser181 in PGRMC1 (Jin et al.,
2004), Ser442 in SRCA (Dai et al., 2007), Ser475 in JPH1 (Rigbolt
et al., 2011), and Ser298 and Ser304 in BIN1 (Ballif et al., 2004;
Huttlin et al., 2010) (Table S3).
To compare the alterations in the modiﬁed peptidome with the
changes observed at the protein level, we mapped the proteins
harboring PTMs affected by heteroplasmy onto the protein dis-
tribution plots depicting coordinated protein responses (red
and blue dots in Figure 3D). Most increased modiﬁcations map-
ped onto the OXPHOS protein category in heart, which was
decreased, whereas proteins belonging to other categories
were mostly unaffected. This ﬁnding suggests that the oxidative
damage produced by heteroplasmy in heart OXPHOS proteins
induced their degradation, and is consistent with the increase
in oxidative stress we have observed in heart slices, embryonic
ﬁbroblasts, and adult ﬁbroblasts of heteroplasmic mice (unpub-
lished data).
Most heteroplasmy-induced oxidative modiﬁcations in
OXPHOS proteins occurred in the four respiratory protein com-
plexes, except for Trp oxidations, which were mostly concen-
trated in C-IV (Figure 6). The modiﬁcations were clustered in
groups of proteins located together in the structure of the com-
plexes and predominantly affected proteins oriented toward the
mitochondrial matrix, where proteins are more exposed to mito-
chondrial reactive oxygen species (ROS). In further analysis, we
used Consurf to calculate evolutionary conservation proﬁles for
the affected residues (Ashkenazy et al., 2016) and mapped the
modiﬁcations onto the known three-dimensional (3D) structures
of the complexes, when available, or onto their predictedmodels
(Meier and So¨ding, 2015). We found that 70% of the modiﬁed
residues were conserved or interacted with conserved regions
(Table S4). Moreover, most of the modiﬁcations were located
on the protein surface, and those that were buried tended to
have high conservation scores, suggesting they are important
for structural stability or folding (Table S4). These ﬁndings sug-
gest that these oxidative modiﬁcations compromise OXPHOS
protein function. This view is supported by the decreased ATP
synthesis capacity we have detected in heteroplasmic heart.
DISCUSSION
Comprehensive analysis of PTMs inmass spectrometry data ob-
tained through shotgun approaches has historically presented a
bioinformatics challenge because conventional (or closed) data-
base searches can only identify predeﬁned subsets of modiﬁca-
tions. This limitation impedes truly hypothesis-free analysis of
modiﬁcations, to the point that the proportion of chemical and
PTM in biological systems has remained unknown. The open
database search strategy (Chick et al., 2015) provided a starting
point for resolving this problem, allowing a truly unbiased high-
throughput identiﬁcation of modiﬁed peptides without previous
knowledge on the nature of these modiﬁcations. An improved
fragment-ion indexing method (MSFragger) later demonstrated
that OS can be performed on a timescale similar to or shorter
than that required for CS (Kong et al., 2017). The open-search
strategy has the additional advantage that modiﬁed and nonmo-
diﬁed peptide forms are identiﬁed simultaneously (Kong et al.,
2017). These strategies, however, are not comprehensive and
provide limited information on the nature of modiﬁed residues.
The computational approach presented here enables the
open-search strategy to match the performance of CS, identi-
fying the vast majority of detectable peptide modiﬁcations.
Although Comet-PTM is built on the framework of a well-known
database searching engine, it is important to note that the under-
lying concept can be extrapolated to any other searching engine,
opening the way to near-complete analysis of the protein-modi-
ﬁcation landscape in biological systems using tools already used
by the proteomics community. In addition, our method provides
information on the most probable site containing the modiﬁca-
tion with an estimated accuracy of 85%. It should be noted
that, in its current state of development, the method might fail
if the peptide contains more than one modiﬁcation. However,
the impact of this limitation on the general performance of the al-
gorithm seems small, since the fraction of multiply modiﬁed pep-
tides that were not identiﬁed was almost negligible. We also
introduced a conservative, three-layered approach to control
the FDR of peptide identiﬁcation. Our local FDR calculation is
similar to that used by MSFragger (Kong et al., 2017), with the
only difference that we used the decoy/target competition strat-
egy to estimate FDR, whereas Kong et al. modeled local score
distributions, in the same 1-Da bins, as a mixture of correct
and incorrect identiﬁcations and calculated the probability of
correct identiﬁcation by the Bayes rule. As recognized by these
authors, their approach did not take into account the parts-
per-million levels of accuracy produced by high-resolution
Figure 5. Functional Distribution of Proteins Post-translationally Modiﬁed by Heteroplasmy
(A–C) Functional enrichment analysis of the proteins containing PTMs that are signiﬁcantly increased (brown scale) or decreased (blue scale) in heart (A), liver (B),
or muscle (C) of heteroplasmic mice in relation to control mice. The analysis was performed separately per different kinds of modiﬁcation (slices). Color intensity
represents the number of proteins in each category. Asterisks indicate statistical signiﬁcance of category enrichment relative to the list of proteins identiﬁed in
each tissue. Inner circular rings are used for categories at the cellular component level, whereas outer rings correspond to biological processes.
(D) Heatmap of the Zpq values for two modiﬁed proteotypic peptides from the two HSP90 isoforms (HSP90AB1 and HSP90AA1) for all control and heteroplasmic
replicates in the heart and in liver. These two isoforms are included in the ‘‘chaperone protein assembly’’ functional category displayed in (A) and (B).
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Figure 6. PTMs Induced by Heteroplasmy in OXPHOS Proteins
(A–D) Scheme of heteroplasmy-induced PTMs in proteins of complex I (A), complex IV (B), complex III (C), and complex V (D) from the OXPHOS system. PTM-
containing proteins are highlighted in red, with the spatial position of the modiﬁed residue indicated. The heatmaps show statistically signiﬁcant changes in
(legend continued on next page)
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instruments (Kong et al., 2017), which we have considered in our
model by applying an additional peak FDR estimation. In addi-
tion, we found it necessary to introduce a third global FDR ﬁlter
to avoid identiﬁcation of low-scoring peptides in local bins or
in peaks that, as in the case of oxidation, concentrate high
numbers of target PSMs.
The algorithm allowed us to produce peptide maps containing
realistic proportions of unmodiﬁed peptides, PTMs, and chemi-
cal artifacts in mouse tissues, and of amino acid residues
subjected to each type of modiﬁcation. We show that the basal
distribution of modiﬁcations and modiﬁed amino acids is
remarkably similar across the three mouse tissues studied, indi-
cating that the algorithm generates reproducible results and that
most peptide modiﬁcations are of an oxidative nature. Many of
the modiﬁcations are introduced during sample preparation,
including those induced by exposure to Cys-alkylating and
amine-directed isobaric labeling reagents; although these
agents are thought to be highly speciﬁc, in practice they produce
secondary reactions with other nucleophiles.
The ability to perform a truly hypothesis-free high-throughput
analysis of modiﬁcations can contribute to a deeper understand-
ing of the relation between protein chemistry and function;
however, the most important biological insight obtainable with
shotgun proteomics is how these modiﬁcations are altered dur-
ing normal physiological processes or as a consequence of dis-
ease. Detecting these speciﬁc alterations allows to concentrate
the study on biologically meaningful modiﬁcations, obviating the
analysis of the abundant artifacts produced by sample prepara-
tion. The statistical approach presented here enables quantita-
tive analysis of the modiﬁed peptidome within the same frame-
work used to analyze the unmodiﬁed proteome; this approach
thus allows coherent interpretation of all of the results and opens
theway to integrated systems-biology analysis.We demonstrate
the performance of our algorithm by simultaneously character-
izing, in three tissues of a mouse model, the quantitative impact
of heteroplasmy on the proteome and on the modiﬁed pepti-
dome. To our knowledge, this is the ﬁrst study to apply open-
search-based approaches together with quantitative MS, allow-
ing comprehensive and unbiased characterization of alterations
in the protein modiﬁcation landscape produced in a biological
system.
Our results reveal that the major hallmark of mitochondrial
heteroplasmy in 12-week-old animals is oxidative damage to
OXPHOS proteins in the heart. This is mainly reﬂected in
the increased levels of oxidative modiﬁcations and in the
decreased levels of OXPHOS proteins. Our data support the
notion that heteroplasmy involving different nonpathological
mtDNA variants affects the performance of the OXPHOS sys-
tem in the heart, resulting in compromised mitochondrial ROS
handling that triggers an oxidative stress response and impairs
the ability to supply energy to the sarcomere. Heteroplasmy is
known to be related to ROS production (Ha¨ma¨la¨inen et al.,
2013, 2015) and also affects the levels of contractile proteins
in muscle. These alterations do not occur in liver, which is
able to resolve heteroplasmy (unpublished data). Our data
thus provide a molecular mechanism that explains the func-
tional ﬁndings we have observed in the heteroplasmic heart,
which include a diminished ability of mitochondria to produce
ATP, increased glucose uptake, an exacerbated phosphocrea-
tine/ATP ratio, and mitochondrial disruption and structural
alterations.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Mouse Model of Heteroplasmy
B Generation of Heteroplasmic Mice
B Mice Breeding
d METHOD DETAILS
B Benchmarking MS Dataset
B Preparation of Protein Extracts
B Protein Digestion, Peptide Labeling, and Fractionation
B LC-MS Analysis
B Database Search
B Comet-PTM
B SHIFTS
B Annotation of Modiﬁcations
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Peptide Quantiﬁcation and Statistical Analysis
d DATA AND SOFTWARE AVAILABILITY
B Code Access
SUPPLEMENTAL INFORMATION
Supplemental Information includes six ﬁgures and four tables and can be
found with this article online at https://doi.org/10.1016/j.celrep.2018.05.080.
ACKNOWLEDGMENTS
We thank Simon Bartlett (CNIC) for English editing. This study was supported
by competitive grants from the SpanishMinistry of Economy and Competitive-
ness (MINECO) (BIO2015-67580-P) through the Carlos III Institute of Health-
Fondo de Investigacio´n Sanitaria (PRB2, IPT13/0001-ISCIII-SGEFI/FEDER;
ProteoRed), by Fundacio´n La Marato TV3, and by FP7-PEOPLE-2013-ITN
‘‘Next-Generation Training in Cardiovascular Research and Innovation–Cardi-
onext.’’ N.B. is a FP7-PEOPLE-2013-ITN-Cardionext Fellow. The CNIC is sup-
ported by the MINECO and the Pro-CNIC Foundation, and is a Severo Ochoa
Center of Excellence (MINECO Award SEV-2015-0505).
abundance ðZpqÞ of the indicated peptides in heart and liver from control mice (Ctrl) and heteroplastic mice (Htpl). Gray squares indicate that themodiﬁed peptide
was not detected in the tissue sample. Modiﬁed residues that are unambiguously assigned are underlined bold red letters; tentatively assigned sites are in bold
blue letters. Asterisks mark statistically signiﬁcant changes between control and heteroplasmic samples according to Student’s t test (p < 0.05). Themodiﬁcation
type is indicated in the column to the right of the peptide sequences: ox, oxidation; 2ox, dioxidation; 3ox, trioxidation; Kyn, Trp to kynurenine; OH, Trp to hy-
droxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-hydroxy formyl kynurenine; OL, Trp to oxolactone; Q, Trp to quinone; I, iodination. The
conservation scores of these peptides are listed in Table S4, from which the results of Vseq analysis can also be downloaded.See also Table S4.
Cell Reports 23, 3685–3697, June 19, 2018 3695
PhD Dissertation - Appendices 102 Navratan Bagwan
AUTHOR CONTRIBUTIONS
N.B., E.B.-K., E.C., and J.V. designed the algorithms. S.M. and M.T.-H. pro-
grammed Comet-PTM code. N.B. programed SHIFTS and analyzed Comet-
PTM performance. N.B., E.B.-K., and M.T.-H. programmed the generic inte-
gration algorithm and performed the quantitative analysis of PTM. A.V.L.-V.,
A.L.-P., and J.A.E. developed the heteroplasmic mouse model. E.C.,
A.V.L.-V., and R.M. prepared the tissue extracts. E.C. and R.M. performed
the mass-spectrometry analysis. I.E. and J.M.R. performed the bioinformatic
analysis of PTM. N.B., E.B.-K., E.C., and J.V. wrote the manuscript. J.V.
directed the research.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: January 8, 2018
Revised: April 13, 2018
Accepted: May 23, 2018
Published: June 19, 2018
REFERENCES
Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., and Ben-
Tal, N. (2016). ConSurf 2016: an improved methodology to estimate and visu-
alize evolutionary conservation in macromolecules. Nucleic Acids Res. 44
(W1), W344–W350.
Ballif, B.A., Ville´n, J., Beausoleil, S.A., Schwartz, D., and Gygi, S.P. (2004).
Phosphoproteomic analysis of the developing mouse brain. Mol. Cell. Prote-
omics 3, 1093–1101.
Bern, M., Cai, Y., and Goldberg, D. (2007). Lookup peaks: a hybrid of de novo
sequencing and database search for protein identiﬁcation by tandem mass
spectrometry. Anal. Chem. 79, 1393–1400.
Bonzon-Kulichenko, E., Garcia-Marques, F., Trevisan-Herraz, M., and Va´z-
quez, J. (2015). Revisiting peptide identiﬁcation by high-accuracy mass
spectrometry: problems associated with the use of narrow mass precursor
windows. J. Proteome Res. 14, 700–710.
Chalkley, R.J., Baker, P.R., Medzihradszky, K.F., Lynn, A.J., and Burlingame,
A.L. (2008). In-depth analysis of tandem mass spectrometry data from dispa-
rate instrument types. Mol. Cell. Proteomics 7, 2386–2398.
Chen, Y., Chen, W., Cobb, M.H., and Zhao, Y. (2009). PTMap—a sequence
alignment software for unrestricted, accurate, and full-spectrum identiﬁcation
of post-translational modiﬁcation sites. Proc. Natl. Acad. Sci. USA 106,
761–766.
Chick, J.M., Kolippakkam, D., Nusinow, D.P., Zhai, B., Rad, R., Huttlin, E.L.,
and Gygi, S.P. (2015). A mass-tolerant database search identiﬁes a large pro-
portion of unassigned spectra in shotgun proteomics as modiﬁed peptides.
Nat. Biotechnol. 33, 743–749.
Choi, H., and Nesvizhskii, A.I. (2008). Semisupervised model-based validation
of peptide identiﬁcations in mass spectrometry-based proteomics.
J. Proteome Res. 7, 254–265.
Cogliati, S., Calvo, E., Loureiro, M., Guaras, A.M., Nieto-Arellano, R., Garcia-
Poyatos, C., Ezkurdia, I., Mercader, N., Va´zquez, J., and Enriquez, J.A.
(2016). Mechanism of super-assembly of respiratory complexes III and IV. Na-
ture 539, 579–582.
Craven, L., Tuppen, H.A., Greggains, G.D., Harbottle, S.J., Murphy, J.L., Cree,
L.M., Murdoch, A.P., Chinnery, P.F., Taylor, R.W., Lightowlers, R.N., et al.
(2010). Pronuclear transfer in human embryos to prevent transmission of mito-
chondrial DNA disease. Nature 465, 82–85.
Dai, J., Jin, W.H., Sheng, Q.H., Shieh, C.H., Wu, J.R., and Zeng, R. (2007). Pro-
tein phosphorylation and expression proﬁling by Yin-yang multidimensional
liquid chromatography (Yin-yang MDLC) mass spectrometry. J. Proteome
Res. 6, 250–262.
Eng, J.K., Jahan, T.A., and Hoopmann, M.R. (2013). Comet: an open-source
MS/MS sequence database search tool. Proteomics 13, 22–24.
Eng, J.K., Hoopmann, M.R., Jahan, T.A., Egertson, J.D., Noble, W.S., and
MacCoss, M.J. (2015). A deeper look into Comet—implementation and fea-
tures. J. Am. Soc. Mass Spectrom. 26, 1865–1874.
Ferries, S., Perkins, S., Brownridge, P.J., Campbell, A., Eyers, P.A., Jones,
A.R., and Eyers, C.E. (2017). Evaluation of parameters for conﬁdent phosphor-
ylation site localization using an orbitrap fusion tribrid mass spectrometer.
J. Proteome Res. 16, 3448–3459.
Garcı´a-Marque´s, F., Trevisan-Herraz, M., Martı´nez-Martı´nez, S., Camafeita,
E., Jorge, I., Lopez, J.A., Me´ndez-Barbero, N., Me´ndez-Ferrer, S., Del Pozo,
M.A., Iba´n˜ez, B., et al. (2016). A novel systems-biology algorithm for the anal-
ysis of coordinated protein responses using quantitative proteomics.Mol. Cell.
Proteomics 15, 1740–1760.
Griss, J., Perez-Riverol, Y., Lewis, S., Tabb, D.L., Dianes, J.A., Del-Toro, N.,
Rurik, M., Walzer, M.W., Kohlbacher, O., Hermjakob, H., et al. (2016). Recog-
nizing millions of consistently unidentiﬁed spectra across hundreds of shotgun
proteomics datasets. Nat. Methods 13, 651–656.
Ha¨ma¨la¨inen, R.H., Ahlqvist, K.J., Ellonen, P., Lepisto, M., Logan, A., Oton-
koski, T., Murphy, M.P., and Suomalainen, A. (2015). ). mtDNA Mutagenesis
Disrupts Pluripotent Stem Cell Function by Altering Redox Signaling. Cell
Rep. 11, 1614–1624.
Ha¨ma¨la¨inen, R.H., Manninen, T., Koivumaki, H., Kislin, M., Otonkoski, T., and
Suomalainen, A. (2013). Tissue- and cell-type-speciﬁcmanifestations of heter-
oplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-
derived disease model. Proc. Natl. Acad. Sci. USA 110, E3622–E3630.
Hu, C.W., Hsu, C.L., Wang, Y.C., Ishihama, Y., Ku, W.C., Huang, H.C., and
Juan, H.F. (2015). Temporal phosphoproteome dynamics induced by an
ATP synthase inhibitor citreoviridin. Mol. Cell. Proteomics 14, 3284–3298.
Huttlin, E.L., Jedrychowski, M.P., Elias, J.E., Goswami, T., Rad, R., Beausoleil,
S.A., Ville´n, J., Haas, W., Sowa, M.E., and Gygi, S.P. (2010). A tissue-speciﬁc
atlas of mouse protein phosphorylation and expression. Cell 143, 1174–1189.
Jenuth, J.P., Peterson, A.C., Fu, K., and Shoubridge, E.A. (1996). Random ge-
netic drift in the female germline explains the rapid segregation of mammalian
mitochondrial DNA. Nat. Genet. 14, 146–151.
Jin, W.H., Dai, J., Zhou, H., Xia, Q.C., Zou, H.F., and Zeng, R. (2004). Phospho-
proteome analysis of mouse liver using immobilized metal afﬁnity puriﬁcation
and linear ion trap mass spectrometry. Rapid Commun. Mass Spectrom. 18,
2169–2176.
Keller, A., Nesvizhskii, A.I., Kolker, E., and Aebersold, R. (2002). Empirical
statistical model to estimate the accuracy of peptide identiﬁcations made by
MS/MS and database search. Anal. Chem. 74, 5383–5392.
Kim, S., and Pevzner, P.A. (2014). MS-GF+ makes progress towards a univer-
sal database search tool for proteomics. Nat. Commun. 5, 5277.
Kong, A.T., Leprevost, F.V., Avtonomov, D.M., Mellacheruvu, D., and Nesvizh-
skii, A.I. (2017). MSFragger: ultrafast and comprehensive peptide identiﬁcation
in mass spectrometry-based proteomics. Nat. Methods 14, 513–520.
Lee, Y., Stiers, K.M., Kain, B.N., and Beamer, L.J. (2014). Compromised catal-
ysis and potential folding defects in in vitro studies of missense mutants asso-
ciated with hereditary phosphoglucomutase 1 deﬁciency. J. Biol. Chem. 289,
32010–32019.
Leyfer, D., and Weng, Z. (2005). Genome-wide decoding of hierarchical
modular structure of transcriptional regulation by cis-element and expression
clustering. Bioinformatics 21 (Suppl 2), ii197–ii203.
Link, A.J., Eng, J., Schieltz, D.M., Carmack, E., Mize, G.J., Morris, D.R., Garvik,
B.M., and Yates, J.R., 3rd. (1999). Direct analysis of protein complexes using
mass spectrometry. Nat. Biotechnol. 17, 676–682.
Liu, L., and Pilch, P.F. (2016). PTRF/Cavin-1 promotes efﬁcient ribosomal RNA
transcription in response to metabolic challenges. eLife 5, e17508.
Lo´pez-Carballo, G., Moreno, L., Masia´, S., Pe´rez, P., and Barettino, D. (2002).
Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by reti-
noic acid is required for neural differentiation of SH-SY5Y human neuroblas-
toma cells. J. Biol. Chem. 277, 25297–25304.
3696 Cell Reports 23, 3685–3697, June 19, 2018
PhD Dissertation - Appendices 103 Navratan Bagwan
Lundby, A., Andersen, M.N., Steffensen, A.B., Horn, H., Kelstrup, C.D., Fran-
cavilla, C., Jensen, L.J., Schmitt, N., Thomsen, M.B., and Olsen, J.V. (2013).
In vivo phosphoproteomics analysis reveals the cardiac targets of b-adren-
ergic receptor signaling. Sci. Signal. 6, rs11.
Ma, C.W., and Lam, H. (2014). Hunting for unexpected post-translational mod-
iﬁcations by spectral library searching with tier-wise scoring. J. Proteome Res.
13, 2262–2271.
Martı´nez-Acedo, P., Nu´n˜ez, E., Go´mez, F.J., Moreno, M., Ramos, E., Iz-
quierdo-A´lvarez, A., Miro´-Casas, E., Mesa, R., Rodriguez, P., Martı´nez-Ruiz,
A., et al. (2012). A novel strategy for global analysis of the dynamic thiol redox
proteome. Mol. Cell. Proteomics 11, 800–813.
Meier, A., and So¨ding, J. (2015). Automatic prediction of protein 3D structures
by probabilistic multi-template homology modeling. PLoS Comput. Biol. 11,
e1004343.
Mollapour, M., and Neckers, L. (2012). Post-translational modiﬁcations of
Hsp90 and their contributions to chaperone regulation. Biochim. Biophys.
Acta 1823, 648–655.
Navarro, P., and Va´zquez, J. (2009). A reﬁnedmethod to calculate false discov-
ery rates for peptide identiﬁcation using decoy databases. J. Proteome Res. 8,
1792–1796.
Navarro, P., Trevisan-Herraz, M., Bonzon-Kulichenko, E., Nu´n˜ez, E., Martı´nez-
Acedo, P., Pe´rez-Herna´ndez, D., Jorge, I., Mesa, R., Calvo, E., Carrascal, M.,
et al. (2014). General statistical framework for quantitative proteomics by sta-
ble isotope labeling. J. Proteome Res. 13, 1234–1247.
Rigbolt, K.T., Prokhorova, T.A., Akimov, V., Henningsen, J., Johansen, P.T.,
Kratchmarova, I., Kassem, M., Mann, M., Olsen, J.V., and Blagoev, B.
(2011). System-wide temporal characterization of the proteome and phospho-
proteome of human embryonic stem cell differentiation. Sci. Signal. 4, rs3.
Sharpley, M.S., Marciniak, C., Eckel-Mahan, K., McManus, M., Crimi, M.,
Waymire, K., Lin, C.S., Masubuchi, S., Friend, N., Koike, M., et al. (2012). Het-
eroplasmy of mouse mtDNA is genetically unstable and results in altered
behavior and cognition. Cell 151, 333–343.
Shortreed, M.R., Wenger, C.D., Frey, B.L., Sheynkman, G.M., Scalf, M., Keller,
M.P., Attie, A.D., and Smith, L.M. (2015). Global identiﬁcation of protein post-
translational modiﬁcations in a single-pass database search. J. Proteome Res.
14, 4714–4720.
Skinner, O.S., and Kelleher, N.L. (2015). Illuminating the darkmatter of shotgun
proteomics. Nat. Biotechnol. 33, 717–718.
van Pe´e, K.H., and Patallo, E.P. (2006). Flavin-dependent halogenases
involved in secondary metabolism in bacteria. Appl. Microbiol. Biotechnol.
70, 631–641.
Wang, Y.T., Pan, S.H., Tsai, C.F., Kuo, T.C., Hsu, Y.L., Yen, H.Y., Choong,
W.K., Wu, H.Y., Liao, Y.C., Hong, T.M., et al. (2017). Phosphoproteomics re-
veals HMGA1, a CK2 substrate, as a drug-resistant target in non-small cell
lung cancer. Sci. Rep. 7, 44021.
Wisniewski, J.R., Ostasiewicz, P., and Mann, M. (2011). High recovery FASP
applied to the proteomic analysis of microdissected formalin ﬁxed parafﬁn
embedded cancer tissues retrieves known colon cancer markers.
J. Proteome Res. 10, 3040–3049.
Wolf, D.P., Mitalipov, N., and Mitalipov, S. (2015). Mitochondrial replacement
therapy in reproductive medicine. Trends Mol. Med. 21, 68–76.
Cell Reports 23, 3685–3697, June 19, 2018 3697
PhD Dissertation - Appendices 104 Navratan Bagwan
STAR+METHODS
KEY RESOURCES TABLE
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests should be directed to and will be fulﬁlled by the Lead Contact, Jesu´s Va´zquez (jvaquez@cnic.es).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Model of Heteroplasmy
All animal procedures conformed to EU Directive 86/609/EEC and Recommendation 2007/526/EC regarding the protection of ani-
mals used for experimental and other scientiﬁc purposes, enforced in Spanish law under Real Decreto 1201/2005. Themice were fed
a standard chow diet (5K67 LabDiet).
Generation of Heteroplasmic Mice
Heteroplasmic mice were generated by electro-fusing cytoplasts from conplastic BL/6NZB zygotes to recipient C57BL/6JOlaHsd
(BL/6C57) one cell embryos, cultured overnight and transplanted as two-cell embryos into pseudo pregnant Hsd:ICR (CD-1) females
to complete development to term as previously described (Jenuth et al., 1996). To the best of our knowledge, no consensus rule to
name heteroplasmic mouse strains exists. Here, we propose the following designation to name heteroplasmic mouse strains:
NUCLEAR GENOME-mtCYTOPLASMIC GENOME #1 + CYTOPLASMIC GENOME #2 [i.e., C57BL/6J-mtC57BL/6+NZB, a strain
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals
Filter Aided Sample Preparation (FASP) kit Expedeon Cat# SKU: 44250
10 plex-TMT Thermo Fisher Scientiﬁc Cat# 90110
OASIS HLB extraction cartridges Waters Corp. Cat# 186000383
high pH reversed-phase peptide fractionation kit Thermo Fisher Scientiﬁc Cat# PI84868
EASY-nLC 1200 instrument Thermo Fisher Scientiﬁc Cat# LC120
EASY-Spray NG Ion Source Thermo Fisher Scientiﬁc Cat# ES082
Q Exactive HF mass spectrometer Thermo Fisher Scientiﬁc Cat# IQLAAEGAAPFALGMBFZ
Acclaim PepMap100 C18 100 A nanoViper
Trap column.
Thermo Fisher Scientiﬁc Cat# 11352013
EASY-Spray column, 50 cm 3 75 mm ID, PepMap
RSLC C18, 2 mm particles,100 A pore size
Thermo Fisher Scientiﬁc Cat# ES803
Deposited Data
Raw and analyzed data This paper ftp://ftp.peptideatlas.org/
username: PASS01085 password:
TC4334fh.
Experimental Models: Organisms/Strains
Mouse:12-week-old BL/6C57, BL/6NZB
and BL/6 C57 -NZB males.
Jose´ Antonio Enrı´quez Lab, Centro
Nacional de Investigaciones
Cardiovasculares (CNIC)
BL/6C57, BL/6NZB and BL/6 C57 -NZB
Software and algorithms
Comet release 2016.01 Eng et al., 2013, 2015 http://comet-ms.sourceforge.net
Comet-PTM This paper https://github.com/CNIC-Proteomics/
Comet-PTM
SHIFTS (Systematic Hypothesis-free Identiﬁcation of
modiﬁcations with controlled FDR based on ultra-
Tolerant database Search
This paper https://github.com/CNIC-Proteomics/
SHIFTS
Vseq program Cogliati et al., 2016 available upon request
Generic Integration Algorithm (GIA) This paper and Garcı´a-Marque´s
et al., 2016
https://github.com/CNIC-Proteomics/
PTM-Quant-Stats
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with the nuclear genome of C57BL/6J and the cytoplasmic (mitochondrial) genome of C57BL/6J and NZB]. To simplify we are calling
it BL/6C57-NZB along this report. The female heteroplasmic offspring (named BL/6C57-NZB) werematedwith C57BL/6JOlaHsdmales to
prevent nuclear genetic drift in our particular mice lines. Only offspring of the established heteroplasmic mice were used.
Mice Breeding
Heteroplasmic females (BL/6C57-NZB) were outcrossed with males BL/6C57. Only females with an initial level of NZB heteroplasmy
above 20% were used for colony maintenance.
Themice used in this workwere 12-week-old control (C57BL/6JOlaHsd strain) and heteroplasmicmales (containingmore than one
mtDNA in the same cytoplasm, C57BL/6 background). The effect of heteroplasmy on the PTMs of the proteome of different tissues
was studied on liver, heart, and skeletal muscle (gastrocnemius) samples. In the last two tissues, the heteroplasmy was stable, while
the liver was selected as a control tissue since it spontaneously selected one of the alternative variants of mtDNA (manuscript in sub-
mission For each tissue, biological replicates from different control (N = 3) and heteroplasmic mice (N = 4) were analyzed.
METHOD DETAILS
Benchmarking MS Dataset
To test the performance of the developed algorithms, we used the publicly available HEK293 dataset (Chick et al., 2015), containing
1.121.149MS/MS spectra in 24 raw ﬁles acquired on a Q-Exactive Orbitrap mass spectrometer. For the bench-marking of site local-
ization through CometPTM we used a synthetic phosphopeptide dataset from the Pride database (dataset identiﬁer
PXD007058)(Ferries et al., 2017).
Preparation of Protein Extracts
Mice were sacriﬁced by cervical dislocation and liver, heart, and skeletal muscle tissues were extracted. 20 mg of each tissue were
homogenized in lysis buffer (10mM Tris-HCL pH7.4, 1 mM EDTA, 0.32 M sucrose, 2% SDS) freshly supplemented with protease and
phosphatase inhibitors (Roche) and 50 mM DTT, using a MagNA Lyser instrument (Roche). The lysate was boiled for 5 min and cell
debris were removed by centrifugation.
Protein Digestion, Peptide Labeling, and Fractionation
Proteins were treated with 50 mM iodoacetamide (IAM) and digested with trypsin using the Filter Aided Sample Preparation (FASP)
digestion kit (Expedeon) (Wisniewski et al., 2011) according to manufacturer’s instructions. Dried peptides were labeled using 10
plex-TMT reagents according tomanufacturer’s instructions (Thermo Fisher Scientiﬁc), desalted onOASIS HLB extraction cartridges
(Waters Corp.) (Leyfer and Weng, 2005), separated into 7 fractions using the high pH reversed-phase peptide fractionation kit
(Thermo Fisher Scientiﬁc) and dried-down before MS analysis.
LC-MS Analysis
Each fraction of the labeled peptide samples were analyzed using an Easy nano-ﬂow HPLC system (Thermo Fisher Scientiﬁc)
coupled via a nanoelectrospray ion source (Thermo Fisher Scientiﬁc, Bremen, Germany) to a Q Exactive HF mass spectrometer
(Thermo Fisher Scientiﬁc, Bremen, Germany). C18-based reverse phase separation was used with a 2-cm trap column and
a 50-cm analytical column (EASY column, Thermo). Peptides were loaded in buffer A (0.1% formic acid (v/v)) and eluted with a
240 min linear gradient of buffer B (80% acetonitrile, 0.1% formic acid (v/v)) at 200 nL/min. Mass spectra were acquired in a
data-dependent manner, with an automatic switch between MS and MS/MS using a top 15 method. MS spectra were acquired in
the Orbitrap analyzer with a mass range of 400–1500 m/z and 60,000 resolution. HCD fragmentation was performed at 27 of normal-
ized collision energy and MS/MS spectra were analyzed at 60,000 resolution in the Orbitrap.
Database Search
Unless indicated otherwise, all searches were performed using Comet release 2016.01 (Eng et al., 2013, 2015) using trypsin digestion
with 1 missed cleavages (unless otherwise speciﬁed) and ﬁxed Cys carbamidomethylation (57.021464 Da). For heteroplasmic mice
data, TMT labeling at N-terminal end and Lys was also considered as a ﬁxed modiﬁcation (229.162932 Da). Fragment ion tolerance
was 0.02 bin, 0 mass offset. Precursor tolerance type and isotope error were set to 1. Precursor charge range was 2-4, maximum
precursor charge 5 and maximum fragment charge 3. Only y- and b-ions were used for scoring.
Closed searches (CS) were performed at 5 ppm precursor ion tolerance, using three dynamic modiﬁcations: Met oxidation
(15.994915), Asn and Gln deamidation (0.984016) and Ser and Thr phosphorylation (79.966331). False discovery rates (FDR) of pep-
tide identiﬁcations were calculated using the reﬁned method (Bonzon-Kulichenko et al., 2015; Navarro and Va´zquez, 2009); 1% FDR
was used as the default criterion for peptide identiﬁcation.
Open searches (OS) with Comet and Comet-PTM were performed in the same conditions as CS, except that precursor ion toler-
ance was set to 500 Da.
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Comet-PTM
Comet.PTMwas developed by modifying the open-source database search engine (Eng et al., 2015). For every sequence candidate
Comet-PTM calculates the difference between theoretical and experimental precursor mass (DMass), and adds up this mass itera-
tively to each one of the amino acid masses in the peptide sequence, calculating a Xcorr score in each one of the possible modiﬁed
forms of the peptide (Figure 1B). The selected candidate is the modiﬁed peptide form that produces the highest Xcorr. This design
allows Comet-PTM to reach the score that would have been obtained by performing a targeted CS with the same modiﬁcation in the
same position. Note that the scores are not exactly identical, since CS uses the theoretical mass of themodiﬁcation and Comet-PTM
estimates it from the difference between the precursor mass and the theoretical mass of the non-modiﬁed peptide, and experimental
errors on this estimate may affect fragment matching. This effect is, however, small when low ppm precursor mass accuracies are
used (Figures S1A and S1B). Comet-PTM has a user-selectable option of scoring also the non-modiﬁed peptide sequence (even
when DMass is different from zero), to take into account labile modiﬁcations (Kong et al., 2017).
Comet-PTMwas developed to take full advantage of themulti-thread design of Comet. Comet-PTM used less than 4 hr to perform
a 500 Da-wide OS of 16 LC-MS runs, containing an average of 44.390MS/MS spectra each, using a computer cluster with 16 nodes,
where each node is built of 2 x Intel Xeon E5-2695v2 at 2.40 GHz and contained 46 threads/124 gigabyte.
SHIFTS
SHIFTS (Systematic Hypothesis-free Identiﬁcation of modiﬁcations with controlled FDR based on ultra-Tolerant database Search) is
a program that identiﬁes peaks in the DMass distribution, assigns PSM to peaks and calculates FDR for peptide identiﬁcation (Fig-
ure S6). SHIFTS uses as input the Thermo .raw ﬁles and the ﬁles obtained from Comet-PTM search.
Mass Recalibration
SHIFTS ﬁrst recalibrates precursor peptide masses independently in each raw ﬁle. This was done by selecting a population of non-
modiﬁed peptides with a very high score (user selectable; recommended values are those yielding 0.1% global FDR or lower), which
are assumed to be true identiﬁcations and are used to calculate the systematic mass error (median deviation in m/z scale), which is
assumed to be constant in each raw ﬁle. From these data, SHIFTS also calculates the standard deviation of themass error ðsMÞ using
the median absolute deviation (MAD) method.
Peak Identiﬁcation
Recalibrated DMass values were binned using 0.001 Da bins to construct the DMass distribution. The distribution was smoothed
using the median of a 7-point sliding window and then peak apexes were detected as downward zero-crossings in the ﬁrst derivative
of the smoothed curve. Peak widths were similarly calculated as the zero-crossing points of the second derivative; in the current
version of SHIFTS they are computed only for informative purposes.
Peak Assignation
By default SHIFTS assigns a PSM to the closest DMass peak if the mass deviation of the PSM from the peak falls within 3sM, so that
approximately 99%of PSM in each peak are assigned. This value can be user adjusted. PSM not assigned to peaks were considered
as orphan PSM.
FDR Calculation
SHIFTS calculates FDR of identiﬁcation using a conventional target/decoy strategy using the corrected Xcorr score (cXcorr) (Choi
and Nesvizhskii, 2008; Keller et al., 2002). A global FDR was calculated for each PSM as the ratio of the number of decoy PSMs
to the number of target PSMs having a cXcorr equal or higher. Decoy peptides matched by Comet-PTM were observed to be almost
as abundant as target peptides in the negative DMass region below the peak corresponding to neutral loss of Gly (Figure 2A), where
DMass peaks weremostly produced by neutral loss of amino acids. For this reason, the global FDRwas only calculated in theDMass
region above 56 Da (Figure 2A). All the PSM are required to have FDR lower than the global FDR, without exception.
In addition, local FDR ﬁlters are also applied. Some DMass peaks were observed to contain an unusually high number of decoy
PSM; to avoid matching false positive target PSM in these peaks, SHIFTS also calculates a peak FDR counting up the number of
decoys and target PSM assigned to each peak, and these PSM are required to pass the peak FDR ﬁlter in addition to the global
FDR ﬁlter (Figure 2C). Note that peak FDRs are often very low suggesting that the majority of PSM in these peaks are true, even
when they have a low cXcorr. This happens because the probability of ﬁnding a decoy PSM in a peak by chance alone is extremely
low. SHIFTS avoids matching these low scoring target PSM by applying the global FDR ﬁlter.
To apply a local ﬁlter to PSM which are not assigned to DMass peaks, e.g., to orphan PSM, SHIFTS models the periodic mass
distribution of decoy PSM into 1 Da-bins centered at the regions where DMass values concentrate, and calculates a local FDR
by counting up decoy and target PSM in each one of these regions (Figure 2B). The local FDR ﬁlter is applied to orphan PSM in addi-
tion to the global FDR ﬁlter. Default values for peptide identiﬁcation were 1% for peak and local FDR; 5% for global FDR. Among the
peptides signiﬁcantly changed by heteroplasmy and suspected to have relevant biological activity, including all the peptides in Table
S3, only those that passed analysis with Vseq program (Cogliati et al., 2016) were considered as trustable identiﬁcations.
Isotopic Correction
SHIFTS also performs a simple isotopic correction to minimize misassignations of the correct monoisotopic peak of the precursor.
When two PSMhaving the same sequence are encountered having aDMass differencewithin 1 ppmof themass difference expected
for either one or two 13C or one 34S, the DMass of the heaviest precursor is substituted by that of the lightest one.
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Annotation of Modiﬁcations
A Python in-house script was used for semisupervised annotation of the nature of peptide modiﬁcations. The script searched DMass
values against Unimod database, taking into account the amino acid modiﬁed according to Comet-PTM output and also the preced-
ing and consecutive residues, comparing them with the list of amino acids that could be subjected to the modiﬁcation according to
Unimod. If no amino acid was matched, the modiﬁcation was considered as unassigned. Residues containing modiﬁcations that
were ﬁxed in the database search were considered with and without the ﬁxed modiﬁcation; when not indicated, the amino acid
contains the ﬁxed modiﬁcation (e.g., C_oxidation means oxidation of carbamidomethylated Cys and K_oxidation, oxidation of
TMT-labeled Lys). DMass values that could not be matched were tentatively tested assuming one 13C misassignment of the mono-
isotopic mass of the precursor and also as combinations of twomodiﬁcations from a list of the most abundant modiﬁcations found in
the corresponding proteome. Unexplained DMass values were termed as unknown. MS/MS fragmentation spectra from the most
abundant modiﬁcations that changed their abundance in heteroplasmic mice and all the peptides in Table S3 were revised using
Vseq program (Cogliati et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
Peptide Quantiﬁcation and Statistical Analysis
The quantitative information from TMT reporter intensities was integrated from the spectrum level to the peptide level and then to the
protein level on the basis of the WSPP model (Martı´nez-Acedo et al., 2012; Navarro et al., 2014) using the Generic Integration Algo-
rithm (GIA) (Garcı´a-Marque´s et al., 2016) . The algorithm was modiﬁed to include into the statistical model the quantitative values of
modiﬁed peptides as part of the automated workﬂow (Figure 3A). Brieﬂy, for each sample i the values xqps = log2Si=C were calcu-
lated, where Si is the intensity of the TMT reporter corresponding to sample i in the MS/MS spectrum s coming from peptide p and
protein q, andC is the average intensity of all the TMT reporters from the control samples, which is used as a common reference. The
log2-ratio of each peptide ðxqpÞ was calculated as the weighted average of its spectra, the protein values ðxqÞ were the weighted
average of its peptides, and the grand mean ðxÞ was calculated as the weighted average of all the protein values (Navarro et al.,
2014) . The statistical weights of spectra, peptides, and proteins (wqps, wqp and wq, respectively) and the variances at each one
of the three levels (s2S, s
2
P, and s
2
Q, respectively), were calculated as described (Navarro et al., 2014) .
The spectrum, peptide, and protein variances and the protein values were ﬁrst determined including only non-modiﬁed peptides
(Figure 3B). In a second step, the modiﬁed peptides were included in the analysis, which was performed using the variances and
protein values calculated previously. For each modiﬁed peptide, the standardized variable ðzpqÞ was calculated as
zpq = ðxqp  xqÞ ﬃﬃﬃﬃﬃﬃﬃﬃwpqp
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
np
np  1
r
; np>1
where np is the number of non-modiﬁed peptides with which the corresponding protein was quantiﬁed. zpq expresses the deviation
between the peptide log2-ratio and the corresponding protein value in units of standard deviation. In absence of changes, the dis-
tributions of zpq followed very closely the normal distribution Nð0;1Þ (Figure 3C), validating the accuracy of the model.
Signiﬁcant abundance changes of modiﬁed peptides were detected by Student’s t test comparing the zpq values of samples from
heteroplasmic mice (N = 4) with those of control mice (N = 3) (Table S2).
DATA AND SOFTWARE AVAILABILITY
Code Access
The software needed to execute the whole Comet-PTM pipeline can be downloaded from: https://github.com/CNIC-Proteomics/
Comet-PTM.
The software for Comet-PTM FDR control can be downloaded from: https://github.com/CNIC-Proteomics/SHIFTS.
The software for statistical analysis of quantitative data can be downloaded from https://github.com/CNIC-Proteomics/
PTM-Quant-Stats. A readme.txt ﬁle is provided with basic instructions to install and execute the package. Vseq is available upon
request.
The dataset of the raw ﬁles, protein databases, search parameters and results reported in this paper is available in the PeptideAtlas
repository at ftp://ftp.peptideatlas.org/ (username: PASS01085, password: TC4334fh).
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Proteomic footprint of myocardial 
ischemia/reperfusion injury: 
Longitudinal study of the at-risk and 
remote regions in the pig model
Aleksandra Binek  ͷ, Rodrigo Fernández-Jiménezͷǡ͸ǡ͹, Inmaculada Jorgeͷǡ͹, Emilio 
 Camafeita  ͷǡ͹, Juan Antonio Lópezͷǡ͹, Navratan Bagwanͷ, Carlos Galán-Arriolaͷǡ͹, 
 Andres Punͷǡ͹, Jaume Agüeroͷǡ͹, Valentin Fusterͷǡ͸, Borja Ibanezͷǡ͹ǡͺ & Jesús Vázquez  ͷǡ͹
Reperfusion alters post-myocardial infarction (MI) healing; however, very few systematic studies report 
the early molecular changes following ischemia/reperfusion (I/R). Alterations in the remote myocardium 
have also been neglected, disregarding its contribution to post-MI heart failure (HF) development. 
This study characterizes protein dynamics and contractile abnormalities in the ischemic and remote 
ǤǦͺͶȀ͸ͶƤ
ͷ͸Ͷǡ͸ͺǡͺǡͽȋ=ͻȌǤ
followed up by cardiac magnetic resonance (CMR) and tissue samples were analyzed by multiplexed 
Ǥȋͷ͸ͶȌǡ
ƪǡǡǦ
ȋͺͽȌǤ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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and mitochondrial proteins. Subsequent recovery of regional contractility was associated with edema 
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early after I/R and might have implications for new therapeutic targets to improve early post-MI 
remodeling.
Widespread implementation of reperfusion strategies has dramatically reduced mortality associated with myo-
cardial infarction (MI). One consequence of increased survival is an increased prevalence of chronic heart failure 
(HF), because patients surviving the acute episode then live with a significantly damaged heart1,2. Treatments 
for post-MI HF have primarily focused on symptom management after the occurrence of irreversible remode-
ling and functional impairment of the left ventricle (LV)3. A better understanding of the molecular mechanisms 
driving post-ischemia/reperfusion (I/R) cardiac dysfunction at earlier stages might enable the development of 
therapeutic interventions to prevent the onset of HF4,5.
Much of the prevailing knowledge about post-infarcted tissue and the molecular modifications involved 
comes from studies performed in non-reperfused conditions6–8. Surprisingly, although reperfusion is known 
to alter post-MI myocardial healing9,10, to date there have been no systematic studies on the molecular changes 
occurring in the post-reperfused myocardium at early stages after I/R. Moreover, previous proteomic characteri-
zations of post-I/R myocardial tissue were limited to mitochondrial proteins11 or extracellular matrix proteins12 or 
were performed at single time points, mostly at late remodeling stages (weeks after MI)12–15. There has also been a 
notable lack of attention paid to the remote myocardium, which has been used in most studies as a control tissue 
for the analysis of changes in ischemic areas, thus carrying the implicit assumption that no important changes 
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take place in this area. Unsurprisingly therefore, the molecular alterations taking place in the remote myocar-
dium at early post-MI stages are poorly understood. This lack of knowledge is particularly important because the 
remote myocardium plays an important role in the development of maladaptive LV remodeling and subsequent 
HF after MI16,17.
In a pig model of myocardial I/R, serial cardiac magnetic resonance (CMR) imaging shows that tis-
sue composition changes dynamically during the first week after infarction18. After a transient hyperacute, 
reperfusion-related edematous reaction, there is a longer, healing-related deferred phase of edema10. The precise 
molecular and cellular events taking place during these highly dynamic early post-I/R phases remain largely 
unknown.
In this study, we characterize the dynamic changes that take place in both the ischemic and remote myo-
cardium during the first week after infarction in a clinically relevant animal model. This was undertaken by 
high-throughput multiplexed quantitative proteomics of pig myocardium at different times during the first week 
after I/R, together with serial in-vivo tissue characterization by CMR at each time point. In a first screening 
approach, we provide a detailed pattern of the time-course behavior of more than 5.000 proteins in both the 
ischemic and remote areas. This was followed by a further validation step in which we focused on most relevant 
protein changes. Our results reveal a highly coordinated, multimodal pattern of functional protein alterations in 
both myocardium regions in the early stages post infarction. Most notably, the remote myocardium undergoes 
transitory alterations in the contractile machinery that result in a stunned myocardium within the first 24 h. 
Addressing the need for unbiased “omics” approaches, our data constitute a rich resource of information about 
the precise molecular signatures and pathways that characterize early remodeling stages, with potential utility for 
molecular researchers looking for novel drug targets for cardioprotection and HF prevention5.
Results
ƤǦȀǤ Five groups 
of animals (n = 5 per group) were used in this study (Fig. 1a): (1) control pigs (not undergoing I/R), (2) I/R pigs 
sacrificed 120 min after reperfusion, (3) I/R pigs sacrificed 1 day after reperfusion, (4) I/R pig sacrificed 4 days 
after reperfusion, and (5) I/R pigs sacrificed 7 days after reperfusion. Table 1 summarizes functional cardiac CMR 
data obtained during early remodeling after I/R. As expected, regional contractility in the post-ischemic myo-
cardium, as measured by systolic wall thickening (SWT), was impaired at all time-points evaluated. The remote 
myocardium also showed a significant transitory alteration in regional myocardial function, with SWT signifi-
cantly reduced at 120 min and 24 h, and then recovering to baseline values at day 7 post-reperfusion. The SWT 
time course in the ischemic and remote myocardium is shown in Fig. 2, together with a representative bullseye 
display of SWT of one pig at all time-points evaluated.
Proteome changes in the ischemic myocardium during early stage remodeling after I/R. In 
a first screening approach, we subjected pooled heart extracts from five animals per group to high-throughput 
multiplexed quantitative proteomics in three technical replicates. This allowed very precise relative quantification 
of myocardial proteins with very high proteome coverage. We were able to quantify more than 5000 proteins 
from the ischemic and remote myocardium. Functional annotation was followed by a novel systems biology 
analysis developed by our group19. This analysis detected statistically significant biological changes (FDR < 0.05), 
specifically driven by the coordinated action of protein subsets that accurately depict phenotypic alterations in 
myocardial tissue.
Early after reperfusion (120 min), the ischemic myocardium showed a coordinated increase in the expression 
of proteins involved in acute-phase response signaling, response to wounding, wound healing, blood cell adhe-
sion, and production of nitric oxide and reactive oxygen species (Fig. 3a), and this was accompanied by decreases 
in proteins involved in glycolysis, alcohol biosynthesis, and kinase binding (Fig. 3b). These processes reflect an 
early activation of immunological/inflammatory responses in the post-reperfused myocardium. In addition, 
there was also a coordinated decrease in cell junction proteins (Fig. 3b), which is consistent with the initial wave 
of edema formation described in this model18.
At a later stage after reperfusion (day 4 to day 7), the ischemic myocardium showed a coordinated increase 
in protein biosynthesis processes, manifested by increased abundance of proteins related to gene expression, 
ribosomes, and vesicle-mediated protein transport (Fig. 3c). There was also significant increase of collagen and 
extracellular matrix proteins, peaking at day 7 post-reperfusion, and of angiogenesis-associated proteins, starting 
at day 4 and peaking at day 7 (Fig. 3c). The category of proteolysis also increased; although this change was less 
statistically significant, it was consistently increased in the four time points and included a considerable number 
of proteins (183) (Fig. 3c). These changes correlated with significant fibrosis10 and are consistent with a late and 
gradual activation of healing processes. Conversely, between day 4 and day 7 post I/R the ischemic myocardium 
showed a generalized decrease of proteins involved in the mitochondrial electron transport chain (ETC) (mito-
chondrial complexes I-V) (Supplementary Figure S1), fatty acid biosynthesis, amino acid metabolism, fatty acid 
beta-oxidation, tricarboxylic acid (TCA) cycle, and mitochondrial ribosomes (Fig. 3d), suggesting a diminished 
mitochondrial content. A coordinated decrease in muscle contraction was also detected (Fig. 3d). These changes 
seem to reflect the removal of necrotic myocytes (rich in mitochondria) and their replacement by fibroblasts (less 
mitochondrial density) during healing. Interestingly, this stage was also characterized by a coordinated increase 
in proteins implicated in acute renal failure and in renal toxicity biomarkers (Fig. 3c), indicating concomitant 
gradual activation of cardio-renal signaling processes. The coordinated nature of the protein responses detected 
in this analysis is illustrated in Fig. 3e. A representational diagram that relates the changes in water content with 
the protein clusters in the ischemic myocardium is shown in Fig. 3f.
In the next step of this study, we used alternative approaches to validate the main phenotypic changes. In this 
step we wanted not only to validate the previous results, but also to determine whether the protein alterations 
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are consistently reproduced in different individuals. Western blotting analysis of a set of representative proteins 
from complex I (NDUFB8), complex II (SDHB), complex III (UQCRC2, UQCRFS1), complex IV (COXIVI1) 
and complex V (ATP5A, ATP5B) from ETC confirmed that the decrease in mitochondrial proteins at 7 days after 
reperfusion was a generalized event suffered by practically all animals analyzed (n = 5) (Fig. 4a). Similar results 
were obtained when representative contractile proteins from thick filaments (myosin) and from thin filaments 
(TNNT2, TPM1) were analyzed by western blot (Fig. 4b). Furthermore, label-free mass spectrometry analysis in 
individual animals (n = 5) also confirmed that the absolute amounts of proteins, expressed as iBAQ intensities20, 
belonging to mitochondria or implicated in contractile processes were decreased (Figs 4c,d, S2 and S13a,b), while 
acute phase response proteins were clearly increased at 7 days after reperfusion (Figs 4d, S2 and S13c). The total 
amount of collagens or extracellular matrix proteins were also confirmed to increase (Fig. 4d, S2 and S13d,e). In 
addition, both the total amount of proteolytic and gene expression proteins were consistently found increased in 
the animals after 7 days of reperfusion (Figs 4d, S2 and S13f,g). These results suggested that the increase in col-
lagen and extracellular matrix proteins was the result of a net balance between increased mRNA expression and 
increased proteolytic activity, as proposed by other authors21.
Figure 1. Study design. (a) The study population comprised 5 groups of pigs (n = 5/group). Groups 1 to 5 
were used for the histopathological characterization of myocardial tissue changes during the first week after 
ischemia/reperfusion (I/R). CMR (cardiac magnetic resonance) scans included cine steady-state free-precession 
(SSFP) sequences to provide high quality anatomical references and functional information. CMR scans were 
performed at all follow-up stages until sacrifice, so that animals sacrificed at day 7 underwent baseline, 120 min, 
24 h, day 4, and day 7 CMR. CMR and myocardial water content data from animals in groups 1 to 5 have been 
reported previously18. (b) For proteomic analysis, remote and ischemic tissue samples from these animals 
were processed for protein extraction, tryptic digestion, multiplexed stable isotope labeling, and fractionation 
followed by nano-liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) and systems biology 
analysis. Graphical elements in panel b were adapted from the Servier Medical Art Powerpoint image bank. 
Servier Medical Art by Servier (http://www.servier.com/Powerpoint-image-bank) is licensed under a Creative 
Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
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Proteome changes in the remote myocardium during early stage remodeling after I/R. At early 
post-reperfusion stages (120 min to 24 h) the remote myocardium showed a transient coordinated upregulation 
of proteins related to ATPase activity, muscle thin filament (mainly troponins, tropomyosins, and tropomodulin), 
proteolysis, fibrillar collagen deposition, and mitochondrial ribosomes (Fig. 5a). Conversely, there was a tran-
sient downregulation of muscle thick filament proteins, accessory contractile proteins, and proteins related to 
several mitochondrial processes (including carriers, tricarboxylic acid cycle, fatty acid beta-oxidation, and ETC 
complexes, mainly affecting complexes III and IV) (Figs 5b, S3 and S4). With the exception of fibrillar collagen, 
Baseline R-120 min R-24 hours R-Day 4 R-Day 7
Group 1 (Control)
I 75.7 (16.7)
R 61.8 (20.1)
Group 2 (I/R-120min)
I 38.4 (10.2) −21.4 (15.1)
R 18.3 (7.0) −12.3 (9.3)
Group 3 (I/R-24hour)
I 47.5 (11.6) −15.8 (12.4) −4.3 (9.7)
R 30.6 (14.0) 6.7 (16.1) 9.7 (13.9)
Group 4 (I/R-4days)
I 45.4 (17.7) −14.6 (9.7) −3.7 (7.9) 12.9 (16.9)
R 35.3 (16.3) −5.5 (9.4) 7.9 (21.5) 39.7 (21.7)
Group 5 (I/R-7days)
I 80.6 (16.2) −10.2 (18.6) 3.6 (15.3) 21.6 (7.8) 17.6 (15.5)
R 65.6 (14.9) 14.1 (11.3) 18.6 (21.3) 40.0 (12.7) 35.4 (19.7)
Pooled
I 57.5 (22.1) −15.5 (13.8)* −1.5 (11.2)* 17.2 (13.2)* 17.6 (15.5)*
R 42.3 (23.3) 0.7 (15.2)* 12.0 (18.4)* 39.8 (16.7) 35.4 (19.7)
Table 1. Left ventricular regional systolic wall thickening analysis in the ischemic and remote pig myocardium 
during the first week after I/R. Left ventricular regional systolic wall thickening in the ischemic and remote 
myocardium, reported as mean % (standard deviation). A priori pairwise comparisons between baseline and 
pooled data for each time point were performed using generalized linear mixed models. Multiple comparison 
adjustment of p-value was performed according to the sequential Holm-Bonferroni procedure. *Statistically 
significant differences (p < 0.05) between baseline and corresponding pooled time-point data. The different 
myocardial states (ischemic vs. remote) were initially defined by the localization relative to late gadolinium 
enhanced defined infarction41,42. In the case of baseline imaging, i.e. before ischemia/reperfusion, such a 
definition was retrospectively performed based on follow-up imaging; while matched areas were selected in the 
case of controls. I: Ischemic; R: Remote
Figure 2. Functional cardiac magnetic resonance during early post-I/R remodeling. Time course of regional 
contractility in the ischemic and remote myocardium. Systolic wall thickening (SWT) in the ischemic and 
remote myocardium: (A) Absolute values. (B) Percentage SWT change relative to baseline. Symbols and bars 
denote mean and standard error of the mean. Dashed lines indicate reference values from healthy pigs, before 
induction of myocardial infarction. Myocardial segments were considered dysfunctional if SWT is 30% or 
less. (C) Representative bullseye display of SWT in one pig at baseline and over the first week post I/R after 
40-minute mid left anterior descending coronary artery occlusion. Transient contractile dysfunction was 
observed in the remote myocardium at early post-I/R phases.
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Figure 3. Quantitative proteomics time course analysis of early reperfusion after acute infarction in the 
ischemic myocardium. Quantitative proteomics screening approach results were analyzed using the Systems 
Biology Triangle (SBT) model to detect coordinated protein changes in functional categories over time. 
Functional categories significantly altered (False Discovery Rate, FDR < 0.05) at least one time point were 
classified into four clusters (a–d) Cluster a, increasing after 120 min with sustained upregulation for 7 days 
after ischemia onset; Cluster b, decreasing after 120 min and recovering to baseline values at day 7, except for 
glycolysis and kinase-binding proteins. Cluster c, increasing at days 4 and 7, with maximum change at day 7; 
and Cluster d, decreasing over time, with a tendency to reach minimum values at day 7. Protein values (Zq) and 
functional category values (Zc) are reported as log2 fold changes with respect to baseline, in units of standard 
deviation. The complete set of proteins changing in each category is listed in Supplementary Tables S1–S4. Panel 
(e) displays the cumulative distributions of Zq from proteins belonging to a set of representative categories from 
clusters c and d, showing the high coordination of protein responses. (f) Schematic chart of changes in water 
content and protein clusters. The proteomics results presented here are representative of three technical replicate 
experiments using five animal sample pools.
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values for these coordinated processes returned to normal by day 7 after reperfusion (Figs 5a,b and S3). The 
imbalance in the proportion of sarcomere components strongly suggests uncoupling of the finely-tuned con-
tractile machinery in the remote myocardium early after myocardial infarction. Notably, unlike the pattern seen 
Figure 4. Validation of the most representatitve protein changes detected in ischemic myocardium after 
acute infarction. (a) Western blot analysis and corresponding quantitative densitometry of ATP5A, UQCRC2, 
SDHB, NDUFB8, UQCRFS1, COXIV and ATP5B confirming the decrease in mitochondrial protein content 
7 days after reperfusion with respect to baseline. (b) Western blot analysis and quantitative densitometry of 
cardiac Myosin heavy chain, TNNT2 and TPM1 confirming the decrease in sarcomeric contractile proteins 7 
days after reperfusion. Each lane of western blot corresponds to a protein extract obtained from one animal. 
Protein values are normalized relative to GAPDH. In the bar plots, results are shown as the mean ± s.e.m. of five 
determinations. *Indicates p value < 0.05; **indicates p value < 0.01 versus baseline by Mann-Whitney test. 
Full-length blots from panels a and b are presented in Supplementary Figure S8 as well as their raw integrated 
densities before and after normalization can be consulted in Supplementary Figures S9 and S10. iTRAQ 
quantifications of the proteins from panels a and b are shown in the Supplementary Figure S11a for comparison. 
(c) Label free individual protein quantifications of ATP5A, ATP5B, UQCRFS1, SDHB, MYH7, TNNT2 and 
TPM1 confirming the decrease in mitochondrial and contractile protein content. Protein quantifications 
are represented as log2(fold-change) of iBAQ intensities of individual animals from R-Day 7 compared with 
pooled average of iBAQ intensities from all Baseline group animals. (d) Label free quantitative proteomics 
confirming the decrease in mitochondrial and contractile proteins and the increase in acute-phase related 
proteins, collagens, extracellular matrix proteins (ECM), proteolysis related proteins and gene expression related 
protein contents, 7 days after reperfusion with respect to the baseline. Protein abundances were expressed 
as the iBAQ values. Results are shown as the mean ± s.e.m of five determinations performed in individual 
animals, *indicates FDR < 0.05; **indicates FDR < 0.01, ***indicates FDR < 0.001 versus baseline by Mann-
Whitney test after Benjamini–Hochberg correction. Label free individual protein quantifications included in 
the mitochondrial, contractile, acute-phase, collagens, ECM, proteolysis and gene expression protein groups are 
shown in Supplementary Figure S13.
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in the infarcted area (Figs 3d, 4a,c and S1), mitochondrial proteins in the remote myocardium did not all follow 
the same trend (Figs 5a,b and S4). This finding suggests that mitochondrial protein alterations do not reflect a 
decrease in mitochondrial number, but rather a progressive dysfunctional imbalance. Furthermore, this transient 
uncoupling of the mitochondrial and contractile protein machinery correlated with the temporary contractile 
dysfunction (SWT) observed by CMR during the first 24 h of reperfusion (Fig. 2). These findings clearly indicate 
that the molecular alterations triggered by I/R have a transient impact on remote myocardium function early 
during reperfusion.
Figure 5. Quantitative proteomics time course analysis of early reperfusion after acute infarction in the remote 
myocardium. Quantitative proteomics screening approach results are presented as in Fig. 3. Significantly 
altered functional categories were classified into five clusters (a–e): Cluster a, showing a transient increase 
at 120 min or 24 h; Cluster b, decreasing at 120 min and 24 h and reverting to almost normal values at day 7; 
Cluster c, reaching maximum upregulation at day 4, Cluster d, increasing gradually over time (this cluster 
included ribosome and collagen categories for comparison of results with the infarcted area); and Cluster e, 
decreasing in the late phase of reperfusion, reaching minimal values at day 7. Panel (f) shows a schematic chart 
of changes in water content and protein clusters. The complete set of proteins changing in each category is listed 
in Supplementary Tables S5–S9. The proteomics results presented here are representative of three technical 
replicate experiments using five animal sample pools.
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Functional analysis in the remote myocardium in late reperfusion phases (4 and 7 days post I/R) revealed an 
increase in proteins related to acute phase response signaling, wound healing, and blood cell adhesion (Fig. 5c and d). 
These functional alterations correlated with the linear edema in this area, revealed by progressively increasing CMR 
T2 relaxation times during the first week after reperfusion18,22. Furthermore, there were also increases in proteins 
related to chromatin organization and cardio-renal signaling processes (acute renal failure and renal toxicity bio-
markers), reaching peak values on days 4 and 7 post-I/R (Fig. 5d). Collagen and ribosome-related proteins showed a 
similar trend, although with lower statistical significance. Downregulated proteins included NAD and NADP accep-
tor proteins and proteins implicated in oxidative stress and DNA damage (Fig. 5e). Finally, the biological processes 
grouped in Fig. 5c and d show intriguing time offset/timeline discrepancies compared with the observations in the 
ischemic myocardium. A schematic diagram of changes in water content and protein categories clusters which occur 
in the remote myocardium is represented in Fig. 5f.
The main phenotypic changes in remote myocardium were also validated by alternative analysis. Western blot 
results obtained in at least four animals confirmed the generalized transitory increase at 120 min after reperfusion 
of a contractile protein belonging to thin filaments (TPM1) (Fig. 6a). Label-free mass spectrometry of individual 
animal samples (at least n = 4 per each condition) also confirmed that the absolute amount of proteins belonging 
to thick filaments was decreased at 120 min, while those belonging to thin filaments were increased (Figs 6b, S5 
and S14). A more accurate quantification of specific groups of proteins was also performed in individual ani-
mal samples (at least n = 4 per each condition) by targeted proteomics, performing two technical replicates per 
sample. These analysis confirmed the transient decrease at early times (120 min to 1 day) followed by subsequent 
recovery (7 days after reperfusion) of proteins belonging to mitochondrial carriers (ANT2), TCA cycle (ACO2, 
MDH), complex V (ATP5A1, ATP5O), complex III (UQCRC1), complex IV (COX6B), thick filaments (MYH7) 
or the accessory contractile proteins category (MYOM1). Similarly, we could also confirm the transient increase 
at early times of proteins implicated in ATPase activity regulation (MYL3) or belonging to thin filaments (TPM1). 
The protein used as internal control (GAPDH) was not significantly altered (Figs 6c and S6). Finally, as stated in 
the previous paragraphs, in our exploratory iTRAQ experiments of the remote myocardium tissue, we detected 
a coordinated initial disengagement (at 120 min) of the values of mitochondrial and sarcomeric proteins fol-
lowed by the latter coordinated restoration to normal (at day 7), which is shown in Fig. 7a-left and Fig. 7a-right, 
respectively.
Discussion
In the present study, advanced proteomic analysis in a pig model of I/R provides quantitative time-course infor-
mation on thousands of proteins and unravels an array of coordinated early changes in the heart proteome after 
MI. We have assessed not only the particular altered protein signatures that characterize the post-reperfused 
ischemic and remote myocardium, but also their relation to functional changes detected by CMR. This is the 
first study reporting a comprehensive proteomics analysis of molecular changes during early reperfusion in the 
post-MI remote myocardium.
Early reperfusion is characterized by an abrupt edematous reaction10,18 and a rapid and profound acute 
inflammatory response23,24. Upon reperfusion, intracellular, mitochondrial and sarcolemma Ca2+ concentrations 
increase abruptly, inducing cardiomyocyte hypercontraction and opening of the mitochondrial permeability 
transition pore (MPTP), the hallmark of reperfusion-induced cardiomyocyte death25. MPTP opening collapses 
the mitochondrial membrane potential and disconnects the electron transport chain, resulting in ATP depletion 
and subsequent cell death26. Our deep proteomics analysis of ischemic myocardium fully supports and extends 
these observations by establishing the time-course of hundreds of protein changes and by demonstrating a coor-
dinated activation of proteins implicated in inflammation, wound healing, and production of reactive oxygen 
species as soon as 120 min after reperfusion. Furthermore, at these early time-points, we identified downregu-
lation of cell junction and glycolytic metabolism proteins, consistent with the reperfusion-induced interstitial 
edema10 and the disruption of the normal mitochondria function11,27. Our study identifies a rich repository of 
early-response proteins directly related to reperfusion injury that could contribute to the development of thera-
pies and diagnostic tools5.
At later reperfusion phases (4 and 7 days post reperfusion), coordinated protein changes in the ischemic 
myocardium indicated activation of protein biosynthesis, synthesis of collagen and interstitial proteins, and for-
mation of new vasculature, together with decreases in mitochondrial and muscle proteins. These processes reflect 
a phenotypic change in the infarcted myocardial tissue caused by the replacement of necrotic myocytes (rich in 
mitochondria and with high metabolic activity) by collagen, extracellular matrix proteins, and fibroblasts (lower 
mitochondrial content and metabolic activity). Notably, in the ischemic myocardium we also identified a progres-
sive increase in proteins related to cardio-renal signaling, suggesting active cross-talk between the acutely injured 
heart and the kidney.
The remote myocardium plays an important role in ventricular function after AMI, and acute post-AMI HF 
can be exacerbated by transitory stunning of the non-ischemic region28. Similarly, the long-term inflammatory 
response in the remote region can lead to progressive adverse remodeling, chronic ventricular dilatation, and 
HF17. Therefore, understanding the molecular changes occurring in the remote region is of the utmost impor-
tance for the development of therapeutic strategies targeting this region. However, the early post-infarct behavior 
of the remote tissue, particularly at the molecular level, has remained unexplored until now. In this study, we 
contribute to fill this gap of knowledge by providing a first insight into the transiently stunned myocardium and 
a highly detailed characterization of phenotypic events taking place in the remote area during the first week after 
I/R.
We demonstrate that I/R significantly impacts the remote myocardium, inducing molecular changes that 
correlate precisely with CMR-evaluated alterations in contractile function (transient stunned myocardium) 
and tissue composition (late progressive edema). In the period from 120 min to 24 h after reperfusion, transient 
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Figure 6. Validation of the most representatitve protein changes detected in remote myocardium after 
acute infarction. (a) Western blot analysis and quantitative densitometry of TPM1 confirming the transient 
increase in thin filament sarcomeric proteins early after reperfusion. Full-length blots are presented in 
Supplementary Figure S8 as well as their raw integrated densities before and after normalization can be 
consulted in Supplementary Figure S12. Protein values are normalized relative to GAPDH. Results are shown 
as the mean ± s.e.m. of values obtained in at least four animals. *Indicates p value < 0.05 versus baseline by 
Mann-Whitney test. (b) Label free proteomics analysis confirming the decrease in thick filament proteins and 
an increase in thin filament proteins early after reperfusion (in at least four animals). Results are expressed as 
in Fig. 4d. Label free individual protein quantifications included in the thick filament and thin filament protein 
groups are shown in Supplementary Figure S14. (c) Quantitative analysis by PRM targeted proteomics of 
proteins ANT2, ACO2, ATP5A1, ATP5O, UQCRC1, MDH2, COX6B, GAPDH, MYH7, MYOM1, MYL3 and 
TPM1, confirming the transient changes in abundance of mitochondrial and contractile sarcomeric proteins 
after early reperfusion. Protein values are normalized by the total base peak area of the chromatograms. Results 
are shown as the mean ± s.e.m. of at least four animals at each time point in two technical replicates. *Indicates 
p value < 0.05; **indicates p value < 0.01, ***indicates p value < 0.001 versus baseline by Mann-Whitney test. 
iTRAQ quantifications of the proteins from panels a and c are shown in the Supplementary Figure S11b for 
comparison.
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molecular alterations of sarcomere components are detected in the remote myocardium, associated with alter-
ations in mitochondrial components (Figs 7a and S3), coinciding with CMR-detected temporal alterations in 
systolic wall thickness. At later phases (one week post I/R), these changes reverted to the levels detected in the 
control sample, coinciding with restored systolic contractile function in the remote myocardium.
Figure 7. Affected functional processes in sarcomeres and mitochondria of the remote myocardium. (a) Cumulative 
distributions of all Zq values from proteins in the categories depicted in (Supplementary Figure S3) after 120 min 
(left) or 7 days (right) of reperfusion; for clarity, all proteins belonging to mitochondrial electron transport chain 
(ETC) complexes are grouped into one category. (b) Outline of the mechanical uncoupling within the contractile 
machinery and the transient decrease in processes crucial for energy production (tricarboxylic acid (TCA) cycle, 
fatty-acid beta-oxidation, mitochondrial complexes III and IV) and energy transfer and supply (mitochondrial 
substrate/solute carrier proteins). For clarity, mitochondrial complexes are drawn as simple entities, neglecting their 
complex structures. Graphical elements in Fig. 7 were adapted from the Servier Medical Art Powerpoint image 
bank. Servier Medical Art by Servier (http://www.servier.com/Powerpoint-image-bank) is licensed under a Creative 
Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
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Acute loss of myocardial function after MI has classically been considered to trigger rapid increases in load-
ing conditions and adaptive responses to preserve stroke volume; these responses include deformation of the 
remote myocardium, which alters Frank/Starling relations, and activation of the sympathetic adrenergic and 
renin-angiotensin-aldosterone systems29. Our results suggest that these responses might be temporarily mala-
daptive, because the decrease in regional contractility in the remote myocardium early after reperfusion is almost 
fully recovered some days later.
Our findings indicate that abrupt post-MI overload of the heart’s contractile apparatus and the temporary 
energy-supply cut-off during early reperfusion induces a compensatory response in the remote myocardium 
involving transient molecular changes in thin filament components, mitochondrial biosynthesis machinery, and 
ATPase regulators. However, these adaptive changes are accompanied by a temporary mitochondrial dysfunction 
that affects energy-producing components (ETC, TCA cycle, fatty acid beta-oxidation, and mitochondrial energy 
carriers), while there are transient alterations in other sarcomere components (thick filaments and accessory 
contractile proteins) (Fig. 7b). This view is supported by recent evidence that thin and thick filaments are inde-
pendently and separately regulated30. Likewise, transcriptional analysis of the failing mammalian myocardium 
suggests an orchestrated dysregulation of energy supply (metabolism) and expenditure (muscle contraction and 
ion homeostasis)31. In addition, the strong alteration of mitochondrial complexes III and IV (at 120 min and 24 h, 
Supplementary Figure S2) is in good agreement with a recent report that succinate accumulating during ischemia 
in mice is rapidly metabolized after reperfusion, producing a large proton motive force through ETC complexes 
III and IV32.
State-of-the-art T2 mapping CMR sequences show a moderate edematous reaction appearing progressively 
several days after I/R, evidenced by the progressive increase in T2 relaxation times during the first week after rep-
erfusion18,22. These results also correlate precisely with the proteomics analysis in the remote myocardium, which 
shows changes in proteins involved in inflammation, wound healing, and fibrotic processes. Notably, edema in 
the remote region follows a different pattern to that found in the ischemic region18,22. The at-risk region shows a 
bimodal pattern of edema, with the initial wave secondary to reperfusion and the deferred associated with tissue 
repair; in contrast, in the remote region edema formation is unimodal and progressive. In the infarcted region, 
activation of inflammatory response proteins coincides with the initial edema wave, whereas in the remote region 
it correlates with the later progressive edema formation. This observation reinforces the idea that these edematous 
processes are closely related to inflammation and indicate that the inflammatory response in the remote region is 
delayed by some days relative to the reaction in the infarcted region. Inflammation also coincided with increased 
collagen levels that were also observed in the remote myocardium at these later reperfusion phases10. A subtle 
post-MI inflammation in the remote myocardium is also supported by the accumulation in this region of mono-
cytes and macrophages, albeit more slowly and in lower amounts than the ischemic myocardium33.
The different timing of inflammatory responses in the remote and ischemic post-MI myocardium might play 
an important role in modulating extracellular matrix protein composition, which contributes to adverse remode-
ling of the remote region and heart failure33–37. Well-healed infarcts contain large amounts of extracellular matrix, 
occupying up to 80% of the infarcted area. Collagen deposition in the non-infarcted remote myocardium occurs 
predominantly in the interstitium, where it contributes to ventricular stiffness and dysfunction16. Although colla-
gen deposition initially helps to maintain ventricular morphology after MI, over time it can contribute to geomet-
ric changes and functional deterioration35. Phenotypically transformed myofibroblasts and inflammatory cells, 
including those located in the remote myocardium, seem to be central to fibrosis at remote sites after MI due to 
their possible contribution to the upregulation of the renin-angiotensin system, which is strongly implicated in 
ventricular remodeling16,17,38.
Limitations. The results presented are from a juvenile healthy animal model in the absence of comorbidi-
ties and classical risk factors for cardiovascular disease; therefore, care should be taken in extrapolating to the 
clinic39. Nonetheless, the pig is one of the most clinically translatable large animal models for the study of I/R 
issues, because unlike other mammals its coronary artery anatomy and distribution resembles that of humans, 
including a minimal pre-existing coronary collateral flow40. The use of a large animal model is of great transla-
tional value, especially considering the difficulty of performing such a comprehensive myocardial tissue analysis 
at the molecular level in patients. The time course of tissue changes in the post-I/R myocardium in pigs, albeit 
slightly briefer, is similar to that observed in humans10,41. In general, cardiac contractility and performance, and 
therefore cardiac tolerance against ischemia/reperfusion injury might be influenced by anesthesia with additional 
potential inter- and intra-individual variations in experimental models. We tried to overcome this limitation by 
performing different but complimentary analysis as follows. Firstly, we analyzed the individual percentage SWT 
change relative to baseline; therefore taking account for inter-individual variations. Secondly, we analyzed SWT 
results by using generalized linear mixed models for ischemic and remote myocardium separately; therefore 
taking account for repeated measurements, inter- and intra-individual variations. Finally, we demonstrated that 
infarct transmurality and final tissue damage was very similar among pigs. All these data together reinforce the 
notion that the time profile of regional contractility and final injury inflicted after I/R was quite homogeneous 
in our experimental model with little influence (if any) of anesthesia in our results, though we cannot definitely 
exclude any potential interaction.
Another limitation is that the proteomics results in the present study come from homogenized myocardial 
tissue; therefore it is not possible to differentiate protein expression in different cell types or myocardial layers. 
Similarly, our data lacks information on subcellular location, on post-translational modifications and on the 
activity of the proteins quantified. A related problem is the possibility that during reperfusion, blood may occa-
sionally enter the interstitial area through damaged vessels, influencing the proteomics results. The total amount 
of proteins potentially originating from plasma is, however, very low (Supplementary Figure S7), suggesting that 
if present, this kind of contamination is insufficient to significantly alter our results.
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Finally, the incomplete annotation and functional classification of Sus scrofa proteins is also a problem that dif-
ficulties biological interpretation. Although we have managed this issue by assigning pig proteins to their human 
counterparts on the basis of shared peptide sequences, extrapolation of pig protein results to humans should be 
done with caution.
We present the first comprehensive proteomics analysis of the post-I/R myocardium, covering the first week 
after infarction. Our results highlight a dynamic pattern of molecular responses that take place in the ischemic 
and remote myocardium, linked to functional changes revealed by CMR. The results provide evidence of intrigu-
ing transformations in the remote non-infarcted myocardium during the first week after I/R, as demonstrated 
by striking local proteome changes, temporarily reduced contractility function, and the presence of edema in 
this region. These findings provide insight into the precise molecular signatures underlying early remodeling 
stages in both the ischemic and the remote myocardium, with potential for the development of new therapeutic 
approaches to preventing post-MI HF.
Methods
Study design and myocardial infarction procedure. The study population was formed by 25 castrated 
male 3 to 4 month old Large-White pigs weighing 30 to 40 kg. The studies on swine were conducted in accordance 
with the Guide for the Care and Use of Laboratory Animals (the Institute of Laboratory Animal Resources, 1996), 
and with the approval of Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Institutional 
Animal Research Committee (CNIC 05/13) and the Regional Animal Research Committee (PROEX 51/13). We 
previously reported the dynamic changes in edema formation (assessed by T2 mapping CMR) and tissue com-
position (assessed by histology) in the ischemic area in same cohort of pigs18. The study design is summarized in 
Fig. 1a. Five pigs (Group 1) were sacrificed with no intervention other than baseline CMR, and served as controls. 
In 20 pigs, reperfused transmural acute myocardial infarction (I/R) was induced experimentally by closed-chest 
40-minute mid left anterior descending coronary artery occlusion followed by balloon deflation and reestablish-
ment of blood flow18,41,42. These pigs were sacrificed at 120 min (n = 5, Group 2), 24 h (n = 5, Group 3), 4 days 
(n = 5, Group 4), and 7 days (n = 5, Group 5). CMR scans were performed at every follow-up stage until sacrifice 
(i.e. animals sacrificed on day 7 underwent baseline, 120 min, 24 h, day 4, and day 7 CMR exams). The animals 
were euthanized immediately after the last follow-up CMR scan, and transmural myocardial tissue samples from 
ischemic and remote areas were rapidly collected for proteomic evaluations. Based on anatomical correlates and 
standard left ventricle segmentation, those areas from mid-apical ventricular short axis slices matching regional 
contractility analysis were selected for sampling collection. Detailed information about the study design and 
myocardial infarction procedure can be found in a previous publication18.
CMR protocol and analysis. CMR exams were performed immediately before MI induction and at sub-
sequent post-MI follow-up time points until sacrifice. All CMR studies were conducted with a Philips 3-Tesla 
Achieva Tx whole body scanner (Philips Healthcare, Best, the Netherlands) equipped with a 32-element 
phased-array cardiac coil. The imaging protocol included a standard segmented cine steady-state free-precession 
(SSFP) sequence to provide high quality anatomical references and segmental regional contractility18,41,42. CMR 
images were analyzed using dedicated software for regional contractility (QMass MR 7.6; Medis, Leiden, the 
Netherlands) by two observers experienced in CMR analysis and blinded to group allocation. To quantify 
end-diastolic wall thickness (EDWT), end-systolic wall thickness (ESWT), LV volumes, and LV mass, epicardial 
and endocardial contours were detected automatically, and corrected manually on short-axis cine SSFP if needed. 
Systolic wall thickening (SWT) was calculated according to the formula (ESWT − EDWT)/EDWT ×100. SWT 
was summed and then averaged from mid-apical anteroseptal and anterior segments, for the ischemic area, and 
mid-apical inferolateral and inferior segments, for the remote area. Myocardial segments were considered dys-
functional if SWT was 30% or lower43. Detailed information about imaging parameters and CMR analysis can be 
found in the Supplementary Information file.
ǡƤƤǤ Pigs were sacrificed at 
different time-points after CMR (120 min, 1 day, 4 days, and 7 days post-reperfusion). Samples from the ischemic 
and remote myocardium of all pigs were collected within minutes of euthanasia and processed for proteomic 
analysis (Fig. 1b). The 40 minutes-I/R protocol applied in our experimental setting is able to induce a transmural 
necrosis with virtually no viable myocardium within the ischemic area10,18,41,42; therefore ensuring analysis at pure 
infarcted and remote myocardium levels. Protein extracts were obtained by tissue homogenization with ceramic 
beads (MagNa Lyser Green Beads apparatus, Roche, Germany) in extraction buffer (50 mM Tris-HCl, 1 mM 
EDTA, 1.5% SDS, pH 8.5). Free Cys residues were blocked with 50 mM iodoacetamide at the time of protein 
extraction. For the screening proteomics approach, the protein extracts for each time-point from five biological 
replicate samples were pooled according to their concentration. Samples were subjected to tryptic digestion and 
the resulting peptides were labeled with 8-plex isobaric tags for relative and absolute quantification (iTRAQ) 
and separated by cation exchange chromatography. The fractionated peptides were analyzed by nano-liquid 
chromatography-tandem mass spectrometry (nanoLC-MS/MS) using a Q-Exactive hybrid quadrupole orbitrap 
mass spectrometer (Thermo Scientific). The proteomics results presented in Figs 3 and 5 are representative of 
three technical replicate experiments.
Protein identification was performed using the SEQUEST HT algorithm integrated in Proteome Discoverer 
1.4 (Thermo Scientific). Since Sus scrofa gene and protein annotation is not complete, MS/MS scans were 
searched against a combined pig and human database (UniProtKB/Swiss-Prot 2014_02 Release); pig proteins 
are given priority when they share peptides with human proteins. Peptides were identified from MS/MS data 
using the probability ratio method44. False discovery rate (FDR) of peptide identifications was calculated by the 
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refined method45,46. Quantitative information was extracted from the MS/MS spectra of iTRAQ-labeled pep-
tides using the in-house program QuiXoT, as described47. Differential protein expression was analyzed using the 
WSPP model47,48, which uses raw quantifications as input data and computes the protein log2-fold changes (FC) 
expressed in units of standard deviation around the averages (Zq) for each condition (Groups 2–5), with respect 
to the control (Group 1). For protein quantification, no limit was imposed on the minimum number of peptides 
per protein47,48. A quantitative proteomics result of total protein changes globally between remote and ischemic 
myocardium during the first week of reperfusion is summarized in Supplementary Table S10. Alterations in bio-
logical functions as a consequence of the coordinated behavior of proteins, was analyzed by estimating functional 
category averages (Zc) according to the Systems Biology Triangle (SBT) model19. The quantified proteins were 
functionally annotated using the Ingenuity Knowledge Database (IPA)49,50 and DAVID51. The DAVID repository 
includes 13 functional databases, including Gene Ontology, KEGG, and Panther. Further details about proteom-
ics and statistical analysis can be found in the Supplementary Information file.
Parallel Reaction Monitoring Analysis. Samples from individual pigs used in this analysis were 
obtained from five animals for each time-point (baseline, R-24 hours, R-Day 4 and R-Day 7) and four animals 
for time-point R-120 min. For the targeted monitoring, we selected the peptides which were identified with 
the highest SEQUEST score (Xcorr) and that belonged to representative proteins from the functional catego-
ries (Supplementary Table S11). Quantitative targeted protein analyses for each biological replicates were per-
formed by parallel reaction monitoring (PRM)52 by nano-liquid chromatography-tandem mass spectrometry 
(nanoLC-MS/MS) using a QExactive HF Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific) 
in two technical replicates. Raw mass spectrometry files (Thermo) and spectral libraries (msf files obtained with 
Proteome Discoverer 2.1 search engine) were imported into Skyline version 3.6.0.10162 ((https://skyline.gs.wash-
ington.edu) for identification of transitions and peak area integration according to the software instructions53. 
Only b- or y- fragment ions were selected to build the elution profile for peptide quantitation. All extracted ion 
chromatograms (XICs) of selected fragments were manually inspected and adjusted to ensure proper peak pick-
ing and peak integration.
Label Free Proteomics Analysis. Samples used in this analysis obtained from 4 individual pigs 
(time-point R-120 min) or 5 individual pigs (time-points baseline, R-24 hours, R-Day 4 and R-Day 7) were pro-
cessed as described above. Label free experiments for all biological replicates were acquired using nano-liquid 
chromatography-tandem mass spectrometry (nanoLC-MS/MS) in a QExactive HF Hybrid Quadrupole-Orbitrap 
Mass Spectrometer (Thermo Scientific). MS data were acquired with a Top10 data‐dependent MS/MS scan 
method (topN method). Mass spectrometry raw files were analyzed by MaxQuant software (version 1.5.6.5)54. 
Label‐free protein quantitation (LFQ) was performed with a minimum ratio count of 155. Intensity-based absolute 
quantification (iBAQ)20 implemented in MaxQuant was used for the analysis of the label-free proteomics experi-
ments. We express the protein abundances as percentage of the identified proteome, obtained by normalizing the 
iBAQ intensities to the sum of all intensities.
Western Immunoblotting Analysis. Validation by western blot was performed on selected representative 
proteins from each functional category according to antibody availability, giving priority to the proteins identi-
fied with the highest number of peptides by mass spectrometry. Immunoblotting was performed according to 
standard protocols. Briefly, 10 μg of heart tissue extracts were loaded per lane separated on the 4–10% gel and 
transferred to polyvinylidene fluoride (PVDF) (Immobilon-FL, Milipore) membranes for fluorescence applica-
tions. Validation of proteomics results was performed using the following antibodies: ATP5A (Abcam, ab14748), 
UQCRC2 (Abcam, ab14745), SDHB (Abcam, ab14714), NDUFB8 (Abcam, ab110242), UQCRFS1 (Abcam, 
ab14746), COXIV (Abcam, ab14744), ATP5B (Abcam, ab14730), cardiac Myosin (Abcam, ab50967), TPM1 
(Abcam, ab133292), TNNT2 (Abcam, ab10214) and GAPDH (Santa Cruz Biotechnology, sc-32233). Secondary 
antibodies goat anti-mouse IgG DyLight 800 (Rockland, 610-145-121) and goat anti-rabbit IgG Alexa Fluor 680 
(Thermo Fisher Scientific, A-21076) were used against the corresponding primary antibodies and the images were 
acquired with the ODYSSEY Infrared Imaging System (LI-COR).
Statistical analysis. Normal distribution of each data subset was checked using graphical methods and a 
Shapiro–Wilk test. For quantitative CMR variables, data are expressed as mean and standard deviation. To take 
into account repeated measures, the time course of regional contractility was analyzed with generalized linear 
mixed models. Pairwise comparisons were made between baseline and all other CMR time points, and p-values 
were adjusted for multiple comparisons by the sequential Holm-Bonferroni method. Statistical analyses were 
performed with Stata 12.0 (StataCorp, College Station, Texas). Western blot analysis to determine significant 
differences between groups after densitometry analysis and statistical analysis of absolute peptide quantitation 
by PRM were performed using the Mann-Whitney test, using the GraphPad Prism 7.02 software. Results of 
intensity-based absolute quantification (iBAQ) of label free proteomics experiments were tested for significance 
using the Mann-Whitney test with a false discovery rate of <0.05 after Benjamini–Hochberg correction.
Data availability. The dataset from the analysis of the pig myocardium proteome (raw files and excel tables 
with peptide and protein quantification data), the label-free and the PRM analysis raw data as well as the raw 
western blot data from the ODISSEY scanner are available in the PeptideAtlas repository http://www.peptideatlas.
org/PASS/PASS00891), which can be downloaded via ftp.peptideatlas.org.
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free lipid extraction is characterized.
 Resource of tandem mass spectra of
lipid mediators is provided.
 CID MS2 of lipid mediators can
comprise odd-electron fragment
ions.
 Spectrum Comparison Score (SCS)
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SpeCS is introduced to manage
customized spectral libraries and
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a b s t r a c t
We characterized the performance of a micro-ﬂow LC-ESI-MS2 approach to analyze lipid mediators (LMs)
and polyunsaturated fatty acids (PUFA) that was optimized for SPE free lipid extraction. Tandem mass
spectrometry was exclusively performed in parallel reaction monitoring (PRM) mode using TOF and
Orbitrap analyzers. This acquisition strategy allowed in addition to quantitation by speciﬁc quantiﬁer
ions to perform spectrum comparisons using full MS2 spectra information of the analyte. Consequently,
we developed a dedicated software SpeCS that allows to 1) process raw peak lists, 2) generate
customized spectral libraries, 3) test speciﬁcity of quantiﬁer ions and 4) perform spectrum comparisons.
The dedicated scoring algorithm is based on signal matching and Spearman's rank correlation of in-
tensities of matched signal. The algorithm was evaluated in respect of its speciﬁcity to distinguish
structural related LMs on both instrument platforms. We show how high resolution mass spectrometry is
beneﬁcial to distinguish co-eluted LM isomers and provide a generalized quality control procedure for
PRM. The applicability of the approach was evaluated analyzing the lipid mediator response during
M. tuberculosis infection in the mouse lung.
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1. Introduction
Lipid mediators (LMs) are derivatives of omega-3 and -6 (u-3, u-
6) polyunsaturated fatty acids (PUFAs) like arachidonic acid (AA),
eicosapentanoic acid (EPA) or docosahexanoic acid (DHA) by enzy-
matic conversions through lipoxygenases (LOXs) and/or cyclo-
oxygenases (COXs) [1e3]. The oxidation of these C20- and C22-
carboxylate bodies generates messengers comprising hundreds of
constitutional isomers, which can be released from diverse cellular
sources in response to microbial infections, physical and chemical
stresses [4]. The resulting LM proﬁle reﬂects the host's inﬂammation
status and its precise chemical determination can be potentially
exploited for diagnostic purposes [5]. Thus, in the initiation phase of
inﬂammation pro-inﬂammatory LMs, particularly leukotrienes (LTs)
and prostaglandins (PGs) are preponderant, while the resolution of
inﬂammation, in contrast, is dominated by pro-resolving LMs, such
as lipoxins (LXs), maresin (Mar), protectin (PD) and resolvins of the
E- and D-series (RvEs, RvDs) [6]. Herein, all LM types are thought to
exert their regulatory effects by binding to G protein-coupled re-
ceptors (GPCR), this contributing to the control of all aspects of tissue
inﬂammation, including e.g., the recruitment of inﬂammatory cells,
such as neutrophils, monocytes, and macrophages, into peripheral
tissues [7e9]. However, one of the major challenge in study of lipid
mediators is the unequivocally identiﬁcation of isomers that can
fulﬁll diametral roles in homeostatic and pathophysiological events
[10,11]. In recent years, mass spectrometry (MS) based methodolo-
gies have become the state-of-the-art technology for LMs identiﬁ-
cation and quantitation in complex biological tissues. Several
targeted approaches were described to analyze oxidized PUFAs on
the basis of liquid chromatography-electrospray ionization-tandem
mass spectrometry (LC-ESI-MS2) [12e17]. Generally, LC-MS2 ana-
lyses were performed using triple quadrupole (QqQ) mass analyzers
providing low mass resolution but optimal duty cycle. Product ions
of LMs were monitored by using selected reaction monitoring (SRM)
and multi reaction monitoring (MRM), respectively. LM identiﬁca-
tion was based on the speciﬁc retention time (RT) of reference
compounds and the detection of speciﬁc product ions. The devel-
opment of new MS-analyzer designs like the Orbitrap [18] and HR-
TOF MS [19] made accurate mass information compatible with
conventional LC as well as UPLC time scales. With these instruments
the full MS2 spectra are recorded and can be utilized for post pro-
cessing termed as parallel reaction monitoring (PRM) [20]. Hence
“mediator lipidomics” [21] or “targeted lipidomics” [22] were
introduced for describing the merging of targeted and untargeted
approaches. Recently, LC-HR-MS2 approaches were successfully
applied for identiﬁcation and quantitation of LMs [23,24]. However,
metabolite identiﬁcation based on spectrum-spectrum comparison
is a crucial step in all targeted and untargeted approaches [25]. To
build up a MS2 library that provides reliable spectral information of
known and unknown compounds, one can beneﬁt from the full HR-
MS2 spectral information obtained by PRM. This has the advantage of
decreased levels of false positive lipid identiﬁcations, especially
when it comes to isomeric LMs [26].
Recently, we developed a SPE-free extraction procedure coupled
with a micro-ﬂow LC-ESI-MS2 [27]. In this study, we provide a
comprehensive description of the LC-MS2 approach using a quadru-
pole time-of-ﬂight (QqTOF) and a Q Exactice Plusmass spectrometer.
Wediscuss howapplicationof PRM inconjunctionwith the dedicated
software SpeCS can improve quality control of LM quantitation.
2. Materials and methods
2.1. Chemicals
All lipid standards were purchased from Cayman Chemicals
(Ann Arbor, Michigan, USA) (see supplementary Table 1). All sol-
vents with at least LC grade were purchased from Sigma-Aldrich
(Taufkirchen, Germany) and from Merck Millipore (Darmstadt,
Germany). Dulbecco's Modiﬁed Eagle Medium (DMEM) and fetal
calf serum (FCS) were purchased fromMerck Millipore (Darmstadt,
Germany). Used antibodies were purchased from BioLegend (San
Diego, California, USA). Chemicals for ﬂuorescence and staining
assays were obtained from Life Technologies (Carlsbad, California,
USA) and Southern Biotech (Birmingham, Alabama, USA),
respectively.
2.2. Stock solutions and storages
Reference compounds of oxidized PUFAs and the deuterium-
labeled internal standards (IS) for quantitation were dissolved in
ethanol, acetonitrile (ACN) or methyl acetate and stored at 20
or 80 C as recommended by Cayman Chemicals (Ann Arbor,
Michigan, USA). All stock solutions had a concentration of
10 pmol/ml. Prostaglandins (PGs) and tri-hydroxylated PUFAs
(PUFA-O3), were quantiﬁed by using PGE2-d9 and RvD2-d5,
respectively. The groups of di- and mono-hydroxylated PUFAs
(PUFA-O2, PUFA-O1) were quantiﬁed utilizing LTB4-d4 and 5-
HETE-d8. The precursor PUFAs were quantitated using AA-d11.
For each sample set extraction, new IS mixtures with a concen-
tration of 500 fmol/ml for each deuterated compound were
prepared.
2.3. Mycobacteria tuberculosis infection model
Mycobacterium tuberculosis H37Rv (M. tuberculosis) was grown
in Middlebrook 7H9 broth (BD Biosciences) supplemented with
OADC (Oleic acid, Albumin, Dextrose, Catalase) enrichment me-
dium (BD Biosciences). Bacterial cultures were harvested and ali-
quots were frozen at 80 C until use. For aerosol infection,
M. tuberculosis stocks were diluted in sterile distilled water. Ani-
mals were exposed to an aerosol containing 200 CFU for 60min
using an aerosol chamber (Glas-Col, Terre-Haute, IN, USA) and
bacterial burdens in lung and spleenwere evaluated at various time
points p.i. as described before [28]. Lung homogenates have been
formed by mechanical disruption of the organ in 0.05% v/v Tween
20 in PBS. Lung homogenates have been sterile ﬁltered and were
utilized for LM extraction.
2.4. Lipid extraction
Lipids were extracted according to a modiﬁed acidiﬁed
Bligh&Dyer protocol [16,27]. Brieﬂy, 500 ml of the lung homoge-
nates were transferred into an ice-cooled 2.0ml tube covered with
aluminum foil. Afterwards, 2 mL of butyl hydroxyl-toluene in
methanol (BHT; 1.0mg/mL) and 25 ml of the internal standard mix
was added to the tube (Table 1). Afterwards, 320 mL of ice-cold
chloroform was added followed by 640 ml of ice-cold MeOH/HAc
(97:3; v/v) to the mixture. The mixture was incubated for 30min at
room temperature with constant stirring. For phase separation
320 mL of ice-cold water was added and the mixture was incubated
for another 30min under shaking. Finally the samples were
centrifuged at 15,000 g for 15min at 4 C. The organic phase was
collected and transferred to an ice-cooled sample tube. The
extraction procedure was three more times repeated by adding
320 mL of ice-cold CHCl3. Finally, all combined organic phases were
dried under a slight stream of nitrogen. Lipid extracts were dis-
solved in 40 mL of solvent and 2 mL were injected for the LC-MS2
analysis.
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2.5. LC-MS2 analysis
Liquid chromatography was performed using a micro-LC 1100
system Agilent Technologies (Santa Clara, California, USA). For
chromatographic separation a Luna C18(2) reversed phase (RP)
column (0.3mm ID x 150mm) from Phenomenex (Torrance, Cali-
fornia, USA) was used at a ﬂow rate of 10 ml/min. Solvent A
comprised of water, ACN and 1M ammonium acetate (59:40:1, v/v/
v) and the pH was set to 5.6 using acetic acid (HAc). Solvent B was
mixed from methanol (MeOH), methyl tert-butyl ether (MTBE), 2-
propanol and HAc (50:40:10:0.1, v/v/v/v). The LC gradient was set
to 0min: 0% (B); 5min: 0% (B); 10min: 100% (B); 30min: 100%;
35min: 0% (B); 70min: 0% (B). Samples were kept at 5 C in the
autosampler and the injection volume was 2.0 ml MS2 data was
recorded on a Q-TOF Ultima™ mass spectrometer from Waters
(Milford, Massachusetts, USA) via the Z-spray ESI source. All ex-
periments were performed in the negative ion mode using a
capillary voltage of 2.6 kV, cone voltage 65 V and RF lens 1 at 32.5 V.
The source and desolvation temperaturewere set to 100 and 210 C,
respectively. The cone and desolvation gas ﬂow was set 180 and
250 L/h, respectively. Precursor isolation was performed with 1 Da
selection window and collision induced dissociation (CID) was
achieved using argon as collision gas using adjusted collision en-
ergies (CE) for each precursor ion group (Table 1). Full MS2 spectra
were recorded according to a scheduled selection of precursor
masses to enable sufﬁcient sampling of chromatographic peaks.
Peak detection, integration and quantitation of compounds was
performed using MassLynx™ 4.0, Waters (Milford, Massachusetts,
USA) allowing mass error of 500 ppm and 1 Da, respectively.
The HR-MS2 was acquired on a Q Exactive Plus mass spec-
trometer (Thermo Fisher Scientiﬁc, Bremen, Germany). All MS ex-
periments were performed in the negative ion mode using a spray
voltage of 3.0 kV, a capillary temperature of 260 C, sheath gas
pressure of 5 au and the S-lens radiofrequency level of 100. Pre-
cursor isolationwas performedwith 1 Da selectionwindow and the
resolution was set to a nominal resolution of 35,000 (FWHM atm/z
200). MS data analysis was performed using Xcalibur software
(Thermo Fisher Scientiﬁc, Bremen, Germany).
2.6. Determination of linear range
All 39 reference compoundsweremixedwith the IS mixture at a
concentration of 500 fmol/ml. All reference compounds were
analyzed in triplicates at concentrations of 10, 25, 50, 85, 100, 500,
Table 1
Retention time (RT), product ions, linear range of reference compounds and limit of detection (LOD), limit of quantiﬁcation (LOQ) of deuterium-labeled internal standards (IS).
Eicosanoids/Docosanoids IS Lipid species RT (min) RSD (%) Precursor ion (m/z) Product ion (m/z) CE LOD* LOQ* Linear range* R2
PUFA-O3 RvD2-d5 2.94 2.4 380.3 175.09 20 0.03 0.11
PG PGE2-d9 2.75 2.7 360.3 189.14 17 0.01 0.02
RvE1 1.85 4.0 349.2 195.12 17 0.25e25 0.9952
20-OH-LTB4 1.86 4.0 351.2 195.12 17 0.05e25 0.9968
LxA5 2.55 5.4 349.2 215.15 17 0.05e25 0.9956
LxB4 2.70 4.2 351.2 221.12 þ 155.08 17 0.05e25 0.9946
PGE2 2.81 4.3 351.2 175.12 þ 207.12 17 0.05e25 0.9985
RvD2 2.96 4.3 375.2 175.09 20 0.05e25 0.9994
PGD2 3.04 3.6 351.2 233.13 17 0.05e25 0.9987
LxA4 3.20 6.1 351.2 115.05 þ 135.09 17 0.125e12.5 0.9905
RvD1 3.40 3.8 375.2 233.17 20 0.25e25 0.9953
13,14-DiH-15k-PGE2 4.02 3.5 351.2 209.12 17 0.25e25 0.993
13,14-DiH-15k-PGD2 4.88 2.8 351.2 207.11 17 0.050e25 0.9996
PUFA-O2 LTB4-d4 7.97 3.1 339.3 197.14 16 0.10 0.33
5,15-DiHETE 7.31 3.3 335.2 255.23 16 0.05e25 0.9991
17,18-DiHETE 7.67 4.0 335.2 247.17 16 0.05e25 0.9973
7-Mar1 7.77 3.5 359.2 250.15 þ 177.15 14.5 0.125e25 0.9972
LTB4 8.12 2.9 335.2 195.12 16 0.05e25 0.9993
PD1 8.38 3.8 359.2 153.11 14.5 0.05e25 0.9973
14,15-DiHETE 9.29 2.8 335.2 207.16 16 0.417e25 0.9857
12-oxo-LTB4 11.52 4.4 333.2 179.0_.2 þ 155.07 16 0.25e25 0.9844
PUFA-O1 5-HETE-d8 35.78 0.2 327.2 116.06 17 0.04 0.14
18-HEPE 26.25 3.2 317.2 255.23 17 1.25e25 0.9864
15-HEPE 32.89 2.2 317.2 219.14 17 0.417e25 0.9955
12-HEPE 34.38 0.4 317.2 179.12 17 0.05e25 0.9989
17,18-EpETE 35.33 0.1 317.2 215.16 17 0.25e25 0.9956
15-HETE 35.34 0.2 319.2 175.17 14 0.05e25 0.9965
17-HDoHE 35.47 0.3 343.2 229.15 13.5 1.25e25 0.9972
13-HDoHE 35.57 0.2 343.2 193.15 13.5 0.05e25 0.9959
10-HDoHE 35.63 0.2 343.2 153.11 13.5 0.05e25 0.9964
14-HDoHE 35.64 0.2 343.2 205.15 13.5 0.05e25 0.994
8-HETE 35.69 0.2 319.2 155.08 14 0.05e25 0.9985
12-HETE 35.70 0.2 319.2 179.13 14 0.05e25 0.998
7-HDoHE 35.74 0.2 343.2 141.07 13.5 0.05e25 0.9967
5-HETE 35.83 0.2 319.2 115.05 14 0.05e25 0.9973
4-HDoHE 35.99 0.2 343.2 101.04 13.5 0.125e25 0.9944
14,15-EET 36.14 0.2 319.2 175.17 14 0.05e25 0.9983
11,12-EET 36.37 0.2 319.2 167.13 14 0.05e25 0.998
5,6-EET 36.41 0.2 319.2 191.18 14 0.05e25 0.9973
8,9-EET 36.42 0.2 319.2 123.08 14 0.05e25 0.9953
PUFA AA-d11 37.86 0.2 314.3 270.33, 216.29 14 0.03 0.11
EPA 37.34 0.2 301.3 257.26, 203.2 11 0.05e25 0.9956
DHA 37.75 0.3 327.3 283.27, 229.23 14 0.05e25 0.9923
AA 37.87 0.2 303.2 205.21, 259.27 14 0.05e25 0.9987
* pmol on column.
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1000, 1500, 2500 and 5000 fmol/ml. The peak areas for each con-
centration was utilized for regression analysis to determine the
coefﬁcient of determination (R2) and applicable linear range
(Table 1).
2.7. Limit of detection and limit of quantiﬁcation
To estimate the limit of detection (LOD) and the limit of quan-
tiﬁcation (LOQ), PGE2-d9, RvD2-d5, LTB4-d4, 5-HETE-d8 and AA-
d11 were used as reference compounds for each PUFA group. The
standard deviation (SD) of the peak area at the lowest detectable
concentrationwas used tomodel the noise of theMCP-detector. For
the estimation of LOD and LOQ the slope of the calibration curve
was multiplied with 3xSD and 10xSD, respectively. All samples
were analyzed in triplicates. The same workﬂow was used for
extracted DMEM (250 ml) containing 10% FCS later on.
2.8. Determination of matrix effect and extraction efﬁciency
Matrix effect and extraction efﬁciency of the IS mixture
(amount: 12.5 pmol) were determined in 250 ml of DMEM con-
taining 10% FCS as described previously [15]. Sample preparation
was done as described above. The matrix effect was calculated as
the peak areas based ratio in percentage of the spiked IS post-
extraction and the pure IS. The extraction efﬁciency was deter-
mined as the peak areas based ratio in percentage of the spiked IS
pre- and post-extraction.
2.9. Tandem-MS analysis of 12-HETE and 11,12 EET
Negative mode Electrospray-(ESI)-MS2 experiments were con-
ducted on an LTQ Orbitrap hybrid instrument [29]. Lipid mediators
were diluted in methanol (250 fmoL/mL concentrations) and intro-
duced into the ion source via a syringe pump (ﬂow rate 5 mL/min).
Spray voltages were typically 2.5e3.5 kV. The ESI heater tempera-
ture was set to 50 C and the capillary temperature to 275 C. To
generate stable spray conditions, sheath and sweep gases were
used (99.999% N2). Monoisotopic precursor ion selection was
performed in the LTQ for all product ion CID experiments. MS2-
product ion experiments (collision gas He 99.999%) were per-
formed in the LTQ with a collision energy adjusted to achieve
extensive fragmentations [30,31]. Exact masses of the precursor
and product ions were measured in the Orbitrap analyzer
(R¼ 30.000, FWHM @ m/z 400), which was externally calibrated
with caffeine, trileucine, and thymopentin. All of the presented ion
structures are consistent with the experimentally determined exact
ion masses (Dm 2 ppm) and match the theoretical isotope dis-
tributions. Data acquisition was conducted with the Tune Plus and
data processing and evaluation with Qualbrowser.
2.10. Spectral comparison score (SCS) application for lipid
mediators
Each of the 36 reference compounds, excluding the three PUFAs
and the ﬁve deuterium-labeled IS, were dissolved at a concentra-
tion of 250 fmol/ml in the solvent composition according to its
retention time and applied LC-gradient. All compounds were
analyzed in direct infusion (DI) at a ﬂow rate of 10 ml/min. The
averaged MS2 spectrum was computed from 0.5min acquisition
time and three technical replicates were recorded. Peak lists were
analyzed using the software package SpeCS (Available at https://
lifs.isas.de/tools/specs). After excluding the precursor and all m/z
values not matching the fragment ion sum composition constraint
CxHyO0-5 (positive list), spectrum correlation score (SCS) were
calculated according to equation (1). The SCS from forward and
reverse spectrum-spectrum matches (SSMs) were averaged for
Fig. 3.
Pairs of AA derived isomers, 8-HETE/8,9-EET, 12-HETE/11,12-EET
and 15-HETE/14,15-EET were mixed in different ratios at an overall
concentration of 1 pmol/ml. Mixed samples were analyzed with DI-
ESI-QqTOF. Afterwards, SCS were computed using full MS2 spectra.
3. Results and discussion
3.1. Lipid extraction and characterization of the LC-MS2 approach
We established an LC-MS2 approach that can have a simpler
sample preparation procedure avoiding the time consuming SPE
enrichment step. For this purpose, an earlier described LC gradient
based on an acidiﬁed water/acetonitrile [14,16] was modiﬁed by
adding MTBE, a strong lipophilic solvent, and 2-propanol. With this
solvent composition, we could largely remove remaining mem-
brane lipids as well as neutral lipids from the column [15,26,32].
We showed recently that this strategy is applicable for complex
matrices like skin biopsies [27]. Here, we describe in detail the
chromatographic behavior using 44 reference compounds of eico-
and docosanoids (Fig. 1). We observed that the degree of oxidation,
accounted in the number of additional oxygen, results in four
distinguishable retention time windows: PUFA (36e40min), PUFA-
O1 (25e36min), PUFA-O2 (RT: 7e15min), PUFA-O3 including
prostaglandins (PG) (RT: 2e6min). For quantitation, ﬁve deuter-
ated standards were chosen that belong to one of the four RT
windows, namely: PGE2-d9, RvD2-d5, LTB4-d4, 5-HETE-d8 and AA-
d11. LODs of these deuterated standards were determined in the
range of 10e100 fmol on column (Table 1). Afterwards, each RT
speciﬁc standard compound was utilized to determine the appli-
cable quantitation range of all LMs and PUFAs with a speciﬁc focus
to utilize only fragment ions that are of highest speciﬁcity. In this
regard, we determined an acceptable linear range for most of the
molecules of around 50 fmol on column and R2 0.98 for 39
compounds of interest (Table 1).
Next, we tested the performance of the LC-MS2 method in
combination with a SPE-free extraction procedure by adding
known amounts of the deuterated standards to 250 ml of DMEM
performing the complete workﬂow. Experiments were conducted
as described previously [15]. We could achieve matrix effects of
20e30% for PGE2-d9, RvD2-d5 and LTB4-d4, which is 15e35%
better than reported for colon matrix. Extraction yields were
determined to be approx. 100% for all IS (Supplementary Table 2).
From these data we concluded that the SPE-free workﬂow and LC
gradient are suitable approaches for LM analysis and are compa-
rable to LC-QqQ based methods published previously [14,16].
We utilized a QqTOF system to perform PRM that record all
fragment ions in the range ofm/z 100e400. All MS spectra and peak
lists of the analyzed reference compounds are provided as resource
(Supplementary Data 1). Such measurements enables us, to
emulate different mass resolution and accuracy for selected tran-
sitions utilized for quantiﬁcation. When we analyzed all 44 stan-
dards, with mass accuracy of 1 Da overlapping quantiﬁer ions
within the standard compound mixture were detectable
(Supplementary Figure 1). Most prominently, one could recognize
unresolved pairs of isomeric AA derivatives, 15-HETE/14,15-EET (m/
z 319.2/175.1), 12-HETE/11,12-EET (m/z 319.2/179.1) and 8-
HETE/8,9-EET (m/z 319.2/155.1). However, if we took advantage
of the speciﬁcity of the TOF e analyzer, applying an accuracy of
500 ppm such overlaps could be clearly minimized as shown in
Fig. 1. A closer inspection of the extracted ion chromatograms and
recorded MS2 spectra points to an additional complexity that the
choice of speciﬁc fragment ions for quantitation (quantiﬁer ions)
has to be performed with sophistication. In a biological samples
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with additional matrix effects one might not be able to indepen-
dently quantify isomeric LMs because of the chromatographic and
mass spectral overlaps. For instance, one can already observe a
spectral overlap between PGE2,13,14-DiH-15kPGD2 and 13,14-DiH-
15kPGE2 for the fragment ion m/z 175.12, which is present in all
three MS2 spectra and recognizable in the extracted ion chro-
matograms (Fig. 1, Supplementary Data 1).
3.2. Tandem mass spectrometric analysis and design of spectral
library
To address such spectral overlap, which might increasingly occur
in complex biological samples, we investigated how the information
of the full MS2 spectra could increase the speciﬁcity for LM identi-
ﬁcation. First, we recorded and compared the DI-MS2 spectra of 36
lipid mediators (Supplementary Data 1). Exemplary, we discuss the
HETE and EET isomers (Fig. 2A). One can recognize that 15-HETE and
14,15-EET spectra are almost identical while 8-HETE/8,9-EET and 12-
HETE/11,12-EET exhibit recognizable differences. Although, intensive
product ions were selected as quantiﬁer, those were not always
decisive for the speciﬁcity of MS2 spectra. In this regard, the quan-
tiﬁer ions commonly used [14,15] for 8-HETE, m/z 155.1 were also
present in 8,9-EET and for 12-HETE, m/z 179.1 was present in 11,12-
EET as wells as in 8,9-EET (Fig. 2A). Just from this example, one can
acknowledge that a quantiﬁcation for a set of structurally related LMs
can be distorted by spectral and chromatographic overlaps.
Accordingly, we developed the software SpeCS to build spectral
libraries, perform spectrum comparisons and to provide a quality
control measure for quantiﬁcation. With SpeCS, peak lists can be
processed by applying several ﬁlters for intensity threshold, mass
accuracy, background signals and residual precursor signals
(Supplementary Figure 2A). During the generation of the spectral
library we recognized in a number of LMs even numbered fragment
ions, for instance for 12-HETE and 11,12EET at m/z 208.1 (Fig. 2) or
m/z 234.126 for HDoHE isomers (Fig. 4A). That was a somehow
unexpected result, because only even-electron fragment anions
were at ﬁrst anticipated from CID-MS2 with a sum composition
constraint of CxHyO0-5. Accordingly, we investigated the fragmen-
tation of 12-HETE and 11,12EET in detail using Q Exactive Plus, Q-
TOF, LTQ Orbitrap XL and LTQ XL Iontrap (Supplementary Figure 3).
A fragmentation pathway to form radical anion was reported for
8,15-diHETE and 12-HETE by Wheelan et al. following a Oxy-Cope
rearrangement [33,34]. Accordingly, we investigated how in-
tensity ratio between m/z 208.1 and 207.1 signifying energetically
very different fragmentation pathway is affected by the CID char-
acteristics of the utilized mass spectrometer. In this respect, we
observed for the Q-TOF, the highest signal intensity for the odd-
electron fragment anion m/z 208.1 (Supplementary Table 3,
Supplementary Figure 3). In contrast, ion trap CID-MS2 showed
much less signal intensity for odd-electron fragment anion. Further
Fig. 1. Representative extracted ion chromatograms of 44 lipid mediators. Negative ESI-Q-TOF-MS2 were acquired in the mass range m/z 100e400 for all indicated precursor
ions. All extracted ion chromatograms (XICs) for selected quantiﬁer ions were determined with mass accuracy of 500 ppm. PUFAs and the LM groups PUFA-O1, PUFA-O2, PUFA-O3
and PG have distinct retention time ranges. XICs of the isomeric HETE and EET derivatives are highlighted that have a spectral overlap.
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analysis of all recorded MS2 spectra showed that structural motifs
like 1,2-hydroxy-3-diene and/or 3-hydroxy-1,5-diene in close
proximity to conjugated double bonds led to odd-electron frag-
ment ions (Supplementary Figure 3, Supplementary Data 1). Eleven
out of 36 recorded lipid mediators comprised odd-electron frag-
ment ions. Accordingly, we added odd-electron fragment ions to
the positive ﬁlter, which contains all m/z values of all possible
CxHyO0-5 compositions of CID induced fragment ions.
SCS ¼ nf
N
r2s (1)
nf: number of matched peaks, N: total number of peaks in query, rs
Spearman's rank correlation. The implemented algorithm of the
SpeCS software is shown in Supplementary Figure 1B.
3.3. Design and characteristics of the spectrum comparison
algorithm
The algorithm for computing spectral comparison score (SCS) is
based on signal matching as well as comparing signal intensities
using Spearman rank correlation (equation (1), Supplementary
Figure 1B). In this way the SCS also included a metric for the
overall intensity proﬁle of matched signals that gives more weight
to intense signals. The SCS, has a well-deﬁned range, where SCS¼ 0
indicates no match and a SCS¼ 1 indicates a perfect match. As ﬁrst
test, we evaluated how stable the fragmentation proﬁle for CID-MS2
are on the Q-TOF mass spectrometer. For three independent mea-
surements, we determined an almost perfect match a spectral
comparison score SCS0.87 for all molecules (Fig. 2A), which
indicated that stable fragmentation pattern were obtained on the
Q-TOF instrument platform. For the six exemplary chosen, all
pairwise comparison were performed using the SCS algorithm,
which was in agreement with the overall similarity between
spectra, with the highest score for the comparison between 15-
HETE and 14,15-EET with SCS¼ 0.63 (Fig. 2B).
Next, we explored with DI experiments, how co-elution of such
highly similarmolecules would affect the scoring algorithm. For that,
we acquired MS2 spectra for each pair of isomers in different ratios
(Fig. 2C). The forward SSMs of 8-HETE and 12-HETE with its corre-
sponding EET isomers returned a signiﬁcantly decreased SCS for the
ratio 90:10 of 0.89 and 0.29, respectively (Fig. 2C). The corresponding
forward SSMs for 8,9-EET and 11,12-EET (ratio 10:90) resulted in
relatively small SCSvalues of 0.24 and0.486. Regarding the SSMof 15-
HETE with 14,15-EET, one can recognize that the speciﬁcity of the
scoringmechanismwas insufﬁcient, because all major abundant ions
werepresent inbothmediators andhadvery similar intensityproﬁles
(Fig. 2B). However, we concluded from this result that the score could
not beutilized to exclude thepresenceof a structurally closemolecule
but might help to recognize major contribution of speciﬁc LM as
qualitycriteria. Co-elutionof LM isomers and the resultingmixedMS2
spectrawas nearly impossible to avoid, when expanding the scope of
LM analysis [26].
Fig. 2. Spectral comparison scores (SCS) for recognition of isomeric oxidized PUFAs. (A) Full negative ESI-MS2 spectra (m/z 100e400) of the indicated AA-derivatives were
shown at a concentration of 250 fmol/ml ([M-H]-: m/z 319.2). m/z values of applied quantiﬁer ions were underlined and indicated in bold. Typical product ions were [M-H-H2O]-:
301.2; [M-H-CO2]-: 275.2; [M-H-CO2-H2O]-: 257.2; [M-H-C5H8O3]-: 203.2. The lowest spectral scores for three technical replicates is shown on top of each spectra. (B) Heat map of
averaged SCS of forward and backward spectrum comparisons. (C) The indicated pairs of isomers were mixed at the given ratio. The obtained spectral data were utilized for forward
spectra comparison of the given isomer shown in the respective panel bar.
A. Wutkowski et al. / Analytica Chimica Acta xxx (2018) 1e96
Please cite this article in press as: A. Wutkowski, et al., Software-aided quality control of parallel reaction monitoring based quantitation of lipid
mediators, Analytica Chimica Acta (2018), https://doi.org/10.1016/j.aca.2018.01.044
PhD Dissertation - Appendices 132 Navratan Bagwan
To further investigate the impact of HR-MS2 to improve speci-
ﬁcity of the LM quantitation using PRM, we compared MS2 of three
isomeric LMs 10-HDoHE, 17-HDoHE and 7-HDoHE on the Q Exac-
tive (Supplementary Figure 4). In particular, fragment ions in them/
z region of 121.04e121.14, 189.1e189.2 and 245.12e245.22 allowed
a clear differentiation between these isomers, which could not be
resolved with the Q-TOF. As result, the speciﬁcity of SCS between
the six HDoHE isomers was clearly improved using HR-MS2
reducing the average SCS of all pairwise comparisons from 0.124
(Q-TOF) to 0.081 (Q Exactive) (Fig. 3A). The improved speciﬁcity of
the SCS was a result of the fact that a mass difference of 0.036 Da is
distinguishable, which is characteristic for exchange of an oxygen
with CH4. In this way, one can unequivocally assign sum compo-
sition for all possible fragment ions within constraint of CxHyO0-5.
Therefore, a better differentiation between positional isomers for
hydroxyl groups was achieved. We further concluded that resolu-
tion of 35,000 (FWHM @m/z 200) and accuracy of 0.005 Da should
be sufﬁcient to achieve best scoring speciﬁcity.
3.4. Estimation of false discovery rates for PRM based quantitation
To gain insight into the overall performance of the scoring
approach in dependence to mass accuracy and resolution we calcu-
lated theSCSof36 reference compounds recordedontheQ-TOFandQ
Exactive, respectively. For that, a MS2 spectrum library was compiled
which was made available as a resource together with the SpeCS
software package. Subsequently, the SCS for 1260 forward and back-
ward spectrum comparisons was computed using both instrument
dependent spectral libraries (Fig. 3).We included allMS2 spectra even
when LMs comprised different precursorsm/z and had different RTs
(Fig. 3A). This strategy was motivated by the fact that the LM share
manystructural features and thedatabasis formodeling falsepositive
rates (FPRs) could be extended. In support of this concept, we
recognized several LMs with increased SCS like LxA5 (precursor ion:
m/z 349.2) and RvD1 (precursor ion:m/z 375.2) with SCS¼ 0.523 (Q-
TOF), SCS¼ 0.324 (Q Exactive) as well as LTB4 (precursor ion: m/z
335.2) and 20-HO-LTB4 (precursor ion: m/z 351.2) with SCS¼ 0.253
(Q-TOF), SCS¼ 0.081 (Q Exactive). At the same time, overall higher
SCS values were computed for LMs of the same precursors like m/z
351.2, 343.2 and 319.2 (Fig. 3A). The distribution of all pairwise SCS
values was utilized to estimate false positive rates (FPRs). For a FPR of
5%, a SCS0.14 (Q-TOF) and SCS¼ 0.07 (Q Exactive) was determined
for all SSMs. When we increased the stringency and performed an
analysis for128SSMsofLMswithprecursorm/z351.2, 343.2and319.2
a SCS0.51 (Q-TOF) and SCS 0.6 (Q Exactive)would be sufﬁcient to
reach a FPR of 1% (Fig. 3 B, C).
From these results, we concluded that the SCS could be utilized
as quality criteria to which degree a quantitation, based on a single
speciﬁc fragment ion, originated from one LM alone. We would
approximate that SCS 0.24 (Q-TOF), SCS 0.46 (Q Exactive) for
FPR: 1% indicates the presence of a structurally related LM during
quantitation. When a score of SCS 0.8 was calculated the quan-
titation was mostly likely based upon a single analyte.
3.5. Quality control of HDoHE isomers quantitation during M.
tuberculosis infection
To investigate the behavior of the SCS algorithm in a biological
application,we proﬁled DHA-derived oxidized PUFAs in the course of
M. tuberculosis infection. In this casewe recorded the full MS2 spectra
Fig. 3. SCS of oxidized PUFAs as estimator of False Discovery Rates. (A) Heat map for the averaged SCS of 36 reference compounds sorted according to their precursor m/z value
for the Q-TOF and Q Exactive data. SCS based on the Intensity threshold of 1% and a bin range of 0.1 for Q-TOF data and 0.005 for Q Exactive data were calculated for all precursor
ions, omitting different retention on the LC-column. (B), (C) Histogram of all 1260 SCS values and histogram of 128 SCS values only for spectral comparison within each precursor ion
group of m/z 319, 343 and 351 for the Q Exactive and Q-TOF data respectively.
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Fig. 4. Spectral comparison analysis of HDoHE isomers during M. tuberculosis. (A) Averaged ESI-MS2 spectra of mono-hydroxylated DHA-derivatives obtained at the RT range of
the precursor peak m/z: 343.2 acquired on the Q Exactive respectively (B) SCS were calculated for each biological replicate during time course of infection and were summarized in
the heat map. (C) Absolute quantitation of 10-HDoHE, 14-HDoHE and 17-HDoHE using the quantiﬁer m/z 153.1, m/z 193.1 and m/z 205.1, respectively. (n¼ 4e5; stars indicate
signiﬁcance in the two-tailed Mann-Whitney U Test with *, p < 0.05, **, p< 0.005).
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ontheQExactive andwewere able toquantify 10-HDoHE,13-HDoHE,
14-HDoHE and 17-HDoHE using PRM (Fig. 4A). For thesemolecules a
clear LC-separationwas impossible andRTdifferencebelow12 swere
detected. When we determined the SCS between the averaged MS2
spectra of biological replicates we retrieved scores of SCS 0.62
(Fig. 4A). By applying our score over all time points we observed that
14-HDoHEwas the most abundant LMwith a score in a range of 0.43
until 0.69. The scores indicated a high probability that similar mole-
cules were present which was in conjunction with the solely quan-
tiﬁer based result. We further noticed that the SCS for 10-HDoHE
showed increased concentrations from day 30 onwards while all
otherderivate showedno signiﬁcant changes (Fig. 4B). The changes in
the score for 10-HDoHE were in good agreement with the quantiﬁ-
cation results. As a negative control we computed SCS for 4-HDoHE,
which was below the LOQ if only the quantiﬁer ionm/z 101.036 was
considered. Accordingly, we had on average over all time points a
SCS¼ 0.07. In case of 17-HDoHE the quantiﬁcation results showed
signiﬁcant increased concentration atday30,whichwasnot reﬂected
in the score. However, concentration of 17-HDoHE at day 30was still
approximately 10 times lower than 10-HDoHE and 14-HDoHE that
had only negligible inﬂuence on the proﬁle of the mixed MS2
spectrum.
4. Conclusion
We described a SPE-free, LC-MS2 based method for the quanti-
tation of LMs and PUFAs. The combination of PRM quantitationwith
the SCS approach enabled to introduce a well-deﬁned quality
control for LM quantitation. In concert with incorporated ﬁlters for
peak list processing, we evaluated speciﬁcally how structurally
relatedmolecules and isomeric LMs could be recognized, which are
difﬁcult to separate by LC. In this study we speciﬁcally focused on
the analytical separation power of the mass spectrometer. Certain
mass spectrometric overlaps can be addressed by improving the
LC-conditions. However, we speciﬁcally wanted to investigate how
much HR-MS2 can help to improve the quality of lipid mediator
quantiﬁcation. Our approach is adjustable to different instrument
platforms and LC method and can be successively expanded in its
scope by increasing the size of the underlying spectral library. The
SpeCS software was designed in such a way that spectrum libraries
for other compound classes could be implemented. We anticipate
that this feature might support the community in building dedi-
cated spectral libraries of metabolites and will help to design and
exchange quantitation approaches based on PRM and LC-HR-MS2.
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